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CHAPTER 1 
INTRODUCTION 
1.1. Definition and detection of shock 
Shock is a complex syndrome with a wide variety of etiologic 
events. Circulatory shock can be caused by myocardial failure, 
hypovolemia (hemorrhage, excessive fluid loss), sepsis, burns or 
anaphylaxis. 
Circulatory shock remains a frequent, acute life threatening 
condition with a high mortality, despite intensive treatment (1-
7). 
Some 2000 years ago Celsus left us an admirable clinical 
description of hemorrhagic shock: "when the heart is wounded, 
much blood issues, the pulse fades away, the colour of the skin 
becomes extremely pallid, a cold and malodorous sweat suddenly 
covers the body, the extremities turn cold and death quickly 
follows" (β). 
Shock is often detected late, because circulatory disturbances 
in shock are clinically visible only to a limited extent. 
Clinical features, such as pallor, an increased pulse rate and, 
when detected, oliguria or anuria are barely specific. The 
diagnosis is usually made when there is a significant and 
persistent fall in the arterial blood pressure along with 
evidence of decreased tissue perfusion (9-11). 
During treatment of shock the commonly measured variables, such 
as heart rate, arterial blood pressure, central venous pressure 
and cardiac output, are the poorest outcome predictors (12). A 
patient in shock may have low, normal or high arterial blood 
pressure, low, normal or high blood volume, low, normal or high 
cardiac output, low, normal or high vascular resistance (13). 
Therefore, the early common physiological denominator in the 
9 
different types of shock is not (low) cardiac output, (low) 
arterial blood pressure and/or (high) peripheral resistance. It 
may thus be that in shock the wrong variables are measured and 
therapeutically corrected. 
The aim of the circulation is to deliver an adequate volume of 
oxygen at an adeguate partial pressure to replace the oxygen used 
at the terminal oxidase of the respiratory chain in the 
mitochondria. This oxygen supply is vital, as 95% of the energy 
generated by the body normally originates from aerobic pathways, 
and as the entire oxygen store of the body would support resting 
needs for maximally 5 minutes (14). Therefore, inadequate tissue 
perfusion results in inadequate oxygen transport to the 
mitochondria. In a study of the cardiorespiratory patterns of 
survivors and nonsurvivors of shock in a large series of 
critically ill patients, the best predictors were the tissue 
perfusion related variables (12). Thus, inadequate tissue 
perfusion and impaired tissue oxygenation, possibly from 
maldistribution of the blood flow, are the common denominators of 
shock (10,15-23). However, direct measurement of tissue perfusion 
and/or oxygenation still is difficult (24). 
Until now only systemic parameters such as arterial blood 
pressure, central venous pressure, pulmonary arterial pressure 
and cardiac output have been monitored. In shock these parameters 
are corrected meticulously, but the therapeutic interventions may 
actually impair tissue perfusion and tissue oxygenation. 
Attaining normal hemodynamic values may thus not be the optimal 
goal of treatment, since the compensatory bodily responses to 
stress also produce departures from the normal hemodynamic values 
(12). 
Direct monitoring of tissue perfusion and/or tissue oxygenation 
may thus provide a more sensitive method for the early detection 
of shock and for guiding treatment. But at the present time no 
clinically applicable method is available to measure tissue 
oxygenation directly. 
1.2. Shock and skeletal muscle PO y 
Correction of cardiac output and arterial oxygen tension in 
hemorrhagic shock does not necessarily ensure normal tissue 
oxygenation (25). Adequacy of tissue oxygenation cannot be 
predicted solely from measurement of arterial PO, since normal 
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values may be associated with inadequate tissue oxygen supply 
(26) . Measurement of mixed venous PO, also does not reliably 
reflect adequacy of tissue perfusion, as in sepsis mixed venous 
PO- may be elevated due to inadequate oxygen extraction in the 
microcirculation (27). In this situation oxygen consumption is 
subnormal and, despite increased arterial oxygen transport, signs 
of anaerobic metabolism and tissue hypoxia may be present (28). 
Monitoring POj in the tissue may allow early detection of a 
disturbance in tissue oxygenation and may indicate how far the 
various compensatory mechanisms have been mobilized. Experience 
with techniques for measuring tissue PO- and PCO- levels suggests 
that the measurement of skeletal muscle tissue gas tensions may 
provide an index of peripheral tissue perfusion (25-26,29-35). 
Mass spectrometry and tonometry with an implanted silicone 
rubber tube have shown that during periods of experimentally 
induced low cardiac output, tissue P0_ decreased virtually 
proportionally to decreases in cardiac output (36). In 
hemorrhagic shock, PO- in the gracilis muscle recorded 
continuously by means of a platinum multiwire surface electrode 
according to the technique of Kessler and Grunewald (37), 
decreased very early during the period of decreasing blood 
pressure (38). We have shown that in experimental hemorrhagic 
shock skeletal muscle PO-, measured with a recessed needle 
electrode, decreased early during hemorrhage before arterial 
blood pressure dropped (39). In experimental septic shock we 
found a 52% reduction in skeletal muscle PO- within 30 minutes 
after the start of an E.Coli infusion, while arterial blood 
pressure was unchanged (40-41). 
The available studies show that skeletal muscle PO- is affected 
early in developing shock and therefore assessment of skeletal 
muscle PO- in patients might be useful for early detection of 
shock. 
1.3. Skeletal muscle PO2 
Skeletal muscle PO- depends upon the balance between rate of 
oxygen delivery to tissue and rate of oxygen consumption by 
tissue (42). Each of these in turn depend upon a complex series 
of interrelated factors. Oxygen delivery to muscle depends on 
blood flow to the muscle, which in turn depends on cardiac output 
and its distribution to different organs and on the oxygen 
11 
Fig.1.1. Krogh's model of tissue oxygenation. 
Art. = arterial side. Ven. = venous side. 
R = radius of tissue cylinder 
r = radius of capillary 
content of the blood. Oxygen content of the blood depends on 
arterial P02, arterial S02 and hemoglobin concentration. The 
arterial P02 depends on the alveolar P02/ ventilation/perfusion 
ratio and pulmonary diffusing capacity. The alveolar P02 depends 
on FjC^ and alveolar ventilation. Oxygen delivery within the 
muscle depends on the condition of the microcirculation. 
Significant elements of capillary behavior are the number of open 
capillaries, the presence of noncapillary pathways from artery to 
vein (shunts) and the range of variation in type, length and flow 
pattern of the capillary bed (heterogeneity) (43). Perfusion 
heterogeneity may be present even under physiological conditions 
(43). Creation of greater than normal heterogeneity in flow or 
its distribution in the peripheral microcirculation has the 
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F i д.1.2. The influence of change in myocardial blood flow [F), myocardial 
oxygen consumption (M), oxygen content of the arterial blood 1С), 
tissue cylinder radius (.R), capillary radius (r) and Krogh's 
diffusion coefficient IK) on myocardial tissue PO у (Fig Л, p. 39 
from Rakusan, 1971). 
inevitable consequence of making tissue hypoxic (24). The final 
determinant of skeletal muscle oxygen tension is the rate at 
which oxygen leaves the capillary blood and the diffusion of 
oxygen through the tissue (44). The rate at which oxygen leaves 
the blood is a function of oxyhemoglobin dissociation curve 
(related to temperature, pH, carbon dioxide tension and 2,3-DPG 
concentration), the time required by the hemoglobin to release 
the oxygen (45) and the oxygen solubility in the plasma. Skeletal 
muscle oxygen tension is not solely dependent upon the rate of 
oxygen delivery to the tissue, but also depends upon the rate of 
oxygen consumption by the tissue. If oxygen delivery increases 
but oxygen consumption increases even more, then tissue oxygen 
tension decreases. 
Krogh developed the concept of the three-dimensional 
distribution of oxygen tension in tissue. He proposed a 
theoretical model which consists of a system of parallel 
capillaries and their surrounding cells, and developed an 
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Table 1.1. Determinants of tissue oxygen pressure 
I. Rate of delivery of oxygen to tissue: 
1. Amount of oxygen in arterial blood 
- Oxygen tension in inspired air 
- Alveolar ventilation 
- Alveolar oxygen partial pressure 
- Ventilation/perfusion ratio 
- Pulmonary diffusing capacity 
- Solubility of oxygen in plasma 
- Amount of hemoglobin 
- Arterial oxygen saturation 
- Arterial oxygen partial pressure 
2. Delivery of arterial blood to tissues 
- Cardiac output 
- Arterial blood pressure 
3. The microcirculation 
- Blood viscosity 
- Red blood cell size 
- Adherence of cellular blood components 
- Arterio-venous shunts 
- Number of open capillaries 
- Capillary radius 
- Capillary flow 
- Capillary oxygen content 
- Intercapillary distance 
4. Rate at which oxygen leaves the blood 
- Affinity of oxygen for hemoglobin 
- Rate of dissociation of oxygen from hemoglobin 
- Oxygen solubility in plasma 
II. Rate of transport of oxygen in tissue 
- Krogh's oxygen diffusion coefficient 
- Difference in oxygen partial pressure 
- Diffusion distance 
III. Rate of consumption of oxygen by tissue as influenced by 
- Work 
- Drugs 
- Hormones 
epinephrine 
cort icosteroids 
thyroxine 
insulin 
- Temperature of the tissue 
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F i д. 1.3. Determinants of tissue oxygen pressure. 
The numbers І.1-І.Ч, II and III are presented in table 1.1. 
The heart, lungs, kidneys and arteries indicate the parts of 
the circulation, which are monitored clinically 
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equation to calculate the oxygen pressure at distance χ from the 
center of a capillary with a diameter r, which supplies a tissue 
cylinder with diameter R (fig.1.1)(46). 
Rakusan showed the influence of oxygen consumption, blood flow, 
arterial oxygen content, radius of the tissue cylinder, capillary 
radius and Krogh's diffusion coefficient on myocardial tissue PO-
using the "Krogh cylinder" (fig.1.2)(47). 
Tissue oxygen pressure measurements indicate the net result of 
the simultaneous changes occurring in the factors mentioned above 
and listed in table 1.1 and fig.1.3. However, they provide no 
information as to the cause of such changes (48). 
7.4. Purpose of this study 
In medical practice the clinical condition of the patient 
still remains the most important criterion for detecting 
circulatory shock. During monitoring of a patient in shock or 
imminent shock, arterial blood pressure, heart rate and urinary 
production are routinely measured. For more extensive monitoring 
indwelling central venous catheters are required. Central venous 
pressure, pulmonary arterial blood pressure, pulmonary capillary 
wedge pressure and cardiac output can then be determined. If 
arterial and venous blood gas analysis is performed, arterial 
oxygen supply, oxygen extraction and oxygen consumption can be 
calculated. However, knowledge of these data still does not allow 
the determination of tissue oxygenation, the common denominator 
in shock (25-26,32-36,38-41). Monitoring skeletal muscle PO- thus 
might provide the earliest information about imminent shock and 
the most vital information during shock (25-26,32-36,38-41). 
In 1980 a recessed stainless steel platinum needle electrode 
(49) and a measuring unit were developed in Nijmegen. In 
experimental studies it was shown that muscle PO- assessed with 
this method decreased early during hemorrhagic and septic shock 
(39-41). In 25 healthy volunteers a median skeletal muscle PO- of 
2.6 kPa ±1.3 SD was found (41). The presence of rather low values 
of median skeletal muscle PO- assessment in healthy volunteers 
might be a major impediment to the clinical usefulness of 
skeletal muscle PO- assessment. 
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The purpose of t h i s s tudy was: 
l . t o improve the t e c h n i q u e of s k e l e t a l muscle PO- assessment 
( c h a p t e r 3) 
2 . t o e v a l u a t e t h e improved s k e l e t a l muscle PO- assessment i n 
h e a l t h y humans ( c h a p t e r 3) 
3 . t o i n v e s t i g a t e t h e cause of t h e e a r l y d e c l i n e of s k e l e t a l 
muscle PO- i n s e p t i c shock found i n p r e v i o u s exper iments (40-
4 1 ) ( c h a p t e r s 4 and 5) 
4 . t o e v a l u a t e t he u s e f u l n e s s of s k e l e t a l muscle PO- assessment 
i n mon i to r ing p a t i e n t s 
- a f t e r a s eve re burn ( c h a p t e r 6) 
- a f t e r e x t r a c o r p o r e a l c i r c u l a t i o n ( c h a p t e r 7) 
- c r i t i c a l l y i l l p a t i e n t s ( c h a p t e r s 8,9 and 10) . 
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CHAPTER 2 
MONITORING HEMODYNAMICS, OXYGEN PARTIAL PRESSURE, 
OXYGEN TRANSPORT AND OXYGEN CONSUMPTION 
IN CLINICAL PRACTICE 
2.1. Introduction 
Clinical assessment is important for the diagnosis of impending 
circulatory and respiratory failure. If circulatory or 
respiratory failure is suspected, or a patient is at risk, 
monitoring of the patient will be instituted. On the ward only 
non-invasive methods of patient monitoring are available. If the 
patient shows circulatory instability, has fluid management 
problems, or has deteriorating cardiac or pulmonary function, 
more invasive monitoring techniques are necessary and the patient 
has to be transferred to the intensive care unit. The acquisition 
of hemodynamic data "on line" in the management of the critically 
ill patient does not obviate the need for clinical assessment, 
but rather allows diagnosis and therapy to be more refined (1). 
In this chapter the various available monitoring techniques will 
be briefly discussed. 
2.2. Non-invasive methods 
2.2.1. Heart rate 
Palpation of a peripheral artery provides information about the 
heart rate, the quality of the pulse (weak, normal or strong) and 
the rhythm. Continuous registration of the electrical activity of 
the heart by the ECG enables immediate detection of arrhythmias. 
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2.2.2. Arterial blood pressure 
In most situations the sphygmomanometer accurately determines 
blood pressure. However, in some low cardiac output states pulses 
may be poorly palpable and Korotkoff sounds hard to hear, while 
the intra-arterial pressure may be only moderately reduced. 
2.2.3. Transcutaneous oxygen tension 
The purpose of transcutaneous oxygen measurement is the 
continuous monitoring of an oxygen partial pressure at the skin 
surface as an estimate of arterial oxygen tension (2,3). By local 
application of heat to the skin the capillaries and arteriovenous 
anastomoses open, and the peripheral blood flow increases to such 
an extent that the mean capillary blood PO- is practically 
identical to arterial blood PO, (2). The electrodes must be 
repositioned every two to six hours to avoid burning of the 
underlying skin. Physiologic factors such as skin circulation, 
oxygen diffusion through the skin and oxygen consumption by the 
skin as well as characteristics of the electrode such as cathode 
size, membrane material and thickness, and temperature influence 
the relationship between transcutaneously measured PO- and 
arterial P02 (2,4). 
In sick infants there is good agreement between transcutaneous 
PO- and arterial PO- (5-8), while in adults this correlation is 
not consistent (9-11). In adult patients it is generally found 
that transcutaneous PO- values are 10-20% lower than the arterial 
values (4,11). In cases of moderate or severe circulatory 
collapse this discrepancy may be greater, as the transcutaneous 
PO- then reflects the circulatory changes rather than arterial 
PO- (4,11,12). In most intensive care patients there was a wide 
intenndividual variation in the transcutaneous PO- to arterial 
PO- ratio (12,13,14). Therefore, transcutaneous PO- measurements 
can be misleading when the flow is not measured, and should not 
be carried out m these circumstances (3). However, the method 
is suitable for monitoring arterial P0_ in neonates (4-8) and as 
trend monitoring in adults with a stable circulation (13,14). 
2.2.4. Conjunctival oxygen tension 
Placement of an unheated, miniaturized oxygen electrode on the 
palpebral conjunctiva permits noninvasive measurement of tissue 
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oxygen tension (pc-,02) without the heating artefacts present with 
transcutaneous monitoring. The relationship between conjunctival 
oxygen tension and standard cardiorespiratory variables was 
examined in an experimental model with sequential hemorrhage 
(15). The P_,02 fell at an earlier point and more rapidly than 
did blood pressure (15,16) 
2.3. Invasive methods 
2 3.1. Introduction 
Invasive hemodynamic monitoring involves the placement and 
maintenance of intracardiac and intravascular catheters for the 
continuous recording of pressure and the intermittent 
determination of flow. The simplest and earliest system has been 
devised by Steven Hales, an English scientist and clergyman, who 
in 1733 first directly measured the arterial blood pressure of a 
horse. He inserted a brass tube into the carotid artery of a mare 
and connected it through the flexible trachea of a goose to a 
glass manometer tube that measured the height to which the blood 
rose. 
Nowadays, electromechanical transducers are available to 
convert the mechanical energy of a pressure wave into an 
electrical signal. The desirable features of the pressure 
recording system are fourfold: stability, sensitivity, linearity 
and adeguate frequency response The components of a pressure 
recording system are the intravascular catheter, the three-way 
stopcock, the connecting tubing, the pressure transducer and 
mtraflow device, the transducer cable, the amplifier and the 
oscilloscope in the monitor (17). 
The potential problems associated with invasive monitoring fall 
into two general categories, those related to technical pitfalls 
and those related to patient complications. An awareness of these 
problems, combined with technical expertise and an understanding 
of cardiovascular physiology, can minimize complications and make 
hemodynamic monitoring a safe and useful procedure (18). 
2.3.2. Arterial blood pressure 
Monitoring of intra-arterial blood pressure is readily 
accomplished by percutaneous insertion of an 18- or 20-gauge 
cannula into a radial, brachial or femoral artery. 
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2.3.3. Central venous pressure 
Monitoring of central venous pressure can be performed by 
introducing a catheter into the superior cavai vein. The basilic, 
brachial, femoral, subclavian and internal jugular veins are used 
as insertion sites, the latter two being preferred particularly 
by anesthesiologists and surgeons. 
2.3.4. Pulmonary arterial blood pressure, pulmonary capillary 
wedge pressure and cardiac output 
These parameters can be monitored by using a Swan-Ganz 
catheter. In experienced hands, this balloon flotation catheter 
allows for rapid and relatively safe catheterization of the 
pulmonary artery without fluoroscopy (19). Catheterization is 
performed during continuous electrocardiographic monitoring. The 
same entry sites as for placing a central venous line can be 
used. After entry into the selected vein, the catheter is 
advanced until the tip is in or near the right atrium. At this 
time the balloon is inflated to the recommended volume and the 
catheter advanced further. The catheter-tip pressure is 
continuously recorded as the catheter proceeds from the right 
atrium into the right ventricle, pulmonary artery, and finally 
into a "wedge" position. After deflating the balloon, pulmonary 
arterial blood pressure can be continuously recorded. By 
inflating the balloon, pulmonary capillary wedge pressure can be 
measured. 
The pulmonary capillary wedge pressure is of great significance 
in clinical practice, in that it provides information about two 
important determinants of cardiopulmonary function. First, the 
level of this pressure is a basic factor in the etiology of 
pulmonary congestion and in the shift of fluid from the pulmonary 
capillaries into the interstitial tissue and alveoli. Second, the 
pulmonary capillary wedge pressure closely reflects left atrial 
pressure and can, therefore, serve as an index of left 
ventricular filling pressure. 
Since the pulmonary vasculature is a low-resistance circuit, 
the pulmonary arterial end-diastolic pressure is normally only 
slightly higher than the mean pulmonary capillary wedge pressure 
and can, therefore, be used as an index of left ventricular 
filling when the pulmonary capillary wedge pressure can not be 
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obtained. However, in states associated with high pulmonary 
vascular resistance the pulmonary arterial end-diastolic pressure 
may markedly exceed the mean pulmonary capillary wedge pressure 
(20-23) . 
An easy technique for measuring cardiac output by indicator 
dilution is thermodilution. By adding a thermistor in a fourth 
lumen of the balloon catheter. Swan and Ganz developed a 
functional catheter system for measuring cardiac output entirely 
on the venous side of the circulation, i.e. from right heart 
catheterization alone. This technique employs the injection of a 
cold solution, usually NaCl 0.9% at 00C, into the right atrium 
with sampling of the temperature change as a function of time by 
a thermistor near the catheter tip in the pulmonary artery. It is 
recommended that three cardiac outputs be determined in rapid 
succession and the average value used (24,25). Repeated 
measurements can be performed at short intervals, about twice per 
minute. Triplicate cardiac output determinations have a 
reproducibility (coefficient of variation) of 4 per cent, using 
10 ml of cold injectate and a bedside computer. 
Normal central hemodynamics are characterized by a cardiac 
index (cardiac output/body surface area) of 2.5 to 3.5 1/min/m , 
mean right atrial pressure between 1 and 5 mm Hg, mean pulmonary 
capillary wedge pressure between 6 and 12 mm Hg and mean 
pulmonary arterial blood pressure between 10 and 17 mm Hg. 
Multiple complications of balloon catheterization have been 
described, such as balloon rupture, pulmonary infarction, rupture 
of the pulmonary artery, knotting, rhythm disturbances, 
thromboembolic complications and infections (26). 
2.4. Calculations for hemodynamic monitoring (25). 
The pressure and cardiac output are recorded as millimeters of 
mercury (mm Hg) and liters per minute respectively. Mean arterial 
blood pressure and mean pulmonary arterial blood pressure can be 
calculated as follows: 
S.A.P. + (2 χ D.A.P.) 
M.A.P. = ^ 
S.P.A.P. + (2 χ D.P.A.P.) 
M.P.A.P. = ^ 
M.A.P. = mean arterial blood pressure 
S.A.P. = systolic arterial blood pressure 
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D.A.P. = diastolic arterial blood pressure 
M.P.A.P. = mean pulmonary arterial blood pressure 
S.P.A.P. = systolic pulmonary arterial blood pressure 
D.P.A.P. = diastolic pulmonary arterial blood pressure 
Cardiac index is calculated as follows: 
C O . 
C . I . = B . S . A . 
.2 C.I. = cardiac index in liters/min/meter 
CO. = cardiac output in liters/min 
B.S.A. = body surface area in square meters as determined 
from height (H) and weight (W) 
The B . S . A . i s c a l c u l a t e d a c c o r d i n g t o t h e formula ( 2 7 ) : 
B.S.A. = 7 1 . 8 4 * w 0 · 4 2 5 * H 0 · 7 2 5 * 1 0 " 4 
W = kg, H = cm, B.S.A. = m2 
S t r o k e volume i s o b t a i n e d a s f o l l o w s : 
C O . 
S.V. =
 H R χ 1000 
S.V. = stroke volume in mi l l i l i ters/beat 
CO. = cardiac output in liters/min 
H.R. = heart rate during measurement of cardiac output. 
S t r o k e volume i n d e x i s d e t e r m i n e d a s f o l l o w s : 
S.V. 
2 S.V.I. = stroke index in mil l i l i ters/beat/meter 
S.V. = stroke volume in mi l l i l i ters/beat 
B.S.A. = body surface area in square meters 
L e f t and r i g h t v e n t r i c u l a r s t r o k e work a r e c a l c u l a t e d a s f o l l o w s : 
L.V.S.W. = S.V. χ Μ.A.P. χ 0 . 0 1 3 6 
R.V.S.W. = S.V. χ M.P.A.P. χ 0 . 0 1 3 6 
L.V.S.W. = le f t ventricular stroke work in grammeters/beat 
R.V.S.W. = right ventricular stroke work in grammeters/beat 
S.V. = stroke volume in ml/beat 
M.A.P. = mean arter ia l pressure in mm Hg 
M.P.A.P. = mean pulmonary arterial pressure in mm Hg 
0.0136 = conversion factor for mm Hg to metric units 
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Systemic vascular resistance is calculated as follows: 
M.A.P - C . V . P . 
χ 7 9 . 9 
5 
S.V.R. = — χ .  
S.V.R. = systemic vascular r e s i s t a n c e in dynes.sec.cm 
M.A.P. = mean a r t e r i a l pressure 
C.V.P. = c e n t r a l venous pressure 
C O . = cardiac output 
79.9 = c o r r e c t i o n factor 
P u l m o n a r y v a s c u l a r r e s i s t a n c e i s c a l c u l a t e d a s f o l l o w s : 
M.P.A.P. - P.C.W.P 
χ 79.9 
-5 
P.V.R. = ^ ^ χ 79.9 
P.V.R. = pulmonary vascular resistance in dynes.sec.cm 
M.P.A.P. = mean pulmonary arterial pressure 
P.C.W.P. = pulmonary capillary wedge pressure 
CO. = cardiac output 
79.9 = correction factor 
2.5. Oxygen transport to tissue. 
2.5.1. Blood gases 
Analysis of blood gases is a method frequently used to evaluate 
pulmonary function. Oxygen and carbon dioxide are both dissolved 
in plasma and bound directly to the hemoglobin molecule. Blood 
gas analysis involves measurement of the partial pressure of 
dissolved oxygen and carbon dioxide. P 0 2 / PC0 2 / pH, HC0 3" and 
percent saturation provide the initial parameters for assessing 
pulmonary and acid-base status in the critically ill patient. 
In a blood gas analyzer the Clark electrode is used to measure 
blood P0 2. When drawing blood for blood gas analysis, it is 
essential to ensure that the specimen is adequately 
anticoagulated. Sodium heparin can be used. Too much sodium 
heparin changes the pH of the sample to the acid side. It is 
important that no air bubbles enter the syringe. If the analysis 
cannot be performed immediately, the sample should be placed in 
ice. Blood gas analyzers are so equipped that the specimen is 
brought to a given temperature (usually 37'C) either before or 
during the analysis. P0 2 and PC0 2 vary directly with temperature 
at the following rates: 4% increase per degree centigrade for 
PC0 2 and 7 % increase per degree centigrade for PO- (2Θ). 
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Errors are possible, therefore the equipment must be accurately 
calibrated and balanced and special attention must be paid to 
acquiring the blood gas sample (29). 
2.5.2. Oxygen saturation 
The oxygen saturation of the blood is defined as the amount of 
oxygen actually bound by the hemoglobin in the erythrocytes in a 
certain volume of blood divided by the oxygen capacity, the 
maximum amount of oxygen which can be bound by the hemoglobin in 
the erythrocytes in the same volume of blood. 
The oxygen saturation of hemoglobin may be determined directly 
by optical methods or calculated from the oxygen partial 
pressure, carbon dioxide partial pressure and pH values. 
Changes in pH, carbon dioxide partial pressure and temperature 
produce well known and predictable changes in the oxygen 
dissociation curve and may be corrected for by use of a nomogram. 
However, more fundamental changes in the dissociation curve are 
produced by changes in red blood cell concentration of 2,3-
diphosphoglycerate (2,3-DPG) in critically ill patients (30-33). 
The fundamental relationship between saturation and oxygen 
partial pressure in a given patient is expressed by the oxygen 
partial pressure corresponding to 50% saturation (at pH of 7.4, 
carbon dioxide partial pressure of 5.7 kPa and temperature of 
37°C) which is abbreviated as "P50". In critically ill patients 
the P50 may vary, causing marked differences in venous oxygen 
saturation at the same PO-. This produces significant errors in 
the measurements of the arteriovenous oxygen difference and 
oxygen consumption when mixed venous saturation is not measured 
directly. The IL 282 СО-Oximeter system quickly measures THb 
(total hemoglobin), /.O^ Hb (oxyhemoglobin), %C0Hb 
(carboxyhemoglobin) and %Methb (methemoglobin). Routine sample 
volume is 350 μΐ. The IL 282 can be adapted for analyses of 
human, rat or dog blood. Utilizing 4 wavelengths of light, 
specific for each of the four derivatives of hemoglobin, the 
system accurately measures each obtainable parameter. Oxygen 
saturation values derived from oxygen partial pressure 
measurement are at best an approximation, direct measurement of 
oxygen saturation is mandatory (34). 
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2.5.3. The affinity of hemoglobin for oxygen 
The normal value of P50 is approximately 3.5 kPa. A decrease in 
the affinity of hemoglobin for oxygen, or a shift of the 
oxyhemoglobin dissociation curve to the right, is represented by 
an increase in P50, whereas an increased affinity, or a shift of 
the curve to the left, is represented by a decrease in P50. Large 
right or left shifts have little effect on arterial oxygen 
saturation, but at the level of P0_ in the capillaries, a small 
change in PO, is associated with a significant change in oxygen 
saturation (33,35). 
The P50 can be calculated from the Hill equation: 
^
0
'
 ч
 2.65ІПР О, 
:iln ( l n (l - 5 % , ) P50 = ant  "" vl  SV02
 /
 '-' 2 ) 
-2.65 
This formula is better described as follows: 
т^л n-^ / ι - s^ 0o Í 2.es-1 
P50 = Ρν02 χ ( s ^ 0 2 2 ) 
2.6. Oxygen consumption 
Continuous oxygen consumption measurement is now possible 
utilizing computerized monitoring of inspired and expired air 
samples from an air-tight rigid plastic hood enclosing the 
patient's head (36) or from the breathing circuit of mechanically 
ventilated patients (37,38). Oxygen consumption can be calculated 
using the Fick principle: Oxygen consumption = arteno-venous 
oxygen difference χ cardiac output (39). 
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2.7. Calculations of oxygen related parameters (39,40) 
Oxygen c o n c e n t r a t i o n o r oxygen c o n t e n t i s t h e c o n c e n t r a t i o n of 
oxygen i n a b lood sample, i n c l u d i n g c h e m i c a l l y bound and 
p h y s i c a l l y d i s s o l v e d О,, and c a l c u l a t e d as f o l l o w s : 
Ca02=(Hb χ 1.39 χ a r t e r i a l SO-) + (0 .0031 χ a r t e r i a l PO-) 
0^0,=(Hb χ 1.39 χ mixed venous SO-)+(0.0031 χ mixed venous P0_) 
Ca0„ = ar ter ia l oxygen content ml 0-/100 ml 
CvO. = mixed venous oxygen content ml 0-/100 ml 
Hb = Hemoglobin concentration g/100 ml = 1.6 χ mmol/l 
1.39 = Hüfner factor: The maximum amount of oxygen bound by 
1 g of hemoglobin with normal binding power. 
A theoretical value of 1.3897 ml O./g Hb is obtained; 
for practical use 1.39 ml 0,/g Hb is assumed in this 
study. 
0.0031 = 0- solubili ty coefficient (aO.): The 0- solubili ty 
coefficient indicates the volume or the amount of 0„ 
physically dissolved in a unit volume of blood at a 
given 0- part ial pressure. I t is usually expressed as 
ml 0,.ml .atm (Bunsen coefficient) 
A r t e r i o - v e n o u s oxygen d i f f e r e n c e ( Cfa-vJO- ) : 
C(a-v)02 = Ca02 - Cv02 
A r t e r i a l oxygen supply or oxygen d e l i v e r y ( DO- ) 
DO- = CaO- x c a r d i a c ou tpu t 
Oxygen a v a i l a b i l i t y of an organ = CaO, χ b lood flow t o organ 
Oxygen consumption ( a c c o r d i n g t o t h e Fick p r i n c i p l e ) ( VO- ) 
VO- = C(a-v)02 x c a r d i a c o u t p u t 
Oxygen e x t r a c t i o n r a t i o ( EO- ) : 
C ( a - v ) 0 2 
EO- Ca0 2 
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Table 2.1. Normal values of hemodynamic parameters (41). 
M.A.P. = mean arterial pressure 
C.V.P. = central venous pressure 
M.P.A.P. = mean pulmonary arterial pressure 
P.C.W.P. = pulmonary capillary wedge pressure 
C O . = cardiac output 
C.I. = cardiac index 
S.V. = stroke volume 
S.V.I. = stroke volume index 
S.V.R. = systemic vascular resistance 
P.V.R. = pulmonary vascular resistance 
R.V.S.W. = right ventricular stroke work 
L.V.S.W. = left ventricular stroke work 
85 -
1 -
10 -
6 -
5 -
2.5 -
60 -
35 -
900 -
150 -
8 -
51 -
95 
5 
17 
12 
6 
3.5 
70 
45 
mm Hg 
mm Hg 
mm Hg 
mm Hg 
1/rain 
i 1/rain/m 
ml/beat 
ml/beat 
1200 dynes.sec.cm 
25C 
12 
61 
1 dynes.sec.cm 
gm/m 
gm/m 
Table 2.2. Normal values of oxygen related parameters (41). 
Pa0 2 
PaC02 
Pv02 
PvC02 
Sa0 2 = 
S\ro2 
Ca02 
сто2 
C(a-v)0 2 = 
D02 
vo2 
P a r t i a l oxygen pressure in a r t e r i a l 
blood 
Partial carbon dioxide pressure in 
arterial blood 
Partial oxygen pressure in mixed 
venous blood 
Partial pressure of carbon dioxide 
in mixed venous blood 
Percent oxyhemoglobin saturation of 
arterial blood 
Percent oxyhemoglobin saturation of 
mixed venous blood 
Arterial oxygen content 
Mixed venous oxygen content 
Arteriovenous oxygen difference 
Arterial oxygen supply 
Oxygen consumption 
Oxygen extraction ratio 
80 • 
35 · 
41 · 
19 
14 • 
4 
550 
115 
0 
- 95 mm Hg 
40 mm Hg 
- 40 mm Hg 
- 51 mm Hg 
97% 
75% 
- 20 ml/100ml 
- 15 ml/100ml 
- 6 ml/lOOml 
- 650 ml/min/m' 
- 165 ml/min/m' 
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CHAPTER 3 
SKELETAL MUSCLE P02 ASSESSMENT 
3.1. Cenerai introduction 
Oxygen, the most vital element for humans, was discovered in 
1774 by Scheele and Priestley. The most important landmarks in 
the development of PO- measurement are the first measurement of 
oxygen, carried out by Lavoisier in 1779 (1), and the development 
of the Polarographie principle for oxygen measurement by 
Heyrovsky in 1922 (2). Because of its difficult application in 
living tissues the Heyrovsky dropping-mercury electrode was 
replaced by platinum as a cathode. In 1942 the first measurement 
of PO- in skeletal muscle was performed with a platinum wire by 
Davies and Brink (3), followed by a great number of studies on 
skeletal muscle PO- (4-18). For a recent review of the 
Polarographie determination of oxygen in biological materials we 
Φ ì-
Fig.3.1. The Polarographie principle 
le = electrode current. Ve = polarization voltage • 
r e f e r t o t he a r t i c l e by Kreuzer e t a l . ( 1 9 ) . 
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The basic principle of the Polarographie oxygen sensor is shown 
in fig.3.1 (20). 
Oxygen is reduced at the cathode surface at a certain voltage. 
The most probable reaction at the surface of the cathode is: 
02 + 2H20 + 4e" *~ 4 OH-
This is not the only possible route for the electrochemical 
reduction of oxygen (21-22). Another reaction of oxygen on 
precious metals has been described (23). 
In this chapter the different aspects of skeletal muscle PO-
assessment will be discussed. 
3.2. The electrode 
3.2.1. Introduction 
Different types of electrode have been developed for 
measurement of oxygen in tissue. The cathode surface mostly 
consists of Pt or Au. The cathode can be in direct contact with 
the medium (bare electrode), coated by a hydrophilic membrane 
(coated electrode), covered by a hydrophobic membrane (membrane-
covered electrode) or have a recess filled with fluid or solid 
material (recessed electrode). An Ag/AgCl cell is generally used 
as a reference electrode, but silver (24) and a stainless steel 
needle (25) have been used as well. 
The bare electrode was not suitable because the results were 
rarely reproducible; interfering substances are deposited on the 
electrode surface, changing its condition (19). Therefore, a 
membrane or recess had to be applied. The membrane formed by 
coating must be permeable to ions because a membrane impermeable 
to ions would electrically isolate the oxygen cathode from the 
reference electrode and would therefore interrupt the electrical 
circuit between the cathode and anode (1,19). 
In 1956 Clark introduced the principle of an entirely closed 
system where cathode, anode and electrolyte are completely 
separated from the medium by a hydrophobic membrane permeable 
only to oxygen (17,19). The multiwire surface electrode is a 
closed system for tissue PO- measurement based on the Clark 
electrode (18). 
In Nijmegen a recessed Polarographie needle electrode was 
developed recently (fig.3.2). We investigated the characteristics 
of this electrode. 
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FI д. 3.2. The recessed Polarographie needle electrode mounted In the holder 
of the micromanipulator. 
5 0 ^ m Pt 
F Ig. 3.3. Longitudinal cross section of the Polarographie PO y needle 
electrode. 
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3.2.2. Material and methods 
The electrode was constructed by electrolytically etching a 
platinum wire (purity 99.999%, diameter 50μιη) to a diameter of 
about 5 ym. The platinum wire was inserted into a glass capillary 
and subsequently the glass was melted onto the wire. Then the 
glass capillary with the platinum wire was inserted into a 
stainless steel spinal needle (Becton Dickinson, 500 pm in 
diameter, 25 gauge). The remaining space was filled with epoxy 
resin. At the other end of the stainless steel needle the Pt wire 
and the needle shaft were connected to the poles of a Lemo 
connector. The tip of the needle was ground. A two-molar KCN 
solution was used to electrochemically dissolve the Pt in the 
glass capillary to create the recess of the electrode (fig.3.3). 
The electrode was placed in a specially designed calibration 
vessel (glass-workshop. Catholic University Nijmegen) (fig.3.4). 
X 
Fig.3.4. The calibration vessel, see text. 
It is a glass vial with a small and a wide bridge between the 
two columns. In one of the columns, gas of a known oxygen partial 
pressure is dispersed. The difference in diameter of the bridges 
between the two columns causes the fluid in the calibration 
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vessel to circulate as a result of the pressure of the gas 
stream. Equilibration of the fluid with the gas mixture is 
reached within 4 minutes. To enable a sufficient circulation in 
the vessel, its volume must be at least 30 ml. The electrode is 
placed in one column, while the gas is dispersed in the other 
column. The diffusion conditions around the electrode are then 
not disturbed by air bubbles occurring near the tip of the 
electrode The temperature of the vessel is kept at 37 "C, or at 
the temperature of the tissue to be measured, by circulating 
heated water around the calibration vessel. In this way it is 
possible to determine the current in the electrode in a medium 
with a known oxygen partial pressure at the temperature of the 
tissue. The electrodes are calibrated in saline because oxygen 
partial pressure in saline is comparable with the oxygen partial 
pressure in tissue (1,13,26). 
The different characteristics of the electrode, the current-
voltage relationship, flow dependency, drift, pH influence, 
temperature influence, residual current and response time were 
studied. The "current-voltage relation", the polarogram, was 
determined by measuring the current at different voltages and 
different oxygen partial pressures. "Flow dependency" is the 
influence of flow of the medium at the tip of the electrode on 
the current at a certain oxygen partial pressure. It was studied 
in the calibration vessel by investigating the current in stirred 
and unstirred saline. The "drift" is the change of the current at 
a known oxygen partial pressure in percent per hour. It was 
tested by determination of the oxygen partial pressure-current 
relation during 4 hours. The "pH influence" was studied by adding 
phosphate buffer with different pH values to the calibration 
medium. "Temperature influence" was studied by measuring the 
oxygen partial pressure at different temperatures. The "residual 
current" is the current in a medium without oxygen. A residual 
current is caused by electrochemically active substances, by 
leakage current through the insulation between cathode and anode 
or by diffusion of oxygen from the insulation. The residual 
current is determined by measuring the current when 100% nitrogen 
is dispersed in the calibration vessel. "Response time" is the 
time an electrode needs to reach its final reading after a change 
in oxygen partial pressure; in this study the time necessary to 
reach 95% of its final reading was determined. "Calibration" is 
the determination of the relationship between oxygen partial 
pressure and current at a certain polarization voltage. "Aging" 
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is defined as an interaction at the cathode surface causing 
irreversible changes in the electrode (27). "Poisoning" is a 
rapid alteration of electrode characteristics; it can be caused 
by protein deposition on the surface of the cathode (28). 
The "PO, sensitivity" was calculated by dividing the current by 
the oxygen partial pressure (A/kPa). The "oxygen consumption" of 
the electrode was calculated on the assumption that one molecule 
of oxygen is reduced by 4 electrons. The current at 600 mV 
polarization voltage was used to calculate oxygen consumption of 
the electrode. 
The polarograms are constructed automatically with the use of a 
microcomputer. In the first series of electrodes we investigated 
all characteristics. In later studies, only the polarogram and 
the response time were measured in all electrodes. 
The criteria for accepting an electrode were as follows: 
1. A residual current of less than 20 pA 
2. At an oxygen partial pressure of 10 kPa a current of more 
than ten times the residual current. 
3. A polarogram showing an approximate plateau between 600 and 
900 mV 
All electrodes that did not fulfil these criteria were discarded. 
3.2.3. Results 
All the above mentioned characteristics were studied in the 
first series of electrodes (29). The temperature coefficient was 
2%/°C. The drift differed between the electrodes but was always 
less than 5% during the first hour. Flow dependency was less than 
2%. In the physiologic pH range (6.9-7.7) the pH influence was 
0.5% / 0.1 pH unit. 95% response time in the first series was 8.0 
- 16.0 sec. Oxygen consumption of the electrodes was 7.5 - 20 χ 
10" 1 6 Mol 02/s. The P02-sensitivity was 27.8 - 86 pA/kPa. 
In the last series of 36 carefully constructed electrodes, the 
residual current was less than 20 pA in 31 electrodes (86%). 16 
electrodes met all the criteria described above (44%). The 95% 
response time of these electrodes was 2.0 - 3.0 seconds. Flow 
dependency was less than 2.0%. The oxygen consumption by the 
electrode was 2.5 χ 10"16Mol 02/sec ±0.8 χ IO
- 1 6
 SD. The P0 2 
sensitivity was 14.9 pA/kPa ±4.8 SD. 
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3.2.4. Discussion 
The recessed needle electrode, developed in Nijmegen, meets the 
basic requirements of a PO- electrode: reproducible current for a 
given oxygen partial pressure, fast response, constant current 
during constant oxygen partial pressure, low oxygen consumption, 
easy insertion and calibration and a low residual current (1,30). 
A recessed electrode has several advantages. A linear diffusion 
field is created within the recess, less current is necessary 
after equilibrium is reached, aging and poisoning of the cathode 
are reduced, the electrode is flow-independent and the PO-
measurement is independent of the oxygen transport capacities of 
the tissue (3,12). The cathode surface is the zero PO-
equipotential and with increasing distances from the cathode, the 
equipotential surfaces increase asymptotically to 100%, 
corresponding to the initially uniform PO- of the external 
medium. The accuracy of an electrode measurement depends upon the 
ability of the recess to contain all of the PO- disturbance such 
that it extends insignificantly into the external medium. With a 
recess of 0.5 times the diameter of the cathode, 55% of the 
equipotential surface is contained entirely within the recess 
A00 600 800 
τ г 
1000 
Vpol mV 
FIд.3.5. The polarogram of an electrode 
70% oxygen, 904 nitrogen 
5% oxygen, 95% nitrogen 
0% oxygen, 1004 nitrogen 
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(31). 
The initial rise of the current seen in the polarogram 
(fig.3.5) is due to the presence of enough oxygen in relation to 
the voltage. As oxygen transport to the cathode is not limited by 
diffusion to the cathode, the current is limited by the voltage. 
After the curve levels off, the oxygen flux is limited by 
diffusion in the recess and in the calibration medium. It is 
clear that a well shaped recess is necessary for a well shaped 
polarogram. Thus the relation between measured PO, and actual PO, 
is dependent on a good recess. A small recess will influence 
measurement of POj in tissue because the measured PO, will depend 
on the diffusion characteristics of oxygen m the tissue. On the 
other hand, a very large recess will create a slow electrode. 
As changes in flow dependency and response time are 
counteracting, a fast electrode will show flow dependency. Since 
electrochemical reactions only take msec, the response time 
depends on diffusion of oxygen to the electrode. Therefore, a 
recess or membrane increases the diffusion pathway and thus slows 
the electrode. A decrease in flow dependency and in response time 
can be achieved by decreasing the cathode diameter. For this 
reason small cathodes have been proposed by several authors 
(20,32,33); the last series of electrodes had smaller cathodes 
and thus showed a decreased oxygen consumption by the electrode 
and a decreased current at a given oxygen partial pressure as 
compared to the first series. The recess could now be reduced 
without influencing flow dependency, while reducing the response 
time to 2 - 3 sec. This reduction in response time is important 
as it enables a reduction of the duration of the skeletal muscle 
PO, assessment. 
The limited influence of pH in this type of electrode was also 
found m other studies (7,12,33). A temperature influence of 
2%/0C is consistent with other studies (1,9,12,33). 
The construction of the electrode is difficult, as indicated by 
the fact that only 44% of carefully constructed electrodes met 
the requirements for accepting the electrode. 
In conclusion, appropiate testing of the electrode by 
constructing a polarogram and determination of the response time, 
is of utmost importance. The electrode must show a residual 
current of less than 20 pA and, at an oxygen partial pressure of 
10 kPa, a current of more than ten times the residual current to 
achieve a good signal/noise ratio. The polarogram must show an 
approximate plateau between 600 and 900 mV. 
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3.3. Procedure for skeletal muscle PO, assessment 
3.3 1. Introduction 
Each muscle fiber is surrounded by a thin connective tissue 
sheath, the endomysium. Muscle fibers are grouped into fasciculi, 
which are enclosed by perimysium A muscle is composed of many 
fasciculi and is surrounded by epimysium, which is closely 
associated with the fascia and is sometimes fused with it (34). 
Striated muscle is particularly well vascularized. Arteries are 
located in the perimysium and branch to form the capillaries of 
the endomysium. The capillaries form elongated loops parallel to 
the muscle fibers and have transverse branches which encircle 
individual fibers (35). 
Since there is an oxygen partial pressure field within any 
tissue, no single value of tissue oxygen partial pressure is 
representative (19). An oxygen gradient is present from the 
capillary wall to the mitochondria and this gradient decays in 
both radial and longitudinal direction. This field depends on 
intracapillary oxygen pressure, geometric arrangement, 
extracellular and intracellular diffusion coefficients, blood 
flow and its distribution, and local oxygen consumption (19) 
(chapter 1). The measured oxygen profile is the result of the 
interference of the diffusion field induced by the electrode with 
the oxygen field of the muscular tissue. 
As local tissue PO, depends on several factors and differs from 
place to place, a single measurement is not sufficient and PO-
values at different places in the tissue have to be obtained 
(19,36,37). When an electrode is inserted into the tissue and 100 
PO- values are obtained at different places, the measured PO-
values are difficult to interpret because of the unknown local 
vascular pattern. Therefore the PO- data are best represented as 
an oxygen distribution curve (36). 
Pilot studies showed that insertion of the electrode caused 
tissue compression influencing tissue PO- measurement and led to 
increasing contamination of the recess fluid by tissue substances 
(29). The pilot studies demonstrated that it is essential to 
insert the electrode 3-4 cm into the muscle and perform the 
measurement while withdrawing the electrode. For reliable PO, 
measurements a carefully prepared sensor, a stable polarization 
voltage, no leaking currents, suitable electrical shielding, and 
stable and sensitive amplifiers are necessary (38). 
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In previous experiments, one skeletal muscle PO- assessment was 
performed with 50 or 100 sequential PO2 measurements, an interval 
of 9.0 - 10.0 sec between two consecutive P0_ measurements and a 
total duration of 8-16 min for a complete skeletal muscle PO2 
assessment (39). 
For experimental and clinical research, a reduction of the 
duration of one skeletal muscle PO2 assessment was desirable. 
In an attempt to reduce the measuring time, the consequence of 
changing the interval between the skeletal muscle PO-
measurements during skeletal muscle PO2 assessment was studied. 
3.3.2. Material and methods 
Skeletal muscle PO- is measured in the quadriceps femoris 
muscle. This muscle was chosen because it is easily accessible, 
contains no vital structures, is homogeneous and allows accurate 
positioning of the electrode. In the majority of the patients and 
in the dogs used in the experiments this muscle is large enough 
for proper measurement. 
The measuring unit consists of an amplifier, a microcomputer, a 
micromanipulator and a calibration vessel (figs. 3.6-3.7). The 
amplifier fulfills the high standards necessary for a correct 
measurement. Because of the very low voltage applied to the 
electrode and the very small current that has to be measured the 
amplifier must have an excellent signal/noise ratio. Even a small 
leakage current will completely disturb the current produced by 
the reduction of oxygen. 
A microcomputer (Apple II plus) is the central unit in the 
skeletal muscle PO- assessment. The software developed guides the 
measurement, takes care of the calibration, the withdrawal of the 
needle and the registration of the measured P0 2 values. It prints 
the results instantaneously and also stores them on a floppy 
disk. A micromanipulator is used to withdraw the electrode from 
the tissue. The calibration vessel consists of three 
calibration-chambers as described in paragraph 3.2.2. 
Special attention has to be paid to the electric circuit. 
Because the measurement is made in vivo, double isolation of the 
electric circuit must be employed. Within the amplifier, the 
electric circuit of the electrode is isolated. An isolation 
transformer is used to connect all the apparatus of the measuring 
unit. The unit meets the highest standards of electric safety. 
In the normal situation the patient leakage current was 0.3 μΑ. 
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Fig.3.7. The measuring unit. 
In the case of a single faulty condition (disconnection of the 
earth lead) the leakage current was 4.9 μΑ. 
The electrode is calibrated just before every measurement to 
check the residual current and linearity. A three point 
calibration is performed in saline equilibrated with 0% Ο,, 5% 0-
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and 10% 02 at body temperature. The computer calculates the 
correction factor and checks the linearity. In the meantime the 
insertion site is prepared. The skin is desinfected with 1% 
iodine solution and locally infiltrated with Citanest 1%. The 
skin and fascia of the muscle are punctured with a 20-gauge 
Abbocath. The electrode is positioned in the vastus lateralis of 
the quadriceps femori s muscle at a depth of approximately 3 to 4 
cm and is fixed in the micromanipulator. The computer takes care 
of the measurement. The electrode is withdrawn 4 mm. The needle 
is than withdrawn stepwise and after each step of 200 ym a PO_ 
value is obtained. In this way 100 P02 values from 100 different 
places in the skeletal muscle are collected. At the end of each 
skeletal muscle P02 assessment the needle is withdrawn from the 
muscle and the Abbocath is removed. 
The data are stored on a floppy disk and the results are 
displayed or printed. From the 100 P02 values, a cumulative 
kPa 
Fig.3.8. The cumulative frequency distribution curve of the skeletal muscle 
P02 assessment of one healthy human. P20 = 1.5 kPa. median = 3.9 
kPa, P70 = S.I kPa, P90 = 6.3 kPa 
frequency distribution curve is constructed (fig.3.8). 
A P20, P50, P70, P90 and mean value are calculated. "P20" for 
instance means that 20 of the obtained values are lower or equal 
and 80 P02 values are higher than this value. The notation "P50" 
should not be confused with the P50 used in describing the 
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position of the oxyhemoglobin dissociation curve. As the P50 is 
equal to the median of 100 skeletal muscle PO- measurements, we 
will call this value the median. 
To investigate whether it was possible to reduce the duration 
of the skeletal muscle PO- assessment, intervals of different 
lengths between two consecutive PO- measurements were studied. In 
two hemodynamically stable dogs skeletal muscle PO, assessment 
was performed with intervals of 0.01, 1.0, 3.0, 5.0 and 9.0 
seconds, 4 times in one and 5 times in the other dog. The 
Wilcoxon signed rank test was used for statistical analysis. 
3.3.3. Results 
For comparing the d i f f e r e n t i n t e r v a l s , means and standard 
d e v i a t i o n s of P20, median, P70, P90 of s k e l e t a l muscle PO-
assessments are shown in t a b l e 3 . 1 . 
Table 3.1. Results of skeletal muscle PO, assessments (P20, median, P70, P90) 
in two hemodynamically stable dogs with different intervals 
(0.01-9.0 sec) between P0, measurements (nine observations for 
each interval were made). 
Interval 
0.01 sec. 
1.0 sec. 
3.0 sec. 
5.0 sec. 
9.0 sec. 
mean 
1.8 
1.4 
2.0 
1.9 
1.5 
P20 
SD 
2.7 
1.4 
1.8 
1.4 
1.2 
median 
mean 
3.9 
3.4 
4.8 
4.1 
5.1 
SD 
3.0 
1.0 
1.9 
1.4 
1.1 
mean 
5.6 
4.9 
6.4 
5.6 
6.9 
P70 
SD 
2.5 
0.9 
1.7 
1.9 
1.4 
P90 
mean 
7.6 
7.0 
7.9 
7.1 
8.7 
SD 
2.9 
1.5 
1.6 
1.8 
1.3 
The standard d e v i a t i o n of the va lues at 0 .01 sec are 
cons iderably higher than the corresponding standard d e v i a t i o n s at 
the other time i n t e r v a l s . According to Wilcoxon's s igned rank 
t e s t , the median, P70 and P90 va lues at 1.0 sec were 
s i g n i f i c a n t l y lower than the corresponding va lues at 9 .0 s ec . 
There were no s i g n i f i c a n t d i f f e r e n c e s between the P20, median, 
P70 and P90 va lues a t 3 . 0 , 5 .0 and 9 .0 s ec . In f i g . 3 . 9 the mean 
and standard d e v i a t i o n of PI to P100 of the s k e l e t a l muscle PO, 
assessments with an i n t e r v a l of 3 .0 sec are shown. 
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Fig.3.9. The mean { J and standard deviation ( ; of the PI to P100 
of the skeletal muscle PO^ assessment in the dog with an interval of 
3.0 sec. Median: 4.8 kPa ±1.9 SD. 
3.3.4. Discussion 
Several determinant factors must be taken into account to 
obtain a correct skeletal muscle P0 2 assessment. The electrode 
should be isolated from the amplifier and the measuring unit must 
have its electric supply from an isolation transformer. The 
electrode must be calibrated prior to each measurement. This 
allows a check of the electrode and the calculation of a 
correction factor. Tissue compression is avoided by withdrawal of 
the needle 4 mm, before starting the measurements. Extension of 
the tissue P0 2 disturbance induced by the electrode is diminished 
by the recess of the electrode and by using a small cathode. The 
minimal muscle thickness necessary for accurately positioning the 
electrode during the measurement is about 3-4 cm. 
A wide scatter of P0 2 values was found when the interval was 
0.01 sec. The short time available to respond probably 
contributed to the large scattering of values. As the selected 
electrodes had a response time of less than 3.0 sec, it is not 
surprising that we did not find significant differences between 
3.0, 5.0 and 9.0 sec intervals in this hemodynamically stable 
situation. The Ί.0 sec interval was too short for correctly 
measuring the tissue P0 2 as evidenced by a significant difference 
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between 1.0 sec and 9.0 sec intervals. We concluded that there 
was no difference between the 3.0 and 9.0 sec intervals during 
skeletal muscle PO, assessment in hemodynamically stable dogs. 
Therefore an interval of 3 0 sec was adopted. The duration of one 
skeletal muscle PO- assessment could thus be reduced from 16 to 5 
minutes, which is of critical importance, especially if this 
method is utilized in non-steady states. 
If the PO- values have a normal distribution, their mean and 
median are equal In this case the representation of the skeletal 
muscle PO- assessment by the mean or median would be equivalent. 
It has been shown that even under normal physiological conditions 
heterogeneity of tissue PO_ is present (40), and in pathological 
situations a maldistribution within the tissue probably occurs. 
In this case the median of the PO- values is preferable to the 
mean of the skeletal muscle PO- assessment. Therefore we 
represent the skeletal muscle PO- assessment by a cumulative 
frequency distribution curve (fig 3 8). The skeletal muscle PO-
assessment is then described by the median. In addition the P20, 
P70, and P90 can be calculated. 
The basic form of the PO- cumulative frequency distribution 
curve resembles the O- dissociation curve of the blood. This is 
demonstrated in fig.3.9. Such a cumulative frequency distribution 
curve would be produced if 0- saturation decreases linearly from 
the arterial to the venous side (37). 
3.1. Skeletal muscle PO2 assessment, regional hemodynamics and oxygen 
related parameters. 
3.4.1. Introduction 
To determine the relationship between skeletal muscle P0-
assessment, blood flow and oxygen-related parameters we studied 
the median of the skeletal muscle PO_ assessment in relation to 
cardiac output, left ventricular stroke work index, systemic 
vascular resistance, mean arterial blood pressure, flow in the 
femoral artery, arterial POo» oxygen supply, arteno-venous 
oxygen difference, oxygen consumption, oxygen extraction, oxygen 
availability to the hindlimb, arteno-venous oxygen difference in 
the hindlimb, oxygen consumption of the hindlimb, PO- in the 
gracilis vein and femoral vein, SO- in the femoral vein, mixed 
venous PO-, mixed venous SO- and lactate. 
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3.4.2. Material and methods 
Seven dogs were studied. The dogs were anesthetized with a 
continuous infusion of pentobarbital 3.5 mg.kg. .h after an 
initial intravenous pentobarbital injection of 25 mg/kg. They 
were intubated and artificially ventilated with room air. The 
aorta was cannulated via the right femoral artery with a 
polyethylene catheter for direct measurement of arterial blood 
pressure with a transducer (Statham P23Db). A Swan-Ganz catheter 
was inserted via the jugular vein using a Cordis catheter. An 
electromagnetic flowprobe (Transflow 600 Skalar) was mounted on 
the femoral artery, the femoral and gracilis vein were cannulated 
for blood sampling. The musculus gracilis was exposed for 
measurement of skeletal muscle PO-. A laparotomy was performed. 
After cannulation and preparation the animal was studied for one 
hour before starting the E.Coli shock experiment as described in 
chapters 4 and 5. During this control period the parameters were 
determined three times. Calculations were performed as described 
in chapter 2. The results were analyzed using Spearman's rank 
correlation test. 
3.4.3. Results 
Results are summarized in table 3.2. Significant correlations 
were found between the median of the skeletal muscle PO- and the 
systemic arterio-venous oxygen difference, the arterio-venous 
oxygen difference of the hindlimb, the oxygen extraction ratio, 
the SO, of the femoral vein, the mixed venous SO- and blood 
lactate levels (p<0.05) 
3.4.4. Discussion 
In the normal physiologic situation the median of the skeletal 
muscle PO- assessment correlates well with the most important 
parameters of tissue oxygenation, such as the arterio- venous 
oxygen difference, oxygen extraction ratio, oxygen saturation of 
the blood of the femoral vein, mixed venous oxygen saturation and 
lactate. Under normal physiologic conditions these parameters 
reflect the balance between oxygen supply and oxygen consumption. 
This correlation shows that skeletal muscle PO- assessment 
closely reflects the balance between oxygen supply and oxygen 
need of the tissue. 
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Table 3.2. 
Correlations (r) during the control period and p-values of 
Spearman s coefficient of rank correlation between median of 
skeletal muscle PO- assessment and other measured variables in 7 
dogs. 
(+) = significant correlation 
Cardiac output 
Left ventricular stroke work index 
Systemic vascular resistance 
Mean arterial blood pressure 
Flow femoral art. 
Arterial PO-
Arterial oxygen supply 
Arterio-venous oxygen difference 
Oxygen consumption 
Oxygen extraction ratio 
Oxygen availability hindlimb 
Arterio-venous oxygen difference hindlimb 
Oxygen consumption hindlimb 
PO- gracilis vein 
PO- femoral vein 
SO. femoral vein 
Mixed venous P0-
Mixed venous SO-
Blood lactate 
3.5. Tissue damage by the needle electrode 
3.5.1. Introduction 
The recessed Polarographie needle electrode used is large 
compared to the size of muscle cells. To evaluate the tissue 
damage induced by the Polarographie needle electrode, 
morphological examination was performed of the sites of skeletal 
muscle PO, assessment in the experiments described in chapters 4 
and 5. 
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3.5.2. Material and methods. 
In all seven dogs studied in the E.Coli septic shock 
experiment, the muscle in which the skeletal muscle PO2 
assessments took place was excised and used for microscopic 
examination. In each muscle 13 skeletal PO2 assessments had been 
performed. 
3.5.3. Results 
In 4 of the 7 dogs no macroscopic or microscopic lesions were 
observed. In 1 dog a superficial hematoma was seen. In the two 
remaining dogs only two stab channels could be discovered; these 
channels were filled with blood. 
3.5.4. Discussion 
Macroscopic and microscopic examination of the muscle in which 
the measurements were performed, showed only in 2 out of 92 
measurements a stab channel filled with blood. This shows that 
skeletal muscle PO, assessment performed with a needle electrode 
in a large skeletal muscle caused minimal tissue damage. 
3.6. Comparison between the Nijmegen needle electrode and the micro 
electrode. 
As a Polarographie needle electrode is large compared to a 
single muscle cell, a micro electrode (5pm) would be more 
suitable for measuring PO- in cells. A study was initiated in 
collaboration with Dr.Whalen (5,12) to compare his glass micro 
electrode with the Nijmegen needle electrode. Due to 
circumstances beyond our control this experiment could not be 
completed. 
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3.7. Comparison between the Nijmegen needle electrode and the multiwire 
surface electrode. 
3.7.1. Introduction 
In several clinical studies (41-45) skeletal muscle PO, was 
measured with the multiwire surface electrode (MDO) according to 
the technique of Kessler and Grunewald (18). This method does not 
invade muscle tissue, but operative exposure of the muscle is 
necessary for positioning the electrode. We compared the Nijmegen 
needle electrode with the multiwire surface electrode in an 
experimental study performed in collaboration with Dr.Spiegel and 
Prof.Dr.Hauss, Universitätsklinik Münster, West Germany. 
3.7.2. Material and methods 
The study was performed in six mongrel dogs weighing 16 -29 
kg. The anesthesia was performed as proposed by Spiegel and Hauss 
(46). Premedication 30 minutes before the experiment consisted of 
an intramuscular injection of 0.01-0.02 mg/kg atropine, 0.5 mg/kg 
droperidol and 0.01 mg/kg fentanyl. After an initial injection of 
0.7 mg/kg piritramide (dipidolor) and 0.15 mg/kg pancuronium 
(pavulon) the dogs were intubated and artificially ventilated. 
The dogs were further anesthetized with a continuous infusion of 
1.0-2.0 mg.kg" .h" piritramide and 0.08 mg.kg" .h~ pancuronium 
bromide. To obtain hemodynamic and respiratory data a Swan-Ganz 
catheter was introduced. The brachial or carotid artery was 
cannulated for arterial blood sampling and recording of the 
arterial blood pressure. The gracilis muscle was prepared on both 
sides for the skeletal muscle PO, assessment. Muscle PO, was 
measured with the MDO electrode and the needle electrode at the 
same time. The hemodynamic and respiratory data were collected. 
The mean and standard deviation of the mean of the skeletal 
muscle PO, measurements with the MDO-electrode and the mean and 
standard deviation of the median and mean of the skeletal muscle 
PO, assessment with the needle electrode were calculated within 
each dog and between the dogs. 
To test the overall correlation between the MDO electrode and 
the needle electrode, the correlation coefficient in each dog was 
computed and transformed according to the method of Hotelling 
(47) to obtain a variable with a distribution which better 
approximates a normal distribution (under the hypothesis of 
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Table 3.3. Results of the measured parameters in 6 
dogs comparing the Nijmegen needle electrode (NNE) and the 
multiwire surface electrode (MDO). 
Parameter 
Arterial P02 
Arterial PCO, 
Arterial pH 
Arterial HC03" 
Arterial BE 
Arterial SO-
Venous P02 
Venous PC02 
Venous SO, 
Hemoglobin 
0,-consumption 
Arterial Öl-
transport 
Art.-Ven.-02 
difference 
02-extraction 
ratio 
Mean MDO 
Mean NNE 
Median NNE 
Heart rate 
Systolic art. 
blood pressure 
Mean arterial 
blood pressure 
Cardiac output 
Mean pulmonary 
arterial 
blood pressure 
Stroke volume 
Left ventricular 
stroke work 
Systemic vase. 
resistance 
Pulmonary vase. 
resistance 
Temperature 
exp 
mean 
15.6 
5.3 
7.29 
18.9 
-6.8 
81.5 
6.7 
5.9 
58.6 
12.8 
191 
710 
4.1 
0.33 
9.1 
3.4 
2.4 
136 
195 
133 
4.8 
17 
37 
68 
2174 
148 
37.4 
.1 
SD 
13.0 
1.7 
0.13 
3.4 
5.1 
30.1 
2.5 
1.3 
27.5 
1.3 
75 
311 
2.0 
0.2 
12 
2.4 
1.7 
42 
39 
22 
1.1 
6 
9 
24 
436 
116 
0.5 
exp 
mean 
11.7 
5.6 
7.32 
21.7 
-3.8 
96.5 
7.5 
6.1 
83.7 
14.1 
161 
1166 
2.6 
0.13 
4.1 
4.1 
4.1 
97 
184 
132 
6.0 
12 
63 
110 
1808 
128 
36.1 
.2 
SD 
0.3 
0.1 
0.02 
1.1 
1.3 
0.4 
0.2 
0.1 
1.5 
0.3 
53 
248 
0.3 
0.01 
0.5 
1.7 
2.5 
7 
11 
10 
1.2 
1 
17 
24 
484 
58 
0.1 
exp 
mean 
11.3 
5.3 
7.35 
21.9 
-2.8 
96.2 
7.0 
5.6 
83.6 
11.9 
125 
926 
2.2 
0.13 
7.3 
2.5 
2.4 
92 
160 
121 
5.6 
12 
61 
101 
1722 
132 
37.0 
.3 
SD 
0.7 
0.5 
0.03 
1.2 
1.4 
1.8 
0.2 
0.3 
2.3 
0.4 
12 
128 
0.4 
0.02 
1.1 
1.0 
1.3 
11 
9 
9 
0.7 
2 
5 
11 
235 
27 
0.2 
exp. 
mean 
11.2 
5.9 
7.36 
25.5 
0.9 
96.5 
7.6 
6.2 
87.7 
12.7 
126 
1355 
1.6 
0.09 
6.3 
2.8 
2.7 
126 
122 
97 
7.7 
12 
62 
80 
1011 
86 
37.2 
4 
SD 
0.4 
1.6 
0.05 
8.9 
10 
0.6 
0.3 
1.5 
2.1 
0.7 
25 
274 
0.3 
0.01 
0.6 
0.8 
0.8 
14 
19 
17 
1.1 
1 
13 
15 
258 
24 
0.1 
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Continuation table 3.3. Results of the measured parameters in 6 
dogs comparing the Nijmegen needle electrode (NNE) and the 
multiwire surface electrode (MDO). 
Parameter 
Arterial P02 
Arterial PCO, 
Arterial pH 
Arterial HC03" 
Arterial BE 
Arterial S02 
Venous PO, 
Venous PCO-
Venous S02 
Hemoglobin 
0„-consumption 
Arterial Öl-
transport 
Art.-Ven.-02 
difference 
02-extraction ratio 
Mean MDO 
Mean NNE 
Median NNE 
Heart rate 
Systolic art. 
blood pressure 
Mean arterial 
blood pressure 
Cardiac output 
Mean pulmonary 
arterial 
blood pressure 
Stroke volume 
Left ventricular 
stroke work 
Systemic vase. 
resistance 
Pulmonary vase. 
resistance 
Temperature 
exp 
mean 
10.7 
5.1 
7.34 
20.8 
-3.9 
95.7 
6.7 
5.4 
80.5 
11.1 
115 
724 
2.4 
0.15 
4.2 
2.2 
1.9 
92 
170 
129 
4.8 
14 
52 
92 
2121 
171 
37.2 
.5 
SD 
0.2 
0.1 
0.02 
0.5 
0.9 
0.5 
0.2 
0.2 
3.5 
0.4 
15 
87 
0.5 
0.03 
0.8 
0.7 
1.0 
11 
16 
14 
0.6 
1 
5 
14 
203 
24 
0.1 
exp 
mean 
12.9 
5.3 
7.37 
21.9 
-2.5 
97.5 
8.2 
5.9 
90.6 
12.6 
85 
1117 
1.3 
0.07 
6.0 
2.6 
2.4 
95 
163 
111 
6.6 
14 
69 
103 
1323 
108 
37 
.6 
SD 
0.6 
0.4 
0.03 
1.3 
1.3 
0.1 
0.4 
0.3 
0.9 
0.4 
10 
65 
0.1 
0 
1.1 
0.7 
1.0 
6 
5 
6 
0.5 
1 
5 
9 
113 
21 
0.1 
all 
mean 
12.1 
5.4 
7.35 
22.3 
-2.5 
94.8 
7.4 
5.9 
82.2 
12.4 
131 
1031 
2.2 
0.14 
6.2 
2.8 
2.5 
104 
158 
117 
6.1 
13 
59 
93 
1619 
126 
37.1 
SD 
4.1 
0.9 
0.05 
4.7 
1.3 
9.9 
0.8 
0.9 
9.4 
0.7 
34 
206 
0.7 
0.07 
3.7 
1.2 
1.3 
17 
15 
13 
0.9 
3 
9 
15 
267 
44 
0.2 
independence of the two variables) than the correlation 
coefficient itself. The test for independence of the two 
variables was then based upon the sum of the Hotelling transforms 
for each of the dogs, having under the null hypothesis an 
approximately normal distribution with zero mean and variance 
equal to the number of dogs. 
3.7.3. Results 
The dogs were hemodynamically stable, except for the first dog 
which developed hypotension after severe hypoxia at the end of 
the experiment. In 6 dogs a total of 73 comparisons were made, 
7,6,17,15,13 and 15 in each dog respectively. The data of the 
experiments are summarized m table 3.3. 
No correlation between the mean of the MDO electrode and the 
mean or median of the needle electrode was found. 
3.7.4. Discussion 
The comparison between the Nijmegen needle electrode and the 
MDO-electrode showed that in this experiment the PO- measured 
with the MDO electrode on the surface of the muscle (6.2 kPa ±3.7 
SD) is different from the results of the skeletal muscle PO-
assessment with the Nijmegen needle electrode (2.θ kPa ±1.2 SD). 
In this experiment the cardiac output was high (mean 6 1/min) 
as compared to the normal value of 3.8 1/min in dogs under 
pentothal anesthesia (29,39). The oxygen extraction ratio was low 
(mean 0.13). This unusually high cardiac output and low 0-
extraction ratio probably are due to the piritramide and pavulon 
anesthesia, as in other experiments with this type of anesthesia 
a similar mean cardiac output of 5.4 1/min ±0.6 SD and a mean 
skeletal muscle PO- measured with the MDO electrode of 5.0 kPa 
were found (46); in this latter study arterio-venous oxygen 
difference was not calculated (46). 
The median of the skeletal muscle PO- assessment measured with 
the needle electrode under piritramide anesthesia was 
significantly lower than in dogs under pentothal anesthesia, 
namely 2.8 kPa ±1.2 SD versus 4.8 kPa ±1.9 SD (paragraph 3.3.3). 
In view of the considerable differences in methodology, such a 
discrepancy may not be too surprising. 
56 
3.8. Skeletal muscle PO y assessment in healthy humans. 
3.8.1. Introduction. 
The high incidence of hypoxic values found in a previous study 
of skeletal muscle PO- in healthy volunteers (39) might severely 
reduce the clinical usefulness of skeletal muscle PO- assessment 
in patients. A serious effort was made to decrease method-related 
causes for these low PO- values by optimizing the electrode 
construction, selecting the electrodes, improving the amplifier 
and electric circuit, using double isolation and an isolation 
transformer. The calibration vessel was improved and an automatic 
calibration was applied. The measuring procedure was 
computerized. The electrode was withdrawn 4 mm before starting 
the skeletal muscle PO- assessment and the interval between 
skeletal muscle PO- measurements was reduced by 66% to 3 sec, 
resulting in a reduction in the time for one skeletal muscle P0_ 
assessment from 16 to 5 min. After introducing these refinements 
of the technique we studied another series of healthy humans to 
obtain normal values for skeletal muscle P0_ assessment. 
3.Θ.2. Material and methods 
The skeletal muscle PO- assessment, as described in paragraph 
3.3.2, was performed in 31 healthy humans. We compared the 
results of the median skeletal muscle PO- assessments with a 
previous series of skeletal muscle PO- assessments (39), using 
Student's two sample t-test. 
As the P0_ measurement might be influenced by the position of 
the needle along the measuring path, we calculated the mean and 
standard deviation of the first to 100th PO- measurement of the 
31 skeletal muscle PO- assessments. 
3.Θ.3. Results 
The age of the 31 healthy humans ranged from 16 to 70 years, 
mean 37.7 years, median 29 years. The procedure was well 
tolerated by all volunteers. In one case we observed a small 
subcutaneous hematoma and in another slight bleeding through the 
cannula. In this last case the measurement was repeated. No 
further complications were observed. 
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7. 
100 
50-
кРа 
Fig.3.10. The mean and standard deviation of PI to PI00 of skeletal muscle 
PO2 assessments In 31 health)/ humans. 
Median: 1.2 kPa ±1.8 SD, ΡΊΟ: 5.5 kPa ±2.1 SD 
The mean and standard deviation of PI to P100 of the skeletal 
muscle P0 2 assessments obtained are shown in fig 3.10. The median 
values of the skeletal muscle P0 2 assessments ranged from 1.4 to 
7.6 kPa, showed a mean of 4.2 kPa and a standard deviation of 1.8 
kPa. The P70 ranged from 2.4 to 10.7 kPa, showed a mean of 5.5 
kPa and a standard deviation of 2.1 kPa. The results of the mean 
and standard deviation of the first to 100th P0 2 measurements 
are presented in fig.3.11. All the P0 2 measurements obtained in 
the 31 healthy humans are shown in one histogram (fig.3.12). The 
number of hypoxic values (£0.1 kPa) was 5% (n=165). The median 
and P70 were significantly higher in this study (4.2 kPa ±1.8 SD 
and 5.5 kPa ±2.1 SD respectively) than in a previous series of 
skeletal muscle P0 2 assessments in healthy humans (2.6 kPa ±1.3 
SD and 3.7 kPa ±1.2 SD respectively) (39) (p<0.001/ Student's two 
sample t-test). 
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F ig. 3.11. The mean and standard deviation of the first to 100th PO 2 
measurement in the skeletal muscle PO y assessment of 31 healthy 
humans. 
N 
200 -
160 -
120 -
80 -
¿0 
к Pa 
Fig.3.12. Histogram of all individual muscle POj values obtained In 31 
skeletal muscle P02 assessments Cn=3100). 
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3.Θ.4. Discussion 
In healthy humans we found an average median skeletal muscle 
PO, assessment of 4.2 kPa ±18 SD. This result agrees with that 
of Kunze, who found a mean value of 5.1 kPa ±0.9 SD in the 
m.tibialis anterior (48), and with the results of Nunikoski (49) 
who measured muscle PO, by means of an implanted Silastic tube 
and found a mean value of 4.1 kPa ±0 7 SD. Lund, using a MDO 
electrode, found a lower value of 2.02 kPa ±0.51 SD in healthy 
volunteers (50). 
The significantly higher average median skeletal muscle PO-
assessment in these humans (4.2 kPa ±1.8 SD) compared with a 
previous series of healthy humans (2.6 kPa ±1.3 SD)(39) and the 
difference in the range between this series (1.4 -7.6 kPa) and 
the previous series (0.3 - 5.7) can be explained by the 
refinements in technique mentioned above. 
3.9. Conclusion 
Skeletal muscle PO- assessment, performed as described m this 
chapter, reflects the balance between oxygen supply and oxygen 
demand in the tissue, because the median of skeletal muscle PO-
assessment correlated with important parameters of tissue 
oxygenation such as arteno-venous oxygen difference, oxygen 
extraction ratio, SO, of the femoral vein, mixed venous SO, and 
blood lactate level. Thus this method may be useful to measure 
alterations in skeletal muscle oxygenation. We have shown that if 
skeletal muscle PO, assesment is meticulously performed, the 
average median skeletal muscle PO, assessment was 4.2 kPa ±1.8 SD 
and the median skeletal muscle PO, assessment ranged from 1.4 kPa 
to 7.6 kPa in healthy humans. No significant complications were 
seen in the human volunteers due to the procedure. Therefore this 
method might enable detection of disturbances of skeletal muscle 
PO, in patients. 
As has been demonstrated m chapters 1 and 3 skeletal muscle 
PO, differs from place to place in the tissue, therefore 100 
different skeletal muscle PO, measurements are performed during 
one skeletal muscle PO, assessment. In the forthcoming chapters 
"skeletal muscle PO," refers to the median of the 100 skeletal 
muscle PO, values obtained during one skeletal muscle PO, 
assessment. 
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CHAPTER it 
REGIONAL HEMODYNAMIC CHANCES DURING THE ONSET OF 
E.COLI SEPSIS 
4.1. Introduction 
Patients with bacteremia develop bacterial shock in 23 - 62% of 
cases (1-8). This clinical condition is characterized by an 
acute, life-threatening circulatory insufficiency. Mortality rate 
still is 30% (9,10) despite new drugs and methods of treatment. 
Therefore, early detection of septic shock and further studies 
into the underlying mechanisms of septic shock are mandatory. 
Previous studies in experimental E.Coli shock have shown a 
decline of skeletal muscle PO, before arterial blood pressure 
dropped (11). This early decline of skeletal muscle PO, may have 
been caused by a decrease in blood flow to the skeletal muscle 
due to a decrease in cardiac output, or by redistribution of 
blood flow in favor of other organs. As in sepsis, contradictory 
results have been reported on blood flow to skeletal muscle (12-
15) as well as on blood flow to other organs (16-20), we studied 
the relationship between cardiac output and blood flow to 
skeletal muscle, liver, kidney and intestines during the onset of 
septic shock. 
4 . 2 . Material and methods 
Seven labrador dogs, weighing 15 - 29 kg, were studied. The 
dogs underwent a splenectomy 3 weeks before the experiment to 
prevent hemodynamic changes due to splenic autotransfusion (21-
24). The dogs were anesthetized with a continuous infusion of 
pentobarbital 3.5 mg.kg" .h~ after an initial intravenous 
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pentobarbital injection of 25 mg.kg" (25). The dogs were 
intubated and artificially ventilated with room air. The 
abdominal aorta was cannulated via the right femoral artery with 
a polyethylene catheter to allow direct measurement of arterial 
blood pressure with a transducer (Statham P23Db). A Swan-Ganz 
catheter was inserted into the pulmonary artery via the jugular 
vein, using a Cordis catheter, for measurement of cardiac output, 
pulmonary arterial pressure, central venous pressure and 
pulmonary capillary wedge pressure. A midline laparotomy was 
performed. In-vivo calibrated perivascular flow sensors of 
suitable size, connected to a sine-wave electromagnetic flowmeter 
(Transflow 600 Skalar), were mounted on the common hepatic 
artery, celiac artery, superior mesenteric artery and left renal 
artery. To obtain zero flow calibration an occluding device was 
placed around each artery about 5 mm distal to the flow sensor. 
In the left inguinal region the femoral artery was exposed and an 
electromagnetic flow sensor was mounted on the femoral artery. 
After cannulation and preparation the animal was allowed to 
stabilize for one hour. Thereafter an infusion of E.Coli 
bacteria (Hinshaw strain B7) (10 bacteria Kg /2h) was started 
into the superior cavai vein. The 4 flow signals and 4 pressure 
signals and heart rate were recorded on a pen-writer (Schwarzer 
Physioscript U 8000). Flow and pressure signals were converted 
from analog to digital (sample rate = 200 points/s) by a PDP 
11/04 and processed by a program to obtain mean flow and mean 
pressure values for every 4 heart beats. 
Sampling was performed 1, 3, 5, 10, 15, 30, 45, 60, 90 and 120 
min after the start of the E.Coli infusion. At sampling times, 
except at 1 and 3 minutes, cardiac output was measured by the 
thermodilution method (26). Calculations were performed according 
to standard formulas (chapter 2). Portal venous blood flow was 
calculated as follows: flow portal vein = flow celiac artery + 
flow superior mesenteric artery - flow hepatic artery. During 
the study the dogs received an intravenous infusion of NaCl 0.9% 
3-5 ml.kg"1.!!"1. 
Differences between t=0 and 3,5,10,15,30,45 and 60 min after 
the start of the E.Coli infusion were tested by Student's t-test 
for paired observations. Values are given as mean and SEM. 
Differences were considered significant if p<0.005, because for 
each variable seven Student t-tests had been applied. 
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4.J. Results 
The results are summarized in tables 4.1 and 4.2 and in figures 
Table 4.1. Hepatic vascular resistance after the start of E.Coli infusion. 
nr. 
1 
2. 
3. 
4. 
5. 
6. 
7. 
A 
650% 
600% 
400% 
300% 
300% 
400% 
200% 
В 
10 
3 
15 
10 
15 
3 
3 
С 
30 
15 
45 
60 
30 
60 
30 
D 
19% 
38% 
55% 
42% 
17% 
37% 
23% 
A: maximal increase of hepatic vascular resistance. 
B: time (rain) after the E.Coli infusion at which maximal increase occurred. 
C: time (rain) after the E.Coli infusion at which the resistance returned to 
the initial value. 
D: percentage of leucocyte count at the time of maximal increase of hepatic 
vascular resistance compared to the control period. 
Nr:number of the experiment 
4.1, 4.2 and 4.3. 
Within 3 minutes after the start of the E.Coli infusion the 
flow in the common hepatic artery, celiac artery and portal vein 
decreased significantly. The hepatic arterial vascular resistance 
increased 200-650% compared to the control period. 
No significant difference of the hepatic .vascular resistance 
was found using the Student t-test because the maximal increase 
persisted for only a few minutes. Additionally the time after the 
start of E.Coli infusion at which the resistance increased 
maximally, differed between the individual experiments. In table 
4.1 it is shown that at the time of maximal increase of hepatic 
vascular resistance, a 45 - 83% fall in leucocyte count occurred. 
Within 5 minutes the leucocyte count dropped from 5.9 χ 109/1 
±1.2 SD to 2.6 χ 109/1 ±1.0 SD (56%, p<0.001). In the same 
period cardiac output and left and right ventricular stroke work 
index decreased significantly. During the first 5 minutes after 
the start of the E.Coli infusion systolic arterial blood 
pressure, mean arterial blood pressure and mean pulmonary 
arterial blood pressure hardly changed, so systemic and pulmonary 
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Table 4.2. 
Parameter 
Significant changes (p<0.005)(X) during the first 60 min aftetthe 
the start of E.Coli infusion (t=0) (7 experiments). 
Student's paired sample t-test 
0 3 5 10 15 30 60 
(min) 
Heart rate 
Systolic arterial blood pressure 
Mean arterial blood pressure 
Mean pulmonary arterial blood pressure 
Systemic vascular resistance (*) 
Pulmonary vascular resistance (*) 
Cardiac output (*) X-
Left ventricular stroke work index (*) X-
Right ventricular stroke work index (*) X-
Pulmonary capillary wedge pressure (*) 
Central venous pressure (*) 
Blood flow superior mesenteric artery 
Blood flow celiac artery 
Blood flow hepatic artery 
Blood flow portal vein 
Blood flow femoral artery 
Blood flow renal artery 
Vascular resistance liver 
Vascular resistance kidney 
Vascular resistance hindlimb 
Leucocyte count (*) X X-
X X 
χ X 
χ X 
X 
-X 
-X X-
-X X-
--X 
--X 
X-
X-
X-
• X — 
-X— 
-X--
- - X — 
— X - - -
--X 
-X 
-X 
-X 
X 
X 
Note: (*): The first measurement was at 5 min after the start of 
the E.Coli infusion. 
vascular resistance increased concurrently, but the rise was not 
as pronounced as the rise in hepatic vascular resistance. 
After 15 minutes blood flow in the common hepatic artery 
recovered to nearly normal levels. On the other hand arterial 
blood pressure decreased progressively, and was significantly 
reduced 30 min after the start of the E.Coli infusion. Shock, 
defined as a systolic arterial blood pressure below 90 mm Hg, was 
present in 2 out of 7 dogs at 30 minutes and in б out of 7 dogs 
at 45 minutes. 
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H e a r t r a t e -
( beats / m m ) 
250 
2 0 0 
150-
-Cardiac o u t p u t · 
( l / m i n ) 
4 5 
35 
2 5 
15-
A r t e r i a l pressure ( mir 
200-
150 
100-
50H 
H g ) Mean p u l m o n a r y a r t pressure ( m m Hg ) 
25-1 
15-
5-
Systemic vascular resistance 
(dynes.sec" 1 c m ' 5 ) 
8 0 0 0 
P u l m o n a r y vascular resistance 
(dynes sec-1· c m " 5 ) 
Left ventricular stroke work index 
( G m . / m*) 
100 
5 0 
Right ventricular stroke work index 
( G m /• т г ) 
6-
V. i-t ь 
Pulmonary cap.llary wedge pressure 
( m m Hg ) 
20 \ 
io-
C e n t r a l venous pressure 
( mm Hg ) 
154 
10 
5 
-60 -30 30 60 9 0 120 -60 -30 30 6 0 9 0 120 
t i m e ( m i n ) 
Fig.1.1. Hemodynamic data, E .Coli sepsis in 7 experiments. 
Values are mean and sem. 
At t=0: Start of E .Coll Infusion. 
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Mean arterial pressure (mm Hg ) 
- Cardiac output • 
( l / m m ) 
Blood flow superior mesenteric artery Blood flow celiac artery ( m l / m m ) (ml/mm ) 
бООН 
Blood flow hepatic artery 
( ml/mm ) 
400 
300 
200 
100 
Blood flow femoral artery 
( ml /mm ) 
80-
Blood flow portal vein ( ml /mm ) 
700 
5 0 0 
3 0 0 
Blood flow renal artery ( ml /mm ) 
400 ] 
1
—
i
—Un i I f 
-60 -30 30 60 90 120 -60 -30 30 60 90 120 
time ( mm ) 
Fig.U.2. Mean arterial blood pressure and blood flow, E.Coll sepsis 
In 7 experiments. 
Values are mean and sem. 
At t=0: Start of E.Coll Infusion. 
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Meon a r t e r i o l pressure-
С mmHg ) 
150-
100-
50 
Pulmonary vascular resistance 
(dynes sec-'.crrrs) 
1000 
6 0 0 
200 
Vascular resistance hmdlimb ( dynes-sec"1· cm-» ) 
1000-
х 1 0 э 
600-
200 - -Л 
M 
-Systemic vascular resistance-(dynes.sec'.cm-» ) 
θ 0 0 0 
6 0 0 0 
4000 
2000 
-60 -ЭО 30 60 90 120 
Vascular resistance liver, arterial 
( dynes.sec"1· cm -») 
400 
Vascular resistance kidney ( dynes.sec1 cm"» ) 
80 
xlO 3 
60-
40-
20 
-60 -30 30 60 9 0 120 
time (min) 
Leucocytes -(counts/ I ) 
10-
«10» 
5-
Flg.4.3. Mean arterial blood pressure, vascular resistance of different 
organs and leucocyte count, E .Coll sepsis In 7 experiments. 
Values are mean and sem. 
At t=0: Start of E .Coll infusion. 
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The flow m the femoral artery had already decreased during the 
control period, a further significant decrease in femoral artery 
blood flow was seen 60 min after the start of the E Coli 
infusion. After 30 min in some dogs the blood flow to the 
hindlimb was almost zero, therefore mean vascular resistance 
could not be calculated from that time. Systemic vascular 
resistance was significantly reduced 60 min after the start of 
the E.Coli infusion. 
The blood flow in the renal artery remained unchanged during 
the first 60 minutes, while the resistance of the renal vascular 
bed decreased in parallel with arterial blood pressure. Heart 
rate, central venous pressure and pulmonary capillary wedge 
pressure did not change during the experiment. 
4.4. Discussion 
After the onset of the E.Coli infusion marked changes occurred 
in the blood flow to several organs. 
After the start of the E.Coli infusion the reduction of blood 
flow to skeletal muscle corresponded with the fall m systolic 
arterial blood pressure. The flow to skeletal muscle decreased 
less than would be expected if blood flow were solely responsible 
for the reduction of skeletal muscle PO- found in previous 
experiments (11). The decline of blood flow to the skeletal 
muscle could therefore only partially explain this early 
reduction of skeletal muscle PO-. In chapter 5 the relationship 
between skeletal muscle PO- and oxygen supply, oxygen 
availability, oxygen extraction ratio and oxygen consumption 
found in this experiment will be presented. 
While renal arterial blood flow did not change at all and 
cardiac output, hepatic arterial blood flow and superior 
mesenteric arterial blood flow recovered after an initial 
decline, a consistent fall m femoral arterial blood flow was 
found. Thus during E.Coli septic shock redistribution of blood 
flow to the vital organs occurred at the cost of the blood flow 
to skeletal muscle. 
In sepsis a decreased blood flow to skeletal muscle has been 
found by other authors using venous outflow measurements (27-31). 
Others, using microsphere techniques, found an increased blood 
flow during sepsis (13,32-34). These contradictory results are 
possibly related to the technique of measurement used. Direct 
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measurement of muscular flow by electromagnetic flow probes or 
venous outflow measurements consistently showed a decreased 
blood flow to skeletal muscle, whereas indirect techniques using 
microspheres showed an increased blood flow 
In this study the most pronounced change was a fall in hepatic 
arterial blood flow by more than 80% of the initial value within 
3 minutes after the start of E.Coli infusion. Similar results 
were found in non-splenectomized baboons (35). The early 
decrease m hepatic arterial blood flow was also found by Asher 
et al. (36). Other investigators have not found an early decline 
in blood flow to the liver (37). 
Increase in vascular resistance is mainly seen in the vascular 
bed of the liver and may be caused by obstruction or constriction 
of the arterioles of the hepatic arterial bed. Obstruction of 
the vascular bed may be due to aggregates of cells and such 
microemboli can be demonstrated by cinephotomicrography to lodge 
in the portal and pulmonary microcirculation during an early and 
terminal phase in endotoxin shock (38). These microemboli can be 
seen 5 min after injection of endotoxin, but disappear after 
10-15 m m (38). Aggregates of leucocytes, especially 
polymorphonuclear leucocytes, have been demonstrated in the 
capillaries of the lung (39-40) and m the liver (38-44) but not 
in skeletal muscle (40). These findings suggest that aggregation 
of leucocytes may play a role in the hemodynamic changes found 
during early sepsis. 
Within 5 minutes after the start of the E.Coli infusion, the 
leucocyte count decreased by 56%. This early leucopenia is a 
consistent finding in experimental infusion of live E.Coli 
(11,22), E.Coli endotoxin (45), or complement-activated plasma 
(39). Aggregation of these leucocytes in the hepatic arterial 
vascular bed might be the cause of the rapid rise m the hepatic 
vascular resistance. The fall in vascular resistance might be 
explained by disintegration of aggregates and/or vasodilatation. 
The progressive decline in cardiac output and arterial blood 
pressure found in this study under the influence of live E.Coli 
infusion agrees with other studies (21-24). Myocardial function 
was depressed within 5 minutes after the onset of E.Coli sepsis 
as indicated by a significant decrease in left ventricular stroke 
work index (46). 
The blood flow to the kidney remained constant despite a 
decrease m arterial blood pressure. Only the kidney apparently 
was able to maintain blood flow by autoregulation of its vascular 
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r e s i s t a n c e . In an E .Col i endotox in shock exper iment i n monkeys, 
no marked f a l l i n r e n a l a r t e r i a l b lood flow occu r r ed , d e s p i t e a 
d e c l i n e i n a r t e r i a l b lood p r e s s u r e ( 4 7 ) . In o t h e r endotox in shock 
exper iments t h e flow t o t h e kidney dec rea sed by 69% ( 1 2 ) . 
In c o n c l u s i o n , t h e r e s u l t s of t h i s s tudy sugges t t h a t t he 
sys temic hemodynamic changes d u r i n g the i n f u s i o n of E .Col i a r e 
t h e r e s u l t of p r o c e s s e s a t t he m i c r o c i r c u l a t o r y l e v e l , p o s s i b l y 
induced by a c t i v a t e d l e u c o c y t e s . F u r t h e r s t u d i e s a r e n e c e s s a r y t o 
e l u c i d a t e t h e u n d e r l y i n g p r o c e s s e s l e a d i n g t o s e p t i c shock. 
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CHAPTER 5 
ALTERATIONS IN OXYGEN PARTIAL PRESSURE, OXYGEN 
AVAILABILITY, OXYGEN EXTRACTION AND OXYGEN 
CONSUMPTION DURING THE ONSET OF E .COLI SEPSIS 
5.1. Introduction 
Previous studies in an E.Coli septic shock experiment have 
shown an early reduction in skeletal muscle PO- before systolic 
arterial blood pressure decreased (1). Skeletal muscle PO2 is 
determined by oxygen availability, PO- in the capillary, affinity 
of hemoglobin for oxygen, capillary surface area available for 
exchange of oxygen, diffusion coefficient of the muscle tissue, 
diffusion distance from the capillary to the cell, and oxygen 
consumption (2)(chapter 1). 
A reduction in skeletal muscle PO- might be caused by a 
decrease in arterial oxygen content, a decrease in arterial blood 
flow, an increase in affinity of hemoglobin for oxygen, an 
increase in diffusion distance from the capillary to the 
mitochondria, a decreased diffusion coefficient for oxygen and/or 
an increase in oxygen consumption. 
To study the cause of the early decline of skeletal muscle P0-
in E.Coli sepsis we measured blood flow to the skeletal muscle, 
P0_ and SO- in the arterial and venous blood of the skeletal 
muscle and skeletal muscle PO- in anesthetized dogs. We 
calculated oxygen availability, oxygen extraction ratio, oxygen 
consumption and affinity of hemoglobin for oxygen. As differences 
in the oxygen availability, oxygen extraction ratio and oxygen 
consumption between different organs might occur, we 
simultaneously studied oxygen supply and oxygen availability, 
oxygen extraction ratio, oxygen consumption and venous PO- and 
SO- in liver, kidney and intestines. 
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5.2. Material and methods 
Seven labrador dogs, weighing 15 - 29 kg, were studied. They 
underwent a splenectomy 3 weeks before the experiment to prevent 
hemodynamic changes due to splenic autotransfusion (3-6). The 
dogs were anesthetized with a continuous infusion of 
pentobarbital 3.5 mg.kg .h after an initial intravenous 
pentobarbital injection of 25 mg/kg (7). The dogs were intubated 
and artificially ventilated with room air. The abdominal aorta 
was cannulated via the right femoral artery for blood sampling. A 
Swan-Ganz catheter was inserted into the pulmonary artery for 
mixed venous blood sampling. A laparotomy was performed. In-vivo 
calibrated peri-vascular flow sensors of suitable size, connected 
to a sine-wave electromagnetic flowmeter (Transflow 600 Skalar), 
were mounted on the common hepatic artery, celiac artery, 
superior mesenteric artery and renal artery. To obtain zero flow 
calibration an occluding device was placed around the artery 
about 5 mm distal to the flow sensor. The common hepatic vein, 
the portal vein and the renal vein were cannulated for venous 
blood sampling. In the left inguinal region the femoral artery 
and femoral vein were exposed and an electromagnetic flow sensor 
was mounted on the femoral artery. The femoral vein was 
cannulated for venous blood sampling. The gracilis muscle was 
prepared for measurement of skeletal muscle PO- with a 
Polarographie needle electrode. The electrode was calibrated 
before each measurement, inserted in the gracilis muscle and, 
using a micromanipulator, the needle was withdrawn in 100 steps 
of 200 vim. In this way one hundred PO, values were obtained. The 
skeletal muscle PO- assessment is represented by the median 
(paragraph 3.3) The animal was allowed to stabilize for one 
hour. Thereafter an infusion of E.Coli bacteria (Hinshaw strain 
Б7) (10 bacteria kg /2h) was started into the superior cavai 
vein. Sampling was performed 1, 3, 5, 10, 15, 30, 45, 60, 90 and 
120 min after the start of the E.Coli infusion. The 4 flow 
signals were recorded on a pen-writer (Schwarzer Physioscript U 
8000). Flow signals were converted from analog to digital (sample 
rate = 200 points/s) by a PDP 11/04 and processed by a program to 
obtain a mean flow value for every 4 heart beats. Blood sampling 
from the abdominal aorta, the pulmonary artery, portal vein, 
hepatic vein, renal vein and femoral vein was performed at the 
times mentioned above. Except for 1 and 3 minutes after the start 
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of the E.Coli infusion, measurements of cardiac output by the 
thermodilution method, skeletal muscle PO, and leucocyte count 
were performed as well. 
Blood gas determinations were performed with a Corning 178 
analyser using 0.1 ml samples. Oxygen saturation was directly 
measured with an IL 262 oximeter; corrections for canine blood 
were made (β) . 
Calculations were performed according to standard formulas 
(chapter 2). During the study the dogs received an intravenous 
infusion of NaCl 0.9% 3-5 ml.kg"1.h-1. 
Differences between t=0 and the sampling times after the start 
of the E.Coli infusion were tested by Student's t-test for paired 
observations. Values are given as mean + SEM. Differences were 
considered significant if p-value was below 0.005, because for 
each variable seven Student t-tests had been applied. 
5.3. Results 
The results of the experiments are summarized in table 5.1 and 
figures 5.1 to 5.5. 
Within 3 minutes after the start of the E.Coli infusion oxygen 
availability to the liver and oxygen consumption by the liver 
decreased. Within 5 min the arterial oxygen supply to the total 
body decreased as well. Five min after the start of the E.Coli 
infusion, the first time the leucocyte count was obtained, 56% of 
the leucocytes had disappeared from the peripheral blood. Within 
15 min the mixed venous SO-, femoral vein PO-, and femoral vein 
SO- decreased, while the P50 of the oxyhemoglobin dissociation 
curve, the oxygen extraction of the body and oxygen extraction 
of the hindlimb increased. At that time the dogs became acidotic 
as shown by a significant decrease of arterial pH and arterial 
base excess. Between 15 and 30 minutes after the start of the 
E.Coli infusion the oxygen availability to the liver returned to 
a nearly normal level, while the hepatic oxygen consumption 
returned to a level slightly higher than before the infusion of 
E.Coli. Thirty min after the start of the bacterial infusion the 
oxygen saturation in the hepatic vein and portal vein were 
significantly reduced. At that time the PO- of the renal vein 
was significantly higher than before the start of the E.Coli 
infusion. Oxygen availability to the hindlimb decreased during 
the control period and even more after the start of the E.Coli 
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Table 5.1. Significant changes (p<0.005)(X) during the first 
60 min after the start of E.Coli infusion (t=0) 
(7 experiments). Student's paired sample t-test. 
Parameter 0 3 5 10 15 30 60(min) 
Arterial PO, 
Arterial SO, X 
Mixed venous PO, 
Mixed venous SO, X X X 
PO, femoral vein X X 
S0 2 femoral vein X X X 
PO, gracilis vein 
SO, gracilis vein X X 
P0 2 renal vein X -X 
SO, renal vein 
PO, hepatic vein 
SO, hepatic vein X X 
PO, portal vein 
SO, portal vein X X 
P50 oxygen dissociation curve X X X 
Skeletal muscle PO, (*) 
Oxygen supply (*) X X---X X X 
Oxygen availability hindlimb X X 
Oxygen availability kidney 
Oxygen availability liver (arterial) X--X X 
Oxygen availability intestines 
Oxygen extraction total body (*) X X X 
Oxygen extraction hindlimb X X X 
Oxygen extraction kidney 
Oxygen extraction liver 
Oxygen extraction intestines 
Oxygen consumption total body (*) 
Oxygen consumption hindlimb 
Oxygen consumption kidney 
Oxygen consumption liver (arterial) X--X X 
Oxygen consumption intestines 
Hemoglobin X X 
Leucocyte count (*) X X χ χ 
Arterial pH X χ -χ 
Arterial base excess X χ χ 
Lactate (mixed venous) 
Pyruvate (mixed venous) X--X 
Note: (*) These parameters were first measured 5 min after the 
start of the E.Coli infusion. 
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Fig.5.1. Oxygen partial pressure, E.Coli sepsis In 7 experiments. 
At t=0: start of E.Coli infusion. 
Values given are mean and sem. 
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Fig.5.2. Oxygen supply and oxygen availability, 
E .Coli sepsis in 7 experiments. 
At t=0: start of E .Coli infusion. 
Values given are mean and sem. 
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Fig.5.3. Oxygen extraction, E.Coli sepsis in 7 experiments. 
At t=0: start of E.Coli infusion. 
Values given are mean and sem. 
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Fig.SA. Oxygen consumption, E .Coll sepsis in 7 experiments. 
At t=0: start of E .Coli infusion. 
Values given are mean and sem. 
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Values given are mean and sem. 
87 
infusion. Pyruvate increased significantly after 45 minutes. Only 
after 60 min did arterial oxygen saturation decrease 
significantly. 
Mixed venous lactate levels increased slightly during the 
course of the experiment. The rate of increase was greater after 
starting the infusion of the bacteria. Although not significant, 
mixed venous PO,, PO, of the hepatic vein and the oxygen 
availability to the intestines showed a slight decline after the 
onset of E.Coli sepsis, with a maximum at 15 minutes and a 
recovery thereafter. The skeletal muscle PO, showed a decrease 5 
minutes after the onset of E.Coli sepsis (t=0 2.3 kPa ±0.5 SEM, 5 
min later 1.1 kPa ±0.5 SEM). Arterial P02 and S02 of the renal 
venous blood, PO, of the portal blood and the oxygen availability 
of the kidney showed no significant changes during the first 60 
minutes after the start of the E.Coli infusion. During the course 
of the experiment, systemic oxygen consumption and oxygen 
consumption of the kidney and intestines were unaltered. The 
oxygen consumption of the hindlimb was maintained during the 
first 60 minutes after the start of the E.Coli infusion. 
5.4. Discussion 
In this study both skeletal muscle PO, and oxygen availability 
to the hmdlimb had already decreased during the control period. 
This was probably due to the extensive preparation and the 
laparotomy required in this experiment, as compared to the 
previous experiments (1). The skeletal muscle PO, during the 
control period was also lower than in our previous experiments 
(2.3 kPa ±1.4 SD versus 4.7 kPa ±1.2 SD)(1). In this study we 
found a reduction in skeletal muscle PO, within 5 minutes after 
the start of the E.Coli infusion. Although not significant 
because of the scattering of the skeletal muscle PO, values 
between the experiments, the percentage change agrees with our 
previous experiments (1). Wells et al. (10) also found low values 
for skeletal muscle PO, at an early stage of endotoxin shock, 
which were not reflected in any other parameter measured. 
The arterial oxygen supply was reduced within 5 minutes after 
the onset of the E.Coli infusion. Oxygen extraction ratio 
increased initially, as found in other studies shortly after an 
intravenous injection of endotoxin (11-14). Other studies showed 
that the oxygen extraction decreased if cardiac output is 
maintained or enhanced (14-17). 
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The P50 of the oxyhemoglobin dissociation curve increased, 
implying that peripheral oxygen release from the blood was 
facilitated (18). This increase of the P50 and the increase in 
oxygen extraction show that initially the blood accommodates to 
facilitate oxygen release to the tissue. 
Oxygen consumption was maintained during the onset of E.Coli 
sepsis, as found in other studies (12-14, 19-20). In high output 
sepsis an increased oxygen consumption (15,20) and in low output 
sepsis a decreased oxygen consumption (16, 20-22) have been 
found. Abnormalities in cellular oxygen metabolism in 
endotoxemia may be secondary to ischemia and are not necessarily 
due to direct cellular injury. In sepsis a reduced oxygen 
consumption may be the result of alterations in the nutritive 
microcirculation (24-25) since no direct cytotoxicity, indicated 
by a normal oxygen consumption of mitochondria, could be 
demonstrated (24, 26-31). 
As the early reduction in skeletal muscle PO- was not due to an 
increase in oxygen consumption nor to an increase in the affinity 
of hemoglobin for oxygen, it might rather be due to a decrease in 
oxygen availability to the muscle. In low and high dose E.Coli 
sepsis a significant and persistent decline in epithelial PO, 
occurred in the gastric mucosa, while gastric blood flow was 
relatively unaltered (5). The authors concluded that a reduction 
in oxygen partial pressure in the epithelium must be the result 
of either an alteration in nutritive blood flow or a defective 
diffusion of oxygen (5). In the present experiment, during the 
first 5 minutes after the start of the E.Coli infusion the oxygen 
availability to the hindlimb decreased by 18%. At this time the 
oxygen consumption of the hindlimb was not altered, the oxygen 
extraction of the hindlimb increased by 32%, femoral venous PO-
decreased by 31% and skeletal muscle PO- decreased by 52%. The 
magnitude of these changes and the time relationship provide no 
satisfactory explanation for the fall in skeletal muscle PO-. A 
reduction in diffusing capacity for oxygen in the skeletal muscle 
tissue and changes in other determinants of skeletal muscle 
tissue PO-, as described in chapter 1 and listed in table 1.3, 
might be important factors in the decrease of skeletal muscle 
PO2. 
We conclude that the early decline of skeletal muscle PO-
during the start of the E.Coli infusion is not caused by an 
increased affinity of hemoglobin for oxygen, nor by an increase 
of oxygen consumption nor by a decreased arterial oxygen content. 
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The r e m a i n i n g p o s s i b i l i t i e s f o r t h e e a r l y d e c l i n e o f s k e l e t a l 
m u s c l e PO- a r e an i n c r e a s e d d i f f u s i o n d i s t a n c e f o r o x y g e n from 
t h e c a p i l l a r y t o t h e m i t o c h o n d r i a o r an a l t e r a t i o n i n t h e 
d i f f u s i o n c o e f f i c i e n t f o r oxygen i n s k e l e t a l m u s c l e t i s s u e . The 
e a r l y and marked r e d u c t i o n i n l e u c o c y t e c o u n t d u r i n g t h e s t a r t o f 
E . C o l i i n f u s i o n s u g g e s t s t h a t a c t i v a t e d l e u c o c y t e s might be 
r e l a t e d t o t h e e a r l y d e c l i n e i n s k e l e t a l m u s c l e PO2. 
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CHAPTER 6 
EARLY DETECTION OF BURN SHOCK 
BY SKELETAL MUSCLE OXYGEN PRESSURE ASSESSMENT 
6.1. Introduction 
One of the first problems in the treatment of patients with 
severe burns is the prevention of burn shock (1). Fifteen % of 
the mortality in burned patients is still due to irreversible 
burn shock (2). The goal of shock treatment is to create optimal 
perfusion of the tissues and optimal delivery of oxygen (3,4) 
without overhydrating the patient (5). The therapy of burn shock 
consists of infusion of large amounts of fluids (6-11). The 
amount of infusion per kilogram body weight and percentage of the 
body surface area burned, and the use of colloids, hypo-, iso- or 
hypertonic saline, may differ from one burn center to the other. 
Careful monitoring of these patients in the intensive care unit 
throughout the shock phase is mandatory. Frequent measurements of 
arterial blood pressure, heart rate, central venous pressure, 
hematocrit, blood gases, infusion rate, kidney function and 
osmolality are commonly performed, but definite parameters for 
effective resuscitation are not known (12). So far, hourly 
urinary output and arterial blood pressure have been considered 
the most important indices of the effectiveness of therapy 
(13,14). 
Maintenance of optimal tissue perfusion in these patients is 
essential for survival as well as to prevent morbidity (5,14,15), 
but direct measurement of tissue perfusion is not yet possible. 
Skeletal muscle PO- is a parameter related to tissue perfusion 
(16-18) (chapter 1). It might be an indicator of developing burn 
shock and of the effectiveness of resuscitation. 
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We investigated skeletal muscle PO, during the first 48 hours 
after a severe burn (body surface area burned > 25 % ) , using a 
Polarographie needle electrode for skeletal muscle P0 2 assessment 
(19,20)(chapter 3). 
6.2. Patients and methods 
Thirteen patients suffering from burns of more than 25% were 
studied. After 6, 8, 10, 14, 18, 24, 30, 36 and 48 hours the 
heart rate, systolic and diastolic' arterial blood pressure, 
skeletal muscle PO,, respiratory rate, hourly urinary output, 
body temperature, amount of oxygen administered, volume of 
infusion fluid, amount of Na administered, volume of colloid 
administered, arterial PO,, arterial P C 0 2 ' arterial oxygen 
saturation, hemoglobin, hematocrit, arterial pH, arterial HCO,", 
serum Na , serum Κ , serum osmolality, serum total protein, 
serum albumin, serum urea, serum creatinine, urine Na , urine К 
and urine osmolality were recorded using routine clinical 
measurements. 
Skeletal muscle PO, was measured in the quadriceps femoris 
muscle using a Polarographie needle electrode (19,20). The 
electrode was calibrated before the measurement and positioned in 
the vastus lateralis of the quadriceps femoris muscle 
approximately 3 to 4 cm deep, using a 20-gauge needle as a 
guiding cannula. The needle was withdrawn stepwise and after each 
step of 200 vm a PO, value was obtained. In this way 100 PO, 
values from 100 different places in the skeletal muscle were 
collected. From these 100 PO, values the median, representing the 
skeletal muscle PO,, was calculated. At the end of each 
measurement the needle was withdrawn from the patient. The 
results were available within 5 minutes. The skeletal muscle PO-
assessment caused no discomfort to the patient and no 
complications related to the method were observed. Skeletal 
muscle PO, assessment is accurate if enough muscle mass is 
involved (thickness at least 3 cm). Therefore in one patient with 
severe muscular atrophy no reliable results could be obtained. 
Because the aim of the study was to evaluate the value of 
additional skeletal muscle PO, assessment, the clinician in 
charge of therapy was not informed of the results. 
Problems during resuscitation were defined as a urinary output 
< 0.5 cc.kg .h and/or a systolic arterial blood pressure < 90 
mm Hg. 
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For statistical analysis of the results the following tests 
were used: 
Tl: Friedman's two-way analysis of variance by ranks for testing 
the agreement of the course of a variable between patients. 
T2: A test based on the average value of Spearman's rank 
correlation coefficients of a variable and time for each 
patient to establish a common increase or decrease of that 
variable. 
T3 : A test based on the average value of Wilcoxon's two sample 
statistics for each patient to test the relationship between 
skeletal muscle PO- and subsequent resuscitation problems. 
T4: A Wilcoxon two sample test applied on the median over the 48 
hour period of observations of the skeletal muscle PO, to 
compare the overall skeletal muscle PO2 level of patients 
with and without resuscitation problems. 
In paragraph 6.3 these tests will be described by Tl, T2, T3 and 
T4. 
6.3. Results 
Out of thirteen patients studied, one patient (nr.l) had 
suffered several injuries: a burn of 80% body surface area, a 
tension pneumothorax, multiple rib fractures and an unstable 
pelvic fracture (I.S.S.-score: 66); one patient (nr.2) was 
overhydrated during the second day and developed pulmonary edema; 
one patient (nr.3) received colloids within 8 hours after trauma 
because of an unstable blood pressure; one patient (nr.4) had a 
severe muscular atrophy, so no reliable skeletal muscle PO-
assessment was possible; one patient (nr.5) died within 48 hours. 
The remaining eight patients (pat.nrs.6-13) had a severe burn 
without other injuries; they received the usual therapy and 
survived the first 48 hours after trauma. These patients were 
comparable and therefore pooled (Table 6.1). In these eight 
patients, therapy consisted of hypertonic saline infusion during 
the first 24 hours; colloids were given after 24 hours. The rate 
of infusion was regulated according to the hourly urinary output. 
During the first 24 hours the heart rate and systolic arterial 
blood pressure increased significantly (p<0.001, T2); during the 
next 24 hours there was no significant change (fig.6.1). The 
respiratory rate, arterial PO,, arterial SO- and arterial PCO-
did not increase or decrease significantly during the first 24 
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Table 6.1. Data of the patients 
NR. AGE 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
Nr.l. 
25 
71 
34 
60 
55 
48 
27 
64 
30 
27 
53 
34 
18 
Pat 
5EX 
F 
F 
M 
M 
F 
F 
M 
F 
F 
F 
F 
M 
M 
% BURN 
degree 
second third 
37 
29 
60 
12 
0. 
43 
56 
12 
8 
β 
24 
18 
11 
42.5 
6 
30 
17.5 
5 67 
3 
24 
37 
25 
17 
4 
18 
24 
I 
total 
79. 
35 
90 
29. 
67. 
46 
80 
49 
33 
25 
28 
36 
35 
.5 
.5 
5 
PLACE 
home 
home 
home 
home 
home 
home 
work 
work 
home 
home 
home 
home 
work 
CAUSE 
fire 
explosion 
fire 
explosion 
fire 
explosion 
explosion 
fire 
fire 
fire 
explosion 
fire 
fire 
Patient with tension pneumothorax, multiple r ib fractures and an 
unstable pelvic fracture (I.S.S.-score:66) 
Nr.2. Patient with overhydration during the second day developing 
pulmonary edema 
Nr.3. Patient receiving colloids within 8 hours because of unstable blood 
pressure 
Nr.4. Patient with severe muscular atrophy 
Nr.5. Patient died within 48 hours 
Nr.6-13. These patients showed no other injuries, received usual therapy and 
survived the f i r s t 48 hours after the burn. 
h o u r s (T2) ( f i g . 6 . 2 ) . Hemoglobin and h e m a t o c r i t d e c r e a s e d 
s i g n i f i c a n t l y (p<0.001, T2) ( f i g . 6 . 3 ) . S k e l e t a l muscle PO-
i n c r e a s e d s i g n i f i c a n t l y (p<0.05 / T2) ( f i g . 6 . 1 ) . A r t e r i a l pH 
i n c r e a s e d s i g n i f i c a n t l y e s p e c i a l l y d u r i n g 24 - 48 h o u r s a f t e r t h e 
burn ( f i g . 6 . 2 ) . 
There was a s i g n i f i c a n t agreement i n t h e c o u r s e of changes i n 
u r i n a r y o u t p u t between t h e e i g h t p a t i e n t s (p<0.05 # T l ) : between 
18 and 24 h o u r s t h e u r i n a r y o u t p u t d e c r e a s e d and between 24 and 
48 h o u r s u r i n a r y o u t p u t i n c r e a s e d s i g n i f i c a n t l y ( f i g . 6 . 1 ) . Serum 
sodium c o n c e n t r a t i o n d e c r e a s e d s i g n i f i c a n t l y d u r i n g t h e f i r s t 48 
h o u r s ( p < 0 . 0 1 , T 2 ) . Potass ium, c h l o r i d e , u r e a , c r e a t i n i n e and 
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FI g. 6.1. Mean and standard error of mean of six parameters in 8 patients 
during the first 48 hours after a burn of more than 25 % body 
surface area without other injuries. 
serum albumin did not increase or decrease s i g n i f i c a n t l y (T2) 
( f i g . 6 . 3 ) . There was a s i g n i f i c a n t agreement between the 
p a t i e n t s in the course of changes in t o t a l p r o t e i n (p<0.01, T l ) : 
between 8 - 2 4 hours t o t a l serum prote in decreased, was lowest 
a t 24 hours and increased therea f ter ( f i g . 6 . 3 ) . Osmolal ity 
decreased s i g n i f i c a n t l y during the f i r s t 48 hours (p<0.01, T2) 
( f i g . 6 . 3 ) . Temperature increased s i g n i f i c a n t l y between 6 and 30 
hours a f ter the burn (p<0.05, T2) ( f i g . 6 . 2 ) . 
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Fig.6.2. Mean and standard error of mean of arterial blood gas parameters 
and temperature of 8 patients during the first 48 hours after a 
burn of more than 25 % body surface area without other Injuries. 
The r e l a t i o n s between ske le ta l muscle PO- and problems during 
the r e s u s c i t a t i o n were studied in a l l p a t i e n t s . Problems were 
defined as a ur inary output below 0.5 ml.kg .h and a 
sy s to l ic a r t e r i a l blood pressure below 90 mm Hg. Table 6.2 
shows the ske le ta l muscle PO, in r e l a t i o n to the r e s u s c i t a t i o n 
problems occurring during the period following the s k e l e t a l 
muscle PO, assessment. 
Urinary output below 0.5 ml.kg .h~ occurred in p a t i e n t s with 
low as well as high ske le ta l muscle PO- values. Skeletal muscle 
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Table 6.2. The r e l a t i o n s h i p between s k e l e t a l muscle P0 7 and 
r e s u s c i t a t i o n problems. 
D,T or С re fers to a problem t h a t occurred in the 
period between t h a t s k e l e t a l muscle P0_ assessment 
and t h e next one. 
D = ur inary output < 0.5 cc/kg/h 
Τ = s y s t o l i c a r t e r i a l blood pressure < 90 mm Hg 
С = D + Τ 
Patient 
Nr. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
6 
0.1T 
3.2 
... 
... 
2.8 
... 
... 
... 
1.9D 
3.6D 
5.3 
2.7 
2.6 
8 
0.7T 
4.8 
... 
0.1D 
1.8T 
6.8 
5.1 
1.0C 
2.OD 
2.2D 
2.4 
1.5T 
3.0 
10 
0.6T 
5.9 
3.8 
0.6D 
2.5C 
4.4 
2.5 
1.6 
4.3D 
2.8D 
6.0 
0.4T 
... 
14 
0.8C 
4.8 
0.5 
0.9D 
0.4C 
6.4 
1.9T 
2. ID 
3.4D 
2.9 
4.2 
0.8 
3.1 
18 
2.2D 
4.4 
6.1 
2.0 
1.3C 
9.8 
2.1 
3.3D 
7.4 
1.5 
1.4 
2.6 
2.3 
24 
1.6 
13.3 
3.2 
2.3 
0.9C 
5.3D 
2.8 
1.6D 
2.9 
1.8 
3.1 
3.0 
4.2 
30 
2.2 
5.6 
4.5 
1.9 
0.3C 
3.7 
3.4 
3.2 
6.8 
2.8 
7.9 
3.7 
2.6 
36 
4.2 
4.4 
Э.8 
0.2 
... 
5.9 
5.8 
1.2 
3.1 
3.1 
7.5 
4.5 
5.1 
48 
9.9 
2.6 
2.4 
0.6 
4.5 
4.0 
2.9 
3.2 
4.9 
3.9 
2.0 
4.4 
48 hours after trauma 
P 0 2 i n p a t i e n t s w i t h a u r i n a r y o u t p u t l e s s t h a n 0 .5 m l . k g ~
1
. h " 1 
d i d n o t d i f f e r s i g n i f i c a n t l y from s k e l e t a l muscle PO, i n p a t i e n t s 
w i t h o u t u r i n a r y o u t p u t problems ( p > 0 . 1 / T 4 ) . S k e l e t a l muscle PO, 
p r e c e d i n g u r i n a r y o u t p u t problems d i d n o t d i f f e r s i g n i f i c a n t l y 
from s k e l e t a l muscle PO2 p r i o r t o p e r i o d s w i t h o u t u r i n a r y o u t p u t 
problems ( p > 0 . 1 / T3) . In p a t i e n t s w i t h c l i n i c a l shock, t h e 
s k e l e t a l muscle P 0 2 l e v e l ( t h e median of a l l t h e s k e l e t a l muscle 
PO2 a s s e s s m e n t s o b t a i n e d i n t h e p a t i e n t ) was s i g n i f i c a n t l y lower 
t h a n t h e s k e l e t a l muscle P 0 2 l e v e l i n p a t i e n t s w i t h o u t c l i n i c a l 
shock ( p = 0 . 0 1 / T 4 ) . 
S k e l e t a l muscle PO2 p r e c e d i n g c l i n i c a l shock was s i g n i f i c a n t l y 
lower t h a n s k e l e t a l muscle PO, p r i o r t o p e r i o d s w i t h o u t s i g n s of 
shock ( p < 0 . 0 0 1 , T 3 ) . In no i n s t a n c e d i d h y p o t e n s i o n deve lop i n 
t h e p e r i o d subsequent t o t h e measurement of a s k e l e t a l muscle PO_ 
v a l u e above 2 .5 kPa. 
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6Λ. Discussion 
After a severe burn intravascular volume decreases and the 
circulation to vital organs such as the heart, brain and kidneys 
will be maintained by redistribution of the circulating blood 
volume. Flow to skeletal muscle and skin will be diminished in 
favor of the circulation to the vital organs. If intravascular 
volume decreases further and is not replaced adequately, 
arterial blood pressure will fall and clinical shock ensues. 
Large amounts of infusion fluids are needed to resuscitate 
severely burned patients. The rate of infusion must be regularly 
adjusted in each patient. Hourly urinary output is commonly used 
as a parameter for fluid therapy (14,21) although its accuracy 
has been disputed by several authors (14,21-23). In fact urinary 
output is related not only to tissue perfusion but also to serum 
osmolality (10). The use of a Swan-Ganz catheter has been 
advocated to determine cardiac output as a more accurate estimate 
of the circulation than hourly urinary output (23). 
Skeletal muscle PO, was studied as a parameter of tissue 
perfusion. If skeletal muscle POj was above 2.5 kPa no 
hypotension occurred in the subsequent period of 2 - 6 hours 
until the next skeletal muscle PO- assessment. If skeletal muscle 
PO, was lower than 2.5 kPa, the risk of subsequent hypotension 
was higher. Skeletal muscle PO- decreased before hypotension 
occurred, and enabled early detection of impairment of the 
circulation before arterial blood pressure dropped below 90 mm 
Hg. Skeletal muscle P0_ significantly increased during the period 
of investigation and was significantly higher 24-30 hours 
postburn as compared with 6- 24 hours postburn. These results are 
in agreement with low cardiac output and elevated systemic 
vascular resistance as found by others during the first 24 hours 
postburn (4,23,24). 
In this study patient monitoring was performed according to the 
current standards of burn shock treatment and infusion rate was 
adjusted according to the hourly urinary output. The infusion 
rate might influence the relation between skeletal muscle PO- and 
hourly urinary output, but no such relationship has been found in 
thi s study. 
Monitoring of cardiac output with the Swan-Ganz catheter has 
been advocated in burned patients, but Swan-Ganz catherization is 
not without risk and produces complications in 21% of cases (4). 
This technique is not therefore generally accepted for monitoring 
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burned patients. Skeletal muscle PO- assessment does not require 
indwelling catheters and causes no discomfort to the patients. 
As burn shock develops gradually, intermittent skeletal muscle 
PO- assessment enables early detection of imminent shock and 
might also be used to evaluate the effectiveness of shock 
therapy. 
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CHAPTER 7 
SKELETAL MUSCLE OXYGEN PRESSURE ASSESSMENT. 
HEMODYNAMICS AND OXYGEN TRANSPORT 
AFTER EXTRACORPOREAL CIRCULATION 
7.1. Introduction 
Close and accurate surveillance early after operation is 
necessary to identify abnormal convalescence in patients with 
suboptimal cardiac performance (1,2). Circulatory and respiratory 
parameters, arterial blood pressure, central venous pressure, 
pulmonary arterial blood pressure, heart rate and temperature are 
recorded continuously after cardiac surgery. Cardiac output, 
urinary production and arterial blood gases are determined at 
intervals. 
The cardio-respiratory function can be considered adeguate if 
it is able to supply a sufficient amount of oxygen to the tissues 
(3,4). Since tissue oxygen pressure represents the net balance 
between oxygen supply and utilization in a particular tissue, the 
tissue PO- level is a direct indicator of the adequacy of tissue 
perfusion (5). Variables estimating peripheral perfusion are 
better predictors of survival than vital signs such as heart 
rate, central venous pressure and hemoglobin (6). 
Direct estimation of tissue perfusion in patients is not yet 
possible, but its approach by skeletal muscle PO- assessment 
might be a more direct indicator of the adequacy of the 
peripheral circulation than recording heart rate, blood pressure, 
cardiac output and urine production. 
To study normal recovery after extracorporeal circulation we 
measured the skeletal muscle PO- as an index of peripheral tissue 
perfusion as well as hemodynamic parameters, oxygen supply and 
oxygen consumption in a group of patients undergoing elective 
coronary artery bypass procedures. 
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7.2. Patients and methods 
Eight patients undergoing elective coronary artery bypass 
procedures were studied (Table 7.1). All patients had given their 
informed consent for the skeletal muscle PO, assessment. The 
experimental protocol was approved by the institutional review 
board. The investigation started 30 minutes after arrival in the 
intensive care unit. Heart rate, arterial blood pressure measured 
in a radial artery, mean pulmonary arterial pressure, pulmonary 
capillary wedge pressure and central venous pressure were 
measured (Gould Swan-Ganz catheter, Philips monitor). Cardiac 
output was obtained using the thermodilution method with the aid 
of a cardiac index computer (Gould cardiac index computer). 
Arterial and mixed venous blood gases (ABL-3, Radiometer), 
arterial and mixed venous oxygen saturation (Oximeter, 
Instrumentation Laboratories) as well as hemoglobin and 
hematocrit were determined. 
Skeletal muscle PO- was measured in the quadriceps femoris 
muscle using a Polarographie needle electrode (7)(chapter 3). 
The electrode was calibrated before the measurement and 
positioned in the vastus lateralis of the quadriceps femoris 
muscle approximately 3 to 4 cm deep, using a 20-gauge needle as a 
guiding cannula. The needle was withdrawn stepwise and after each 
step of 200 ym a PO, value was measured (8). In this way 100 PO, 
values from 100 different places in the skeletal muscle were 
obtained. From these 100 PO, values the median, representing the 
skeletal muscle PO, assessment, was calculated. At the end of 
each skeletal muscle PO, assessment the needle was withdrawn from 
the patient (chapter 3). 
The measurements were repeated after 2, 4, 8 and 16 hours. 
Left ventricular stroke work index, systemic vascular 
resistance, arterial oxygen supply, arterio-venous oxygen 
difference, oxygen consumption and P50 of the oxyhemoglobin 
dissociation curve were calculated (chapter 2). 
All patients were treated in the intensive care unit for the 
first 36-48 hours. The systolic arterial blood pressure was held 
below 150 nun Hg by the use of sodium nitroprusside infusion. When 
the systolic arterial blood pressure was below 80 mm Hg, 
accompanied by decreased urinary production, inotropic drugs were 
administered and, if necessary, an intra-aortic balloon pump was 
inserted to support the left ventricle. 
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Table 7.1. Data of the patients 
Nr Age Sex Anas Oper Pulm ECC ß-blocking 
preoperatively 
1 
2 
3 
4 
5 
6 
7 
8 
52 
64 
54 
55 
64 
61 
70 
48 
m 
f 
f 
m 
m 
m 
Dl 
m 
6 
3 
3 
6 
3 
3 
3 
3 
1 
1 
1 
1 
1 
2 
1 
1 
Y1 
N 
N 
N 
N 
N 
Y2 
N 
168 
98 
89 
160 
106 
163 
136 
125 
Propranolol 
Propranolol 
Atenolol 
Propranolol 
Propranolol 
Propranolol 
Oxprenolol 
40 mg/d 
40 mg/d 
100 mg/d 
120 mg/d 
80 mg/d 
60 mg/d 
80 mg/d 
Nr = patient nr. 
Anas = nr of anastomoses 
Oper = nr of Operations 
Pulm = pulmonary disease 
1 chronic obstructive pulmonary disease 
2 chronic res t r ic t ive pulmonary disease 
ECC = duration of extracorporeal circulation (min) 
ß-blocking = use of ß-blocking agents preoperatively 
Nitro= use of nitroprusside natrium 
When t h e p a t i e n t s were hemodynamically s t a b l e and awake t hey 
u s u a l l y were al lowed t o b r e a t h e spon taneous ly . A l l p a t i e n t s were 
e x t u b a t e d between 4-16 hours p o s t o p e r a t i v e l y , when spontaneous 
r e s p i r a t i o n was unimpeded fo r 1-2 hou r s and blood gas a n a l y s i s 
showed normal v a l u e s . The agreement of changes i n t h e measured 
p a r a m e t e r s between t h e p a t i e n t s over t h e whole p e r i o d of s tudy 
was s t a t i s t i c a l l y t e s t e d by means of F r i edman ' s non -pa rame t r i c 
a n a l y s i s of v a r i a n c e (FT). We compared t h e changes between e a r l y 
a f t e r a r r i v a l a t t h e I . C U . (Oh) and 2 hours l a t e r , t h e changes 
between 8 and 16 hours as wel l as t h e changes b e f o r e and a f t e r 
e x t u b a t i o n of t h e p a t i e n t , u s i n g t h e Wilcoxon s igned rank t e s t 
fo r p a i r e d d i f f e r e n c e s (WST). 
7.3. Results 
One patient (nr.6) who showed low output failure after 
termination of the extracorporeal circulation needed assistance 
nitro 
0-4 h 
0-4 h 
0-2 h 
0-2 h 
0-6 h 
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by i n t r a - a o r t i c b a l l o o n pump and i n o t r o p i c drugs and was 
exc luded from t h i s s t u d y . The remaining seven p a t i e n t s had a 
normal c o n v a l e s c e n c e and could be d i s c h a r g e d from t h e i n t e n s i v e 
c a r e u n i t on t h e second day a f t e r o p e r a t i o n ( t a b l e 7 . 1 ) . 
During t h e 16 h o u r - p e r i o d of t h i s s t u d y , s i g n i f i c a n t changes 
a c c o r d i n g t o t h e Friedman t e s t were observed i n mean a r t e r i a l 
b lood p r e s s u r e , mixed venous oxygen p r e s s u r e , a r t e r i o - v e n o u s 
oxygen d i f f e r e n c e , s k e l e t a l muscle PO, and P50 of t h e 
oxyhemoglobin d i s s o c i a t i o n curve . The r e s u l t s a r e summarized i n 
Table 7.2. Sta t i s t ica l analysis of parameters in 7 patients after 
extracorporeal circulation 
PARAMETER А В С D 
Cardiac index 
Mean arterial blood pressure 
Systolic arterial blood pressure 
Left ventricular stroke work index 
Systemic vascular resistance 
Skeletal muscle PO. 
Arterial PO 
Mixed venous P0 ? 
Arterial PCO, 
Mixed venous PCO,' 
Arterio-venous oxygen difference 
Arterial oxygen transport 
Oxygen consumption 
P50 oxyhemoglobin dissociation curve 
0. 
0, 
0, 
0. 
0, 
0. 
0. 
0. 
0. 
0. 
0. 
0, 
0. 
0. 
.10 
.039 
.09 
.20 
.10 
.015 
42 
.001 
10 
.11 
.0008 
.31 
.18 
.02 
0.20 
0.87 
0.80 
0.24 
0.20 
0.016-
0.83 
0.87 
0.15 
0.031+ 
0.016+ 
0.80 
0.21 
0.22 
0.078 
0.14 
0.094 
0.078 
0.93 
0.062 
0.031-
0.83 
0.40 
0.14 
0.53 
0.29 
0.53 
0.15 
0.27 
0.83 
0.09 
0.08 
0.45 
0.09 
0.08 
0.19 
0.03+ 
0.61 
0.35 
0.45 
0.35 
0.35 
A = p-value of Friedman's tes t for concordance between rankings 
B-D = p-value of Wilcoxon signed rank test for paired differences 
B= between arrival and two hours later 
C= between 8 and 16 hours 
D= before and after extubation 
+ = significant increase 
= significant decrease 
f i g u r e s 7 . 1 and 7.2 and i n t a b l e 7 . 2 . 
The mean a r t e r i a l b lood p r e s s u r e d e c r e a s e d from an average of 
88 mm Hg d u r i n g t h e f i r s t two h o u r s t o 70 mm Hg a f t e r 8 h o u r s . 
The mixed venous oxygen t e n s i o n was low ( 4 . 4 kPa ± 0 . 5 SD and 4 . 1 
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кРа ±0.6 SD) for the first 2 hours and increased at 8 (5.4 kPa 
±0.4 SD) and 16 hours (5.1 kPa ±0.7 SD). The arterio-venous 
oxygen difference was low at 0 (4.3 ml 02/100ml ±0.7 SD), 8 (5.2 
ml 02/100ml ±0.7 SD) and 16 hours (4.7 ml O2/100ml ±0.9 SD) and 
higher at 2 (5.7 ml 02/100ml ±0 6 SD) and 4 hours (5.6 ml 
O2/100ml ±0.7 SD). The skeletal muscle P0 2 was 4.2 kPa ±1.9 SD on 
arrival in the intensive care unit, decreased after two hours to 
1.6 kPa ±1.2 SD, thereafter increased to 2.7 kPa ±0.9 SD after 4 
hours and to 3 4 kPa ±2.9 SD after 8 hours and decreased again to 
1.2 kPa ±0.7 SD after 16 hours The P50 of the oxyhemoglobin 
dissocation curve was low on arrival m the intensive care unit 
(3.2 kPa ±0.2 SD), higher at 2 and 4 hours (3.3 kPa ±0.5 SD and 
3.8 kPa ±0.3 SD respectively), highest at 8 hours (4.1 kPa ±0.3 
SD) and returned to normal levels at 16 hours (3.8 kPa ±0.7 SD). 
According to Wilcoxon's signed rank test, in the first two 
hours the skeletal muscle P0_ decreased and arterio-venous oxygen 
difference and the mixed venous PCO- increased significantly 
(p<0.05). The only significant difference between measurements at 
8 hours and 16 hours was a decrease of arterial PO, (from 18.0 
kPa ±5.2 SD to 12.9 kPa ±2.0 SD respectively) (p<0.05). In this 
period there was an indication of improvement in the 
2 
cardiovascular parameters: cardiac index (from 2.8 l/min/m ±0.4 
SD to 3.34 l/min/m ±0.6 SD respectively) (p=0.08) as well as 
2 
ventricular stroke work index (from 30.4 gm/m ±5.0 SD to 40.3 
2 
gm/m ±9.4 SD respectively) (p=0.08) and systolic arterial blood 
pressure (from 110 mm Hg ±14 SD to 126 mm Hg ±17 SD 
respectively) (p=0.09) increased A decrease in skeletal muscle 
P0 2 was observed, although it was not significant (p=0.08). 
Comparing the situation before and after extubation there was a 
significant increase in arterial PCO- (p<0.05). There was a 
slight increase in systolic arterial blood pressure (p=0.09) and 
left ventricular stroke work index (p=0.08) and a decrease in 
skeletal muscle P0 2 (p=0.09) and the arterial P0 2 (p=0.08). 
7.4. Discussion 
Oxygen delivery to the cells to maintain aerobic metabolism is 
one of the most important functions of the cardiorespiratory 
system. Deterioration of oxygen supply to the tissues results in 
anaerobic glycolysis, metabolic acidosis and finally cellular 
death. The determinants of oxygen supply to the tissues are 
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pulmonary gas exchange, blood flow, hemoglobin concentration and 
affinity of hemoglobin for oxygen. This system is adjusted to 
maintain an adequate end-capillary oxygen pressure in the tissues 
(4). Another important factor is oxygen consumption by the 
tissues. Tissue oxygen pressure represents the net balance 
between oxygen availability and utilization in a particular 
tissue, therefore tissue POj is a direct indicator of the 
adequacy of tissue perfusion (5)(chapter 3). These factors play 
an important role in survival and prevention of tissue damage. 
The operation, anesthetic and extracorporeal circulation, 
including hemodilution, the use of a membrane or bubble 
oxygenator, hypothermia, aortic cross-clamping and blood 
transfusion affect the normal oxygen transport mechanism of the 
body. 
The observed increase in oxygen affinity of hemoglobin after 
extracorporeal circulation agrees with the study of Bordiuk et 
al. (9). The cardiovascular parameters (cardiac index, arterial 
blood pressure, systemic vascular resistance), arterial PO-, 
arterial oxygen supply and oxygen consumption did not change 
significantly. The clinical situation of the patient as judged by 
these cardiovascular and respiratory parameters seemed to be 
satisfactory. However, during the first two hours a significant 
decrease in skeletal muscle POj/ a significant increase in 
arterio-venous oxygen difference and a significant increase in 
mixed venous PCO, were observed. Apparently there are changes in 
the microcirculation in patients, who show clinically normal 
convalescence which are not reflected by the parameters generally 
used in clinical practice. 
In conclusion, skeletal muscle PO- assessment might be a 
parameter to detect an early deterioration of the circulation, 
before the commonly measured parameters are affected. Further 
studies have to be performed to reveal the significance of 
changes in the microcirculation and of all steps in the oxygen 
transport from the capillaries to the cells, including their 
influence on skeletal muscle PO-. 
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CHAPTER 8 
EARLY DETECTION OF SHOCK IN 
CRITICALLY ILL PATIENTS BY 
SKELETAL MUSCLE PO, ASSESSMENT 
8.1. Introduction 
Oxygen is the most flow limited of all substances necessary for 
metabolism (chapters 1 and 2)(1). The oxygen transport system is 
thus of vital importance for the integrity of cellular 
metabolism, but one or more of the several components of the 
oxygen transport system may function abnormally m critical 
illness (2,3). 
Inadequate tissue perfusion and inadequate tissue oxygenation 
are the early common physiologic denominators of shock (chapter 
1), but shock is usually not diagnosed before there is a 
significant and persistent fall m the systolic arterial blood 
pressure. Direct estimation of tissue perfusion m patients is 
not yet possible, but skeletal muscle POj might indicate the 
adequacy of the peripheral circulation (chapter 1). 
The purpose of this study is to evaluate the usefulness of 
skeletal muscle PO- assessment in monitoring patients at risk of 
shock. Critically ill patients were studied to establish whether 
skeletal muscle PO- assessment could detect developing shock at 
an early stage and whether skeletal muscle PO- assessment could 
predict the risk of shock during a period after the skeletal 
muscle PO- assessment. 
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8.2. Patients and methods 
P a t i e n t s were admi t t ed t o t he s tudy i f they conformed t o one of 
t h e e n t r y c r i t e r i a l i s t e d i n t a b l e 8 . 1 . The expe r imen ta l p r o t o c o l 
was approved by t h e i n s t i t u t i o n a l review board . Informed consen t 
was o b t a i n e d from a l l p a t i e n t s or t h e i r r e l a t i v e s . Treatment of 
Table 8.1. Entry c r i te r ia 
I. Imminent shock. Group nr. 
- Urinary output < 0.5 cc.kg .h 1. 
- Heart r a t e > 120/min 2. 
- Decrease of s y s t o l i c a r t e r i a l blood pressure by 30 mm Hg or more 3 . 
- Respiratory r a t e > 30/rain, no pulmonary d isease 4. 
- Temperature > 39 "C 5^ 
I I . Shock 
- Systolic arterial blood pressure < 90 mm Hg 6. 
III. Treatment of shock. 
- Inotropes 7. 
the patients was not influenced by their admission to the study. 
Measurements were performed according to a fixed protocol. 
Heart rate, arterial blood pressure, central venous pressure, 
core temperature, arterial P02, arterial PC02, arterial pH, 
arterial HC03", arterial base excess were determined (chapter 2) 
and urinary output/hour and amount of intravenous fluid 
administered were recorded. Skeletal muscle P02 was assessed in 
the quadriceps femoris muscle using a Polarographie needle 
electrode (chapter 3). The electrode was calibrated before the 
measurement and positioned in the vastus lateralis of the 
quadriceps femoris muscle approximately 3 to 4 cm deep, using a 
20-gauge needle as a guiding cannula. The electrode was withdrawn 
stepwise and after each step of 200 urn a PC^ value was measured. 
In this way 100 P02 values from 100 different places in the 
skeletal muscle were obtained. From these 100 PO, values the 
median, representing the skeletal muscle P02 assessment, was 
calculated. At the end of each skeletal muscle P02 assessment the 
electrode was withdrawn from the patient. One complete skeletal 
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muscle РС^ assessment takes 5 minutes (chapter 3). All 
measurements were performed on entry into the study (tl) and 
repeated 2 ( t2 ), 4 ^ 3 ) , 6(t4), 8(t5) and 16(t6) hours later. 
The dose of inotropes administered was recorded and an 
inotropic score (INS) was determined (table 8.2). Dopamine < 20 
mg/hour was often used to improve diuresis (INS=2). Dopamine > 20 
mg/hour or dobutamine was always used initially for increasing 
arterial blood pressure (INS=3). If dopamine or dobutamine failed 
to increase arterial blood pressure, epinephrine was added 
Table 8.2. Inotropic score (INS) 
1 = no inotropes 
2 = dopamine or dobutamine < 20 mg/hour 
3 = dopamine or dobutamine > 20 mg/hour 
4 = epinephrine 
( I N S = 4 ) . 
For each p e r i o d , t h e p r e s e n c e of shock was r e g i s t e r e d by means 
of a shock s c o r e (SHS). The most s e v e r e e v e n t o c c u r r i n g d u r i n g 
one p e r i o d de termined t h e shock s c o r e ( t a b l e 8 . 3 ) . In some 
p a t i e n t s shock o c c u r r e d when i n o t r o p i c drugs were n o t 
a d m i n i s t e r e d , i n o t h e r p a t i e n t s i n o t r o p i c drug t r e a t m e n t was 
a l r e a d y i n s t i t u t e d . For t h i s r e a s o n t h e s e v e r i t y of t h e 
c i r c u l a t o r y f a i l u r e was a l s o e s t i m a t e d by a combined i n o t r o p i c 
and shock s c o r e (CISHS). The CISHS-score combines t h e i n o t r o p i c 
t r e a t m e n t and t h e e v e n t s b e f o r e and a f t e r s k e l e t a l muscle PO, 
Table 8.3. Shock score (SHS) 
0 = maintenance of s y s t o l i c a r t e r i a l blood pressure above 90 mm 
Hg without a d d i t i o n a l measures 
1 = maintenance of s y s t o l i c a r t e r i a l blood pressure above 90 mm 
Hg by a d d i t i o n a l infusion of plasma expanders, increas ing 
the amount of inotropes and/or ur inary output < 0.5 cc.kg .h 
( i f the p a t i e n t showed no p r e e x i s t i n g terminal renal f a i l u r e ) 
2 = s y s t o l i c a r t e r i a l blood pressure < 90 mm Hg 
3 = systolic ar ter ia l blood pressure < 80 mm Hg 
as ses sment ( t a b l e 8 . 4 ) . 
The r e s u l t s were s t a t i s t i c a l l y a n a l y s e d u s i n g t h e F i s h e r e x a c t 
t e s t f o r 2 x 2 t a b l e s . 
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Table 8.4. Calculation of the combined inotropic shock score (CISHS) 
CISHS = SHS(O) + 0.5 χ SHS(-l) + INS-1 
SHS(O) = maximal shock score occurring 2 hours after the 
measurement 
SHS(-l) = maximal shock score occurring 2 hours before the 
measurement 
INS = inotropic score at time of measurement 
8.3. Results 
The study was performed on 20 patients. Two patients were 
studied twice during the course of their illness. Eighteen 
patients were treated on the intensive care unit (ICU), two 
patients were treated on the ward. One patient (nr.4) died during 
the study period. The patient characteristics: entry criteria, 
diagnosis, age, blood culture, INS-score, SHS-score and CISHS-
score are presented in table 8.5. 
The relationship between the events during the study period and 
the skeletal muscle PO- is presented in table 8.6. 
If the skeletal muscle P0 2 was more than 4.2 kPa no shock 
occurred in the period of 4 hours before and 6 hours after the 
measurement. If skeletal muscle P0 2 was less than 0.4 kPa, shock 
always occurred during the period from 4 hours before to б hours 
after the measurement. 
We compared the incidence of shock scores 1, 2 or 3 in 
patients with and without one or more skeletal muscle P0 2 values 
below 2.0 kPa (mean value for healthy humans minus the standard 
deviation, see chapter 3) during the study period. Significantly 
more patients had one or more periods of shock when at least one 
of the values was less than 2.0 kPa (p=0.007) (table 8.7). We 
also compared the incidence of shock scores 1, 2 or 3 in patients 
with and without one or more skeletal muscle PO, values of more 
than 4.0 kPa (mean value for healthy humans, see chapter 3). 
Significantly fewer patients had one or more periods of shock if 
their skeletal muscle P0 2 was at least once above 4.0 kPa 
(p=0.015) (table 8.7). 
We calculated the risk of shock scores 1,2 and/or 3 following a 
skeletal muscle PO, value below 3.0 kPa versus one above 3.0 kPa. 
The same analysis was repeated in patients not requiring 
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Table 8 .5 . Pat ient c h a r a c t e r i s t i c s . 
nr . entry 
c r i t e r i a 
diagnosis age blood INS SHS CISHS 
culture max mean 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
3,5 
2,5 
6,7 
2,5,6 
3,5,7 
3,5,7 
1,5,7 
7 
7 
7 
4 
13. 5,7 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
5,6,7 
7 
7 
7 
5 
2,5 
1,7 
7 
22. 2,3,5 
bleeding esophageal varices, 52 
transection of the esophagus 
splenectomy, exploratory laparotomy 
multiple abdominal abscesses, 
laparotomy 
septic shock 
varicella pneumonia, cardiac arrest 
succesful reanimation 
pancreatitis 
multiple trauma 
pancreatitis 
multiple abdominal abscesses 
same patient as 7, developed 
multiple organ failure 
perianal abscess, necrotising 
fasciitis, abdominal abscess 
low pressure lung edema, hepato-
splenoraegaly, préexistent renal 
insufficiency, mitral valve 
insufficiency 
mitral valve prosthesis, coronary 45 
bypasses, circulatory arrest. 
septic shock 
subphrenic abscess 
Whipple operation 
multiple trauma 
pancreatitis 
multiple intestinal perforations 
shock, terminal renal insufficiency 
multiple trauma, multiple organ 
failure 
same patient as 1 52 
0.6 1.0 
56 
26 
60 
24 
55 
48 
70 
65 
48 
54 
36 
Ρ 
N 
Ρ 
Ν 
Ρ 
-
-
Ν 
Ν 
-
Ν 
1 
1 
4 
2 
3 
3 
2 
4 
4 
2 
1 
0.2 
0.0 
2.25 
0.83 
1.2 
0.2 
0.0 
1.0 
0.17 
0.0 
0.0 
0.4 
0.0 
6.0 
1.9 
3.6 
2.3 
1.0 
4.5 
3.1 
1.0 
0.0 
0.0 2.8 
73 
68 
58 
80 
45 
72 
70 
49 
-
-
-
-
Ν 
Ρ 
Ν 
-
3 
2 
3 
2 
1 
1 
4 
4 
0.5 
0.0 
1.17 
0.0 
0.0 
1.0 
1.0 
0.0 
2.3 
1.0 
2.7 
1.0 
0.0 
1.3 
4.5 
2.8 
1.5 2.5 
Note: N=negative blood culture 
P=positive blood culture 
Table 8.6. Relation between the shock score (SHS) during the study period 
and the skeletal muscle PO. (M). 
Time: hours after the entry to the study 
Time 
Nr. 
1. 
2. 
3. 
U. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
= 0 
M 
3.1 
3.6 
4.8 
0.6 
3.6 
2.4 
2.6 
6.9 
1.1 
0.5 
6.8 
6.8 
2.7 
4.2 
2.1 
2.7 
3.3 
4.5 
2.2 
2.3 
5.0 
2.5 
I 
SHS 
0 
0 
0 
2 
3 
2 
0 
0 
1 
0 
0 
0 
0 
1 
0 
1 
0 
0 
2 
0 
0 
1 
2 
M 
4.2 
3.1 
8.2 
0.4 
0.3 
2.1 
3.0 
3.9 
2.4 
2.6 
3.6 
3.9 
1.2 
0.7 
2.2 
2.4 
2.8 
3.2 
2.3 
3.6 
7.1 
1.7 
SHS 
0 
1 
0 
3 
1 
2 
0 
0 
1 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
2 
4 
M 
3.0 
2.9 
8.0 
0.6 
3.4 
1.6 
1.8 
3.6 
3.6 
0.4 
6.1 
4.5 
0.4 
2.0 
2.7 
2.1 
2.6 
5.4 
3.7 
2.7 
6.2 
1.2 
SHS 
0 
0 
0 
1 
1 
0 
0 
0 
1 
0 
0 
0 
0 
2 
0 
2 
0 
0 
1 
0 
0 
2 
6 
M 
1.1 
0.6 
7.2 
0.7 
3.1 
1.4 
1.5 
3.2 
2.6 
1.4 
4.0 
4.3 
1.8 
0.4 
4.2 
... 
... 
7.0 
3.6 
3.7 
8.4 
3.0 
SHS 
2 
0 
0 
3 
0 
1 
0 
0 
1 
0 
0 
0 
0 
0 
0 
2 
0 
0 
1 
2 
0 
1 
8 
M 
2.4 
3.3 
4.2 
0.1 
2.4 
1.0 
1.8 
4.7 
2.6 
0.3 
3.1 
3.3 
0.7 
2.4 
1.9 
3.3 
2.4 
5.8 
1.1 
3.8 
4.8 
3.1 
SHS 
1 
0 
0 
died 
0 
1 
1 
0 
1 
1 
0 
0 
0 
0 
0 
1 
0 
0 
1 
3 
0 
.. 
16 
M 
--
6.8 
6.6 
... 
0.3 
2.9 
1.7 
3.1 
3.9 
4.9 
10.2 
0.4 
1.3 
3.6 
3.1 
.-. 
5.8 
3.4 
1.5 
6.9 
h 
SHS 
--
0 
0 
-
-
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
-
0 
. 
Table 8.7. Occurrence of shock score 0 versus shock scores 1,2 
and 3 if the skeletal muscle PO, was one or more tii 
< 2.0 kPa or > 4.0 kPa during the study period. 
SHS 0 
SHS 1-3 
total 
S 
no 
6 
1 
7 
2.0 
yes 
3 
12 
15 
kPa 
total 
9 
13 
22 
SHS 0 
SHS 1-3 
total 
> 4. 
no 
2 
10 
12 
.0 kPa 
yes 
7 
3 
10 
total 
9 
13 
22 
Fisher exact test: ρ < 0.01 Fisher exact test: ρ < 0.05 
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Table 8.8. Risk of shock related to the skeletal muscle PO, in 
relation to the time before and after measurement 
and in relation to the use and amount of inotropes. 
% shock if P0 2 < 3.0 kPa 
Relative risk = 
X shock if P02 > 3.0 kPa 
A. During the period from 4h before to 6h after the measurement 
(if the occurrence of shock is not known it is assumed to be 
absent); nr = number of such periods considered. 
Skeletal muscle PO, 
£ 3.0 kPa > 3.0 kPa 
nr. % SHS 1-3 
66 70 
15 100 
14 43 
16 75 
21 62 
nr. % SHS 1-3 
60 32 
29 28 
18 23 
3 66 
10 50 
Treatment 
All 
no inotropes 
dopamine <20mg 
dopamine >20mg 
epinephrine 
Treatment 
All 
no inotropes 
dopamine <20mg 
dopamine >20mg 
epinephrine 
Treatment 
All 
no inotropes 
dopamine <20mg 
dopamine >20mg 
epinephrine 
Treatment 
All 
no inotropes 
dopamine <20mg 
dopamine >2Drag 
epinephrine 
nr. % SHS 1 
66 26 
15 20 
14 7 
16 38 
21 33 
nr. 
66 
15 
14 
16 
21 
% SHS 2 
32 
80 
29 
31 
0 
nr. % SHS 3 
66 12 
15 0 
14 7 
16 6 
21 29 
nr. X SHS 1 
60 13 
29 14 
18 6 
3 33 
10 20 
nr. % SHS 2 
60 12 
29 14 
18 6 
3 33 
10 10 
nr. 
60 
29 
18 
3 
10 
X SHS 3 
7 
0 
11 
0 
20 
relative risk 
2.2 
3.6 
1.9 
1.1 
1.2 
relative risk 
2.0 
1.4 
1.2 
1.2 
1.7 
relative risk 
2.7 
5.7 
4.8 
0.9 
0.0 
relative risk 
1.7 
0.6 
6.0 
1.5 
В. During the period of 2h a f te r the measurement (pred ic t ive 
v a l u e ) ( i f t h e occurrence of shock i s not known i t i s assumed 
t o be a b s e n t ) ; nr = number of such periods considered. 
Skele ta l muscle PO. 
Treatment 
All 
no inotropes 
dopamine <20mg 
dopamine >20mg 
epinephrine 
Treatment 
All 
no inotropes 
dopamine <20mg 
dopamine >20rag 
epinephrine 
Treatment 
All 
no inotropes 
dopamine <20mg 
dopamine >20mg 
epinephrine 
Treatment 
All 
no inotropes 
dopamine <20mg 
dopamine >20rag 
epinephrine 
i 
nr. 
66 
15 
14 
16 
21 
nr. 
66 
15 
14 
16 
21 
nr. 
66 
15 
14 
16 
21 
nr. 
66 
15 
14 
16 
21 
3. 
% 
% 
% 
% 
0 kPa 
SHS 
42 
73 
28 
31 
39 
SHS 
24 
40 
7 
19 
29 
SHS 
15 
33 
21 
6 
5 
SHS 
3 
0 
0 
6 
5 
1-3 
1 
2 
3 
> 3 
nr. 
60 
29 
18 
3 
10 
nr. 
60 
29 
18 
3 
10 
nr. 
60 
29 
18 
3 
10 
nr. 
60 
29 
18 
3 
10 
.0 
% 
% 
% 
% 
kPa 
SHS 
18 
17 
17 
0 
30 
SHS 
13 
17 
11 
0 
10 
SHS 
2 
0 
0 
0 
10 
SHS 
3 
0 
6 
0 
10 
1-3 
1 
2 
3 
relative 
2.3 
4.3 
1.6 
>100 
1.3 
relative 
1.8 
2.4 
0.6 
>100 
2.9 
relative 
7.5 
>100 
>100 
>100 
0.5 
relative 
1.0 
... 
0 
>100 
0.5 
risk 
risk 
risk 
risk 
i n o t r o p i c a g e n t s and i n p a t i e n t s r e q u i r i n g i n o t r o p e s . These 
c a l c u l a t i o n s were made f o r t h e p e r i o d from 4 h o u r s b e f o r e t o 6 
h o u r s a f t e r s k e l e t a l muscle PO, a s s e s s m e n t (A) and f o r t h e 2-hour 
p e r i o d f o l l o w i n g t h e s k e l e t a l muscle PO- assessment (В) . В 
i n d i c a t e s t h e p r e d i c t i v e v a l u e of s k e l e t a l muscle PO_ assessment 
( t a b l e 8.Θ) . 
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Shock score mean 
3 
4 5 6 7 
Median skeletal nuscle P 0 2 ( k P a ) 
F ig. 8.1. Relation between mean of the skeletal muscle POj, 
mean shock score and I not ropes. 
• no inotropes 
A dopamine and lor dobutamine < 20 mg/h 
Δ dopamine and/or dobutamine > 20 mg/h 
о epinephrine used 
Cum '/. 
100 
8 0 -
6 0 -
4 0 -
2 0 -
- Г 
10 - r 12 
Г 
u 
kPa 
Fig.8.2. Cumulative frequence curve of the skeletal muscle POy 
and corresponding CISHS-score. 
1. CISHS = 0, n=25, median = 1.5 kPa 
2. CISHS = 0.5-1.5, n=37, median = 3.1 kPa 
3. CISHS = 2.0-3.0, п=Щ, median = 2.3 kPa 
H. CISHS = t 3.5. n=20, median = 7.5 kPa 
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If skeletal muscle PO- was below 3.0 kPa, positive shock scores 
were found significantly more often than if the skeletal muscle 
PO, was above 3.0 kPa (p<0.01). The predictive value of the 
median skeletal muscle PO- assessment in patients not using 
inotropic agents was even better (p<0.001). In patients using 
inotropes the skeletal muscle PO, assessment was not predictive 
using the 3.0 kPa limit (p>0.2). The relation between mean shock 
score and mean skeletal muscle PO, is presented in fig.8.1. The 
relation between skeletal muscle PO, and CISHS is shown in 
fig.8.2. 
θ.«. Discussion 
In this study no shock occurred during the study period if 
skeletal muscle PO, was normal (>4.2 kPa, mean value for healthy 
humans, see chapter 3). Skeletal muscle PO, assessments predicted 
the risk of shock, because if the skeletal muscle PO, was below 
3.0 kPa the risk of a positive shock score was 2.3 times higher 
than if skeletal muscle PO, was above 3.0 kPa. If the patient 
received no inotropes, skeletal muscle PO, assessment had a 
definite predictive value, because in these patients the risk of 
a positive shock score was 4.3 times higher if skeletal muscle 
PO, was below 3.0 kPa than if skeletal muscle PO, was above 3.0 
kPa. If, in those patients not receiving inotropes, skeletal 
muscle PO, was below 3.0 kPa, a positive shock score occurred in 
73% of the assessments during the subsequent period of 2 hours, 
and a positive shock score always occurred in the period of 4 
hours before and б hours after the skeletal muscle PO-
assessment. These results demonstrate that, in critically ill 
patients, skeletal muscle oxygenation is decreased before 
clinical shock occurs (fig.8.1). 
The early decrease of tissue perfusion in critically ill 
patients has also been demonstrated by techniques more extensive 
and invasive than skeletal muscle PO, assessment. Skeletal muscle 
PO, was monitored with a multiwire surface electrode in 55 
patients and low values were found to correlate with a low 
circulatory blood volume (4). This measurement enabled control of 
inspiratory oxygen supply and control of pharmaco-dynamic changes 
of local PO- (4). In another study oxygen partial pressure was 
measured by using an implanted Silastic catheter in the 
subcutaneous tissue of the arm in 33 postoperative patients on 
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the day of the operation and the first 5 postoperative days. 
Tissue hypoxia was a common finding and was most pronounced 
immediately after abdominal, vascular and cardiac operations. A 
supplemental bolus of infusion fluid increased low tissue PO- in 
all of 19 measurements, implicating hypovolemia as a common cause 
of postoperative tissue hypoxia (5). Tissue POj measurements 
were also performed by continuous in vivo measurements with a 
mass spectrometer in the deltoid muscle of 9 patients in shock 
after severe trauma (6). Tissue PO, values were lower 
postoperatively (2.7 kPa) despite the maintenance of PaO, above 
13 kPa. In shock low tissue PO- levels were found (2.0 kPa) (6). 
In this study skeletal muscle PO- assessment did not accurately 
predict clinical shock if the patient received inotropes, while 
in these patients the occurrence of positive shock scores was 
29-38% if the skeletal muscle PO, was below 3.0 kPa. The 
occurrence of positive shock scores increased to 73% in patients 
not receiving inotropes. These findings confirm that inotropes 
such as dopamine, dobutamine or epinephrine may maintain arterial 
blood pressure by increasing systemic vascular resistance at the 
cost of peripheral tissue perfusion. The administration of 
dopamine and dobutamine results in increases in cardiac index, 
pulmonary shunting, stroke volume and mean arterial blood 
pressure (7-12). Dobutamine preferentially strengthens the 
heart, whereas dopamine increases urinary output as well (13). In 
only one patient (nr.21) was skeletal muscle PO- normal, although 
high doses of inotropes were necessary to maintain arterial blood 
pressure. If inotropic drugs increase arterial blood pressure by 
augmenting cardiac output, while not increasing systemic 
vascular resistance, they could improve the skeletal muscle PO-. 
However, the use of inotropes impaired skeletal muscle 
oxygenation as the mean of the skeletal muscle PO- was below 3.0 
kPa in 9 out of 10 patients receiving inotropes 
(INS=3-4)(fig.8.1). In these patients, treated with inotropes, 
shock defined as inadeguate tissue oxygenation (chapter 1) 
occurred, but clinical shock as defined by the shock score did 
not occur in 4 patients. 
In the patients receiving inotropes systolic arterial blood 
pressure was artificially elevated, so that shock could not be 
diagnosed according to the clinical criteria such as decreased 
arterial blood pressure and/or impaired hourly urinary output. 
However, in the patients receiving inotropes shock, defined as 
impaired tissue oxygenation, occurred in 9 out of 10 patients. 
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The t r e a t m e n t w i t h t h e s e drugs i n c r e a s e d a r t e r i a l blood p r e s s u r e 
b u t d i d n o t improve t h e oxygenat ion of s k e l e t a l muscle t i s s u e . 
I t i s shown i n f i g . Θ.2 t h a t s k e l e t a l muscle P 0 2 i s d e c r e a s e d 
p r o g r e s s i v e l y i f t h e CISHS s c o r e , i n d i c a t i n g t h e s e v e r i t y of 
shock, i n c r e a s e d . Thus s k e l e t a l muscle PO, assessment e n a b l e s t h e 
d e t e c t i o n of t h e s e v e r i t y of shock. 
F u r t h e r s t u d i e s a r e n e c e s s a r y t o a s s e s s whether keeping 
s k e l e t a l muscle PO- above 4.0 kPa d u r i n g a l l p e r i o d s of t h e 
i l l n e s s may r e s u l t i n a lower m o r b i d i t y and m o r t a l i t y of p a t i e n t s 
a t r i s k . 
In c o n c l u s i o n , i n c r i t i c a l l y i l l p a t i e n t s s k e l e t a l muscle PO-
assessment e s t i m a t e s t h e s e v e r i t y of shock and i s a b l e t o p r e d i c t 
t h e r i s k of shock ( d e f i n e d as d e s c r i b e d i n t a b l e 8 . 3 ) , p r o v i d e d 
no i n o t r o p e s a r e g i v e n . 
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CHAPTER 9 
SKELETAL MUSCLE P02 ASSESSMENT, HEMODYNAMICS 
AND OXYGEN RELATED PARAMETERS 
IN CRITICALLY ILL PATIENTS 
9.1. Introductlon 
Skeletal muscle PO, depends upon the balance between oxygen 
delivery to tissue and oxygen consumption by tissue (1). Each of 
these depend upon a series of interrelated factors (chapter 1.3). 
In critically ill patients, one or more of these factors might be 
influenced by the underlying disease and by the treatment 
instituted. These alterations might lead to an increase or 
decrease of skeletal muscle POj (chapter 1). We therefore studied 
the relationship between skeletal muscle PO-, hemodynamics and 
oxygen related parameters in critically ill patients. 
9.2. Patients and methods 
In six of the 20 critically ill patients described in chapter 
8, a Swan-Ganz catheter was inserted for treatment at the time of 
entry into the study, allowing for more extensive monitoring. In 
these patients the systolic arterial blood pressure, mean 
arterial blood pressure, heart rate, central venous pressure, 
pulmonary arterial pressure and pulmonary capillary wedge 
pressure (Gould Swan-Ganz catheter, Siemens monitor) were 
determined. Cardiac output was obtained using the thermodilution 
method with the aid of a cardiac output computer (Edwards cardiac 
output computer). Arterial and mixed venous blood gases (ABL-3, 
Radiometer), arterial and mixed venous oxygen saturation 
(Oximeter, Instrumentation Laboratories) as well as hemoglobin 
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and hematocrit were determined. Skeletal muscle PO, was measured 
in the quadriceps femoris muscle using a Polarographie needle 
electrode (chapter 3). All measurements were performed at the 
start of the study and again after 2,4,6,8 and 16 hours. Stroke 
volume, left and right ventricular stroke work index, systemic 
vascular resistance, pulmonary vascular resistance, arterial 
oxygen supply, arterio-venous oxygen difference, oxygen 
extraction ratio, oxygen consumption, P50 of the oxyhemoglobin 
dissociation curve, inotropic score, shock score and combined 
inotropic and shock score were calculated (chapters 2 and 8). The 
within-patient correlation between skeletal muscle PO, and the 
other parameters was studied by calculating the Pearson 
correlation coefficient and transformed according to Hotelling 
(paragraph 3.7.2). 
Differences were considered significant if p<0.05. 
9.3. Results 
No significant correlations were found between skeletal muscle 
PO, and hemodynamic parameters in these patients. A significant 
within patient correlation was found only between the skeletal 
muscle PO, and arterial SO,, mixed venous SO- and arterio-venous 
oxygen difference. The correlation between skeletal muscle PO, 
and the other parameters is presented in table 9.1. The patients 
are presented in detail in tables 9.2.1- 9.2.6. 
Patient nr.l died during the study period. Cardiac output was 
maintained, but left ventricular stroke work index decreased 
concomitantly with mean arterial blood pressure. In this patient 
oxygen consumption was low but did not change prior to death, 
while mixed venous SO, decreased during the study period, oxygen 
extraction was low (0.05-0.19), and the median skeletal muscle 
PO, assessment was very low (table 9.2.1). 
Patient nr.2 showed an elevated cardiac output and a low 
systemic vascular resistance. Oxygen extraction was high (0.44-
0.48). Oxygen consumption was elevated. The P50 of the 
oxyhemoglobin dissociation curve was increased (table 9.2.2). 
Patient nr.3 was the only patient in this study not receiving 
inotropic treatment. Stroke volume and left ventricular stroke 
work index were elevated. Arterial oxygen supply, oxygen 
consumption, mixed venous SO, and skeletal muscle PO, were normal 
(9.2.3). 
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In patient nr.4 intra-artenal balloon pumping was necessary 
because of severely restricted cardiac function. Heart rate was 
increased, stroke volume was small and left ventricular stroke 
work index was decreased. Arterial oxygen supply was decreased, 
oxygen extraction was slightly elevated and oxygen consumption 
was normal. Skeletal muscle PO, was low and showed a negative 
correlation with oxygen consumption. The P50 of the oxyhemoglobin 
dissociation curve was increased. This patient survived (table 
9.2.4). 
Patient nr.5 showed normal hemodynamics. The oxygen extraction 
ratio was low as was the oxygen consumption. Between 8 and 16 
hours oxygen consumption increased while skeletal muscle PO-
decreased. The P50 of the oxyhemoglobin dissociation curve was 
decreased. This patient died 5 days later (table 9.2.5). 
Patient nr.6 showed a very high cardiac output, left 
ventricular stroke work index and stroke volume. The systemic 
vascular resistance was low. The arterial oxygen supply was very 
high, but oxygen extraction was low. Oxygen consumption was 
Table 9.1. Correlation of skeletal muscle P0o with other variables 
(6 patients). 
Parameter 
Systolic arterial blood 
Heart rate 
Central venous pressure 
pressure 
Mean arterial blood pressure 
Cardiac output 
Oxygen consumption 
Arterial oxygen supply 
Oxygen extraction ratio 
Arterial pH 
Arterial P0 2 
Arterial SO» 
Mixed venous pH 
Mixed venous PO-
Mixed venous PC02 
Mixed venous S0_ 
Arterio-venous oxygen difference 
mean 
Pearson 
coeff 
0.28 
0.34 
0 02 
0.24 
-0.01 
-0.33 
0.08 
-0.36 
0.12 
-0 07 
0.37 
0.16 
0.24 
0.07 
0.46 
-0.41 
p-val 
0 16 
0.07 
0 99 
0.21 
0.96 
0 09 
0.68 
0.06 
0.28 
0.73 
0.02 
0.42 
0 21 
0.72 
0.02 
0.03 
slightly increased. Skeletal muscle PO- was normal (table 9.2.6). 
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Table 9.2. Hemodynamic and oxygen related parameters in 6 
patients monitored with a Swan Ganz catheter. 
Table 9.2.1. 
Patient nr. 1. 
Age: 60 
Diagnosis: septic shock 
Initial classification: systolic arterial pressure < 90 mmHg 
treatment with inotropes 
Blood culture: Gram negative bacteria, streptococcus. 
Died between T5 and T6 
Time after start of the study 
Heart rate 
Mean arterial blood pressure 
Systolic arterial blood pressure 
Central venous pressure 
Mean pulmonary arterial blood pressure 
Pulmonary capillary wedge pressure 
Cardiac output 
Stroke volume 
Left ventricular stroke work index 
Right ventricular stroke work index 
Systemic vascular resistance 
Pulmonary vascular resistance 
FjO., (%) 
PEEP 
Arterial oxygen supply 
Arterio-venous oxygen difference 
Oxygen extraction ratio 
Oxygen consumption 
Arterial P0o 
Arterial 
Skeletal 
Skeletal 
Skeletal 
SO, 
muscle 
muscle 
muscle 
PO ? ) 
PO 9 > 
PO,,, 
median 
P70 
mean 
Mixed venous PO, 
Mixed venous SO-
PS 0 -Hemoglobin 
INS-score 
Shock-score 
CISHS-score 
0 
118 
115 
165 
16 
26 
17 
5.4 
45 
70 
6 
1466 
133 
100 
17 
875 
0.9 
0.05 
50 
7.6 
89 
1.0 
1.7 
1.2 
6.5 
84 
3.5 
4 
2 
--
2 
114 
70 
90 
14 
23 
15 
6.4 
56 
53 
6 
700 
100 
100 
16 
978 
2.3 
0.15 
149 
7.7 
86 
0.4 
0.9 
0.7 
5.8 
73 
4.0 
3 
3 
6 
4 
113 
65 
95 
16 
26 
15 
7.0 
62 
54 
8 
552 
123 
100 
16 
1097 
1.9 
0.12 
138 
7.8 
68 
0.6 
0.9 
0.7 
6.1 
77 
3.9 
4 
1 
5.5 
6 
110 
50 
74 
15 
22 
12 
4.8 
44 
29 
4 
577 
164 
100 
17 
749 
2.5 
0.15 
120 
7.6 
88 
0.6 
1.0 
0.6 
5.8 
74 
3.9 
4 
3 
6.5 
8 
104 
56 
80 
16 
23 
14 
4.5 
43 
32 
4 
711 
160 
100 
16 
740 
3.2 
0.19 
145 
7.9 
87 
0.1 
0.5 
0.4 
5.5 
70 
4.0 
4 
3 
7.5 
16 h 
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Table 9.2.2. 
Patient nr.2. 
Age: 65 
Diagnosis: multiple abdominal abcesses 
Initial classification: treatment with inotropes 
Blood culture: negative 
Died 24 hours after the study 
Time after start of the study 
Heart rate 
Mean arterial blood pressure 
Systolic arterial blood pressure 
Central venous pressure 
Mean pulmonary arterial blood pressure 
Pulmonary capillary wedge 
Cardiac output 
Stroke volume 
Left ventricular stroke work index 
Right ventricular stroke work index 
Systemic vascular resistance 
Pulmonary vascular resistance 
FJOJ (%) 
PEEP 
Arterial oxygen supply 
Arterio-venous oxygen difference 
Oxygen extraction ratio 
Oxygen consumption 
Arterial P0„ 
Arterial 
Skeletal 
Skeletal 
Skeletal 
so2 
muscle P02, 
muscle PO«, 
muscle PO», 
median 
P70 
mean 
Mixed venous PO. 
Mixed venous SO. 
P50-Heraoglobin 
INS-score 
Shock-score 
CISHS-score 
0 
97 
62 
94 
14 
23 
13 
7.6 
79 
46 
9 
301 
103 
60 
5 
858 
5.4 
0.48 
419 
9.0 
92 
1.1 
1.6 
1.3 
4.4 
45 
4.6 
4 
1 
__ 
2 
108 
71 
109 
11 
23 
14 
9.3 
87 
53 
14 
289 
76 
60 
5 
1083 
5.2 
0.44 
488 
7.9 
91 
2.4 
3.1 
2.3 
4.3 
50 
4.3 
4 
1 
4.5 
4 
106 
68 
105 
13 
25 
13 
10.3 
97 
52 
15 
209 
93 
65 
5 
1126 
5.3 
0.48 
549 
7.8 
88 
3.5 
4.5 
3.7 
4.3 
45 
4.6 
4 
1 
4.5 
6 
106 
73 
110 
15 
26 
16 
8.6 
81 
47 
12 
260 
93 
65 
8 
941 
5.0 
0.44 
428 
7.8 
88 
2.5 
3.0 
2.4 
4.1 
48 
4.2 
4 
1 
4.5 
8 
107 
68 
102 
16 
27 
16 
8.6 
80 
44 
11 
232 
102 
65 
8 
941 
5.0 
0.44 
428 
7.7 
88 
2.5 
3.1 
2.4 
4.1 
48 
4.2 
4 
1 
4.5 
16 h 
95 
69 
108 
15 
28 
17 
8.1 
85 
53 
15 
306 
108 
70 
10 
967 
5.5 
0.45 
447 
8.5 
91 
3.0 
3.8 
3.1 
4.3 
49 
4.4 
4 
1 
4.5 
Table 9.2.3. 
Patient nr. 3. 
Age: 36 
Diagnosis: pulmonary edema, hepatosplenomegaly, préexistent 
renal failure 
Initial classification: respiratory rate > 30 min, 
no pulmonary disease 
Blood cultures: negative 
Survived 
Time after start of 
Heart rate 
Mean arterial blood 
the study 
pressure 
Systolic arterial blood pressure 
Central venous pressure 
Mean pulmonary arterial blood 
Pulmonary capillary 
Cardiac output 
Stroke volume 
pressure 
wedge pressure 
Left ventricular stroke work index 
Right ventricular stroke work 
Systemic vascular resistance 
Pulmonary vascular resistance 
FjO., (%) 
PEEP 
Arterial oxygen supply 
index 
Arterio-venous oxygen difference 
Oxygen extraction ratio 
Oxygen consumption 
Arterial P02 
Arterial SO. 
Skeletal muscle P02! 
Skeletal muscle PO,, 
Skeletal muscle P021 
Mixed venous PO. 
Mixed venous SO, 
PSO-hemoglobin 
INS-score 
Shock-score 
CISHS-score 
, median 
, P70 
, mean 
0 
66 
120 
189 
13 
28 
23 
9.6 
145 
236 
29 
891 
Al 
40 
10 
1189 
3.1 
0.25 
300 
14.6 
95 
6.8 
8.6 
7.1 
5.5 
72 
3.9 
1 
0 
--
2 
60 
114 
180 
10 
24 
21 
8.1 
136 
210 
25 
1014 
29 
40 
5 
1008 
3.2 
0.25 
260 
11.0 
95 
3.9 
4.6 
4.0 
5.4 
71 
3.9 
1 
0 
0 
4 
57 
121 
190 
8 
24 
21 
7.1 
126 
207 
27 
1255 
33 
40 
10 
775 
3.1 
0.28 
222 
13.5 
94 
4.5 
4.9 
4.3 
5.3 
68 
4.0 
1 
0 
0 
6 
56 
119 
187 
8 
22 
18 
8.8 
158 
255 
30 
997 
35 
40 
5 
982 
3.5 
0.32 
315 
11.0 
95 
4.3 
6.0 
4.4 
5.0 
65 
4.0 
1 
0 
0 
8 
60 
132 
203 
8 
22 
18 
7.9 
131 
235 
24 
1255 
40 
40 
5 
887 
3.4 
0.29 
265 
10.2 
95 
3.2 
3.5 
3.6 
5.1 
67 
3.9 
1 
0 
0 
16 
62 
125 
189 
10 
23 
18 
8.5 
137 
232 
24 
1082 
47 
35 
5 
896 
2.8 
0.26 
241 
12.6 
96 
10.1 
10.7 
9.9 
5.1 
71 
3.6 
1 
0 
0 
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Table 9.2.4. 
Patient nr. 4. 
Age : 45 
Diagnosis: mitral valve prosthesis, coronary bypasses, 
circulatory arrest. 
intra-arterial balloon pump inserted 
Initial classification: temperature > 37 0C 
treatment with inotropes 
Blood cultures: negative 
Survived 
Time after start of the study 
Heart rate 
Mean arterial blood pressure 
Systolic arterial blood pressure 
Central venous pressure blood 
Mean pulmonary arterial pressure 
Pulmonary capillary wedge pressure 
Cardiac output 
Stroke volume 
Left ventricular stroke work index 
Right ventricular stroke work index 
Systemic vascular resistance 
Pulmonary vascular resistance 
FJOJ (%) 
PEEP 
Arterial oxygen supply 
Arterio-venous oxygen difference 
Oxygen extraction ratio 
Oxygen consumption 
Arterial P02 
Arterial S02 
Skeletal muscle P02, median 
Skeletal muscle PO,, P70 
Skeletal muscle P02, mean 
Mixed venous PO-
Mixed venous SO« 
P50-hemoglobin 
INS-score 
Shock-score 
CISHS-score 
0 
134 
86 
110 
19 
32 
28 
5.0 
38 
44 
6 
1050 
62 
60 
5 
696 
4.0 
0.29 
204 
8.2 
89 
2.7 
3.5 
2.8 
4.9 
63 
4.0 
4 
0 
3 
2 
137 
94 
115 
17 
29 
24 
6.0 
43 
54 
7 
1026 
66 
60 
5 
777 
3.9 
0.30 
233 
8.0 
87 
1.2 
1.7 
1.3 
4.8 
61 
4.1 
4 
0 
3 
4 
136 
84 
100 
18 
29 
25 
5.4 
39 
44 
5 
977 
59 
60 
5 
790 
5.6 
0.38 
302 
8.1 
89 
0.4 
2.2 
1.3 
4.8 
55 
4.4 
4 
0 
3 
6 
137 
90 
no. 
18 
29 
25 
4.9 
35 
42 
5 
1175 
65 
60 
5 
630 
4.8 
0.36 
234 
8.5 
89 
1.7 
2.1 
1.7 
4.9 
56 
4.5 
4 
0 
3 
8 
136 
88 
110 
18 
29 
25 
5.4 
39 
46 
5 
1037 
59 
60 
5 
687 
4.8 
0.36 
258 
8.8 
88 
0.6 
1.2 
0.9 
4.9 
55 
4.5 
4 
0 
3 
16 
124 
73 
109 
19 
28 
24 
5.3 
42 
41 
5 
815 
60 
60 
10 
— 
— 
— 
— 
--
--
0.4 
1.0 
0.8 
--
--
--
3 
0 
2 
135 
Table 9.2.5. 
Patient nr. 5. 
Age: 70 
Diagnosis: shock, terminal renal failure 
Initial classification: diuresis <0.5 cc/kg/h 
treatment with inotropes 
Blood cultures: negative 
Died 5 days later 
Time after start of the study 
Heart rate 
Mean arterial blood pressure 
Systolic arterial blood pressure 
Central venous pressure 
Mean pulmonary arterial blood pressure 
Pulmonary capillary wedge pressure 
Cardiac output 
Stroke volume 
Left ventricular stroke work index 
Right ventricular stroke work 
Systemic vascular resistance 
Pulmonary vascular resistance 
F I0 2 (%) 
PEEP 
Arterial oxygen supply 
index 
Arterio-venous oxygen difference 
Oxygen extraction ratio 
Oxygen consumption 
Arterial PO, 
Arterial S0 2 
Skeletal muscle P0 2, median 
Skeletal muscle PO,, P70 
Skeletal muscle P0 2, mean 
Mixed venous P0 2 
Mixed venous SO, 
PSO-hemoglobin 
INS-score 
Shock-score 
CISHS-score 
0 
105 
93 
146 
β 
26 
14 
4.5 
42 
53 
10 
1511 
213 
60 
15 
836 
2.2 
0.11 
99 
9.4 
96 
2.2 
2.6 
2.1 
5.0 
85 
2.6 
4 
0 
--
2 
100 
82 
132 
9 
24 
16 
4.5 
46 
51 
9 
1250 
137 
60 
15 
858 
1.4 
0.07 
67 
9.3 
95 
3.5 
4.0 
3.7 
5.0 
88 
2.4 
4 
0 
3 
4 
100 
66 
100 
8 
22 
17 
5.3 
53 
47 
10 
864 
74 
50 
15 
1020 
2.8 
0.14 
152 
8.9 
96 
2.7 
2.9 
2.4 
5.0 
82 
2.8 
4 
0 
3 
6 
100 
71 
115 
8 
23 
16 
4.5 
45 
43 
9 
1098 
122 
50 
15 
--
--
--
--
--
--
3.7 
4.7 
3.7 
--
-· 
--
4 
2 
5 
8 
100 
63 
100 
9 
22 
16 
5.0 
51 
43 
9 
837 
93 
50 
15 
876 
3.4 
0.19 
174 
8.4 
92 
3.7 
4.5 
3.4 
4.9 
74 
3.3 
4 
3 
7 
16 
100 
68 
105 
14 
31 
15 
5.5 
56 
51 
12 
771 
228 
50 
15 
983 
4.1 
0.22 
231 
8.4 
92 
1.5 
3.7 
2.2 
5.1 
73 
3.5 
4 
--
.. 
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Table 9.2.6. 
Patient nr. 6. 
Age: 49 
Diagnosis: multitrauma, multiple organ failure 
Initial classification: treatment with inotropes 
Blood culteres: none 
Died 14 days later 
Time after start of the study 
Heart rate 
Mean arterial blood pressure 
Systolic arterial blood pressure 
Central venous pressure 
Mean pulmonary arterial blood pressure 
Pulmonary capillary wedge pressure 
Cardiac output 
Stroke volume 
Left ventricular stroke work index 
Right ventricular stroke work index 
Systemic vascular resistance 
Pulmonary vascular resistance 
F^j « ) 
PEEP 
Arterial oxygen supply 
Arterio-venous oxygen difference 
Oxygen extraction ratio 
Oxygen consumption 
Arterial PO« 
Arterial 
Skeletal 
Skeletal 
Skeletal 
so2 
muscle 
muscle 
muscle 
P0 ?, 
PO?, 
PO., 
median 
Ρ70 
mean 
Mixed venous PO, 
Mixed venous SO. 
P50-hemoglobin 
INS-score 
Shock-score 
CISHS-score 
0 
90 
76 
132 
17 
31 
20 
16.2 
181 
187 
34 
289 
S3 
40 
8 
2025 
2.0 
0.15 
320 
12.9 
94 
5.0 
5.5 
5.1 
6.0 
80 
Э.6 
4 
0 
.. 
2 
115 
52 
105 
11 
22 
12 
16.7 
146 
103 
21 
195 
47 
40 
8 
2094 
2.0 
0.16 
335 
14.7 
94 
7.0 
7.8 
7.5 
6.5 
80 
3.9 
4 
0 
3 
4 
114 
71 
138 
13 
22 
14 
16.2 
142 
137 
17 
284 
39 
40 
8 
2028 
2.0 
0.15 
322 
13.6 
94 
6.1 
7.5 
6.1 
6.3 
80 
3.7 
4 
0 
3 
6 
108 
80 
145 
11 
22 
11 
15.6 
145 
157 
21 
351 
56 
70 
8 
2309 
1.4 
0.08 
224 
30.1 
94 
8.3 
9.0 
7.5 
7.3 
88 
3.4 
4 
0 
3 
8 
108 
92 
149 
7 
19 
9 
17.0 
157 
196 
25 
400 
47 
40 
8 
2480 
1.9 
0.12 
321 
16.1 
94 
4.8 
5.6 
5.2 
6.4 
83 
3.5 
4 
0 
3 
16 h 
100 
101 
145 
10 
25 
15 
17.0 
170 
233 
34 
428 
47 
40 
8 
2298 
1.9 
0.13 
319 
15.0 
94 
6.9 
7.8 
7.0 
6.6 
82 
3.7 
3 
0 
2 
9Λ. Discussion 
Arterial SO-, mixed venous SO, and arterio-venous oxygen 
difference are parameters which most closely reflect the balance 
between oxygen supply and oxygen consumption. These parameters 
were the only ones that correlated significantly with skeletal 
muscle PO-. This supports the value of the skeletal muscle PO-
assessment in determining the balance between oxygen supply and 
oxygen consumption in skeletal muscle tissue in critically ill 
patients. These findings are in agreement with previous results 
found in an experimental model (chapter 3) and in patients after 
extracorporeal circulation (chapter 7). 
In this limited study of six patients both patients (nr.3 and 
nr.4) who showed a normal oxygen extraction ratio and a normal 
oxygen consumption survived, while the patients who showed a low 
oxygen extraction (nr. 1,5 and 6) or a high oxygen extraction 
(nr.2) died. A deficient oxygen extraction ratio has been 
reported in sepsis (2-7). Peripheral vascular failure has been 
reported to be a major determinant in nonsurvivors, since a 
persistent vasodilatation irrespective of cardiac output was 
found in patients dying from sepsis (8). Systemic vascular 
resistance was low in patients 1 and 6 who both died. 
Patient nr.2 with ARDS showed oxygen supply dependency (9,10) 
because if arterial oxygen supply increased, oxygen consumption 
increased as well. This finding agrees with a study in 20 
patients with ARDS where a direct relationship was found between 
delivery and 0- uptake (11). In another study in 104 critically 
ill patients with various pathological conditions and with some 
hyperdynamic features, an increase in oxygen consumption together 
with an increase in oxygen transport was found (12). 
Patient nr.4 showed cardiac failure. He was treated with 
epinephrine and intra-arterial balloon pumping. Skeletal muscle 
PO- was low, indicating that systemic circulation was maintained 
by limitation of blood flow to the muscle. Nevertheless this 
patient survived. 
In conclusion, in critically ill patients skeletal muscle PO-
assessment indicates the balance between oxygen supply and oxygen 
consumption in the muscle. If skeletal muscle PO- is decreased in 
critically ill patients, the measurement of hemodynamics, 
especially the oxygen related parameters such as oxygen 
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extraction, reveal the cause of a decreased skeletal muscle PO-
and distinguish those patients who show oxygen supply dependency 
or impaired oxygen extraction in the tissues and those who are 
able to regulate normally the oxygen release to the tissue. 
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CHAPTER 10 
IS SKELETAL MUSCLE P02 RELATED TO THE SEVERITY OF 
MULTIPLE ORGAN FAILURE AND SURVIVAL IN CRITICALLY ILL PATIENTS Ì 
A preliminary study. 
10.1. Introduction 
Multiple organ failure (M.O.F.) is presently one of the leading 
causes of death in critically ill patients. Mortality is high 
(59-74%)(1-3) despite intensive care treatment. The causative 
factors remain poorly understood (2,3), but severe infection, 
severe metabolic injury, shock, microemboli, complement 
activation and massive blood replacement have been suggested as 
initiating factors (1-5). In these patients regional hypoxia has 
been suggested to contribute to multiple organ failure (3,4,6) 
and tissue perfusion probably is an important factor for survival 
(7,8). There is presently no study available on tissue PO, in 
M.O.F.-patients; we therefore studied the relationship between 
skeletal muscle PO- and the incidence and severity of multiple 
organ failure, and the relationship between skeletal muscle PO-
and survival in critically ill patients. 
10.2. Patients and methods 
This analysis concerns the same patients as described in 
chapter Θ. The same methods of measurements were applied. From 
each patient a multiple organ failure score (M.O.F.-score) was 
calculated (3). This score measures the severity of organ failure 
in 3 gradings and 7 organ systems. The criteria are summarized in 
table 10.1. The patient was considered to survive if he was 
discharged from the I.C.U. alive. 
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Out of a l l t h e s k e l e t a l muscle PO- assessments ob t a ined du r ing 
t h e 16-hour s tudy p e r i o d in each p a t i e n t t he minimum, t h e mean 
and t h e maximum median va lue as we l l as t h e minimum, t h e mean and 
t h e maximum P70 v a l u e d u r i n g t h e s tudy p e r i o d were analyzed in 
Table 10.1. M.O.F.score (3). 
Grade 
Pulmonary 
failure 
Cardiac 
failure 
Renal 
failure 
Hepatic 
failure 
Hematologic 
failure 
Gastro-
intestinal 
failure 
Central 
nervous 
system 
failure 
Mechanical ventilation 
with PEEP < 10 cm H20 
F r0 2 < 0.4 
Dopamine < 10 pg/kg/min 
Nitroglycerine < 20 
yg/kg/min 
Serum creatinine > 2 mg/dl Dialysis 
Mechanical ventilation 
with PEEP > 10 cm H20 
and/or F 0 2 > 0.4 
Dopamine > 10 ug/kg/min 
Nitroglycerin > 20 
yg/kg/min 
Serum bilirubin > 2 mg/dl 
SGOT > 25 U/l 
Platelets < SOxlO'/l 
and/or 
leucocytes ¿ 30xlOs/l 
Acalculous cholecystitis 
or stress ulcer 
Diminished responsiveness 
Serum bilirubin > 6 mg/dl 
and/or SGOT > 50 U/l 
Disseminated intravascular 
coagulation 
leucocytes < 2.5xl0&.s6./l 
or ¿ 60х10е/1 
Perforation of gallbladder 
Bleeding from stress ulcer 
> 2 units/24 hr 
Necrotizing enterocolitis 
Pancreatitis 
Severely diminished 
responsiveness. Diffuse 
neuropathy. 
Note: No failure: M.O.F.-score = 0 
Total M.O.F.-score = tota l of 7 organ failure scores 
r e l a t i o n t o t h e M.O.F.-score and t o s u r v i v a l . 
R e s u l t s were s t a t i s t i c a l l y ana lyzed u s i n g Spearman's 
c o e f f i c i e n t of rank c o r r e l a t i o n , Wi lcoxon ' s two sample t e s t and 
F i s h e r ' s e x a c t t e s t f o r 2 x 2 t a b l e s . 
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/0.3. Results 
The study was performed in 20 patients. Two patients were 
studied twice during the course of their illness. For statistical 
reasons (independence of observations) only the second study in 
these two patients was used for analysis. One patient (nr.4) died 
during the study period. Six patients died after the study while 
still in the intensive care unit. One patient was excluded from 
the analysis of skeletal muscle PO- assessment and survival, as 
intensive care treatment was not continued because of an 
accompanying terminal malignancy. The patient characteristics are 
presented in table 8.5. The mean, minimum and maximum values of 
the median and P70 skeletal muscle PO- assessment found during 
the study period are presented in table 10.2. 
The M.O.F. scores of the surviving patients were significantly 
lower than those of the patients who died (Wilcoxon two sample 
test, p=0.009). The relationship between skeletal muscle PO-
assessment and M.O.F. score is evaluated in table 10.4. If the 
mean skeletal muscle PO- was below 2.0 kPa, significantly worse 
multiple organ failure occurred (M.O.F. score > 5). The patients 
with a M.O.F. score above 5 had a mean skeletal muscle PO- of 2.4 
kPa ±1.8 SD, whereas the patients with a M.O.F. score of 5 or 
less had a mean skeletal muscle PO- of 3.6 kPa ±1.4 SD. 
A significant correlation was found between minimum, mean and 
maximum values of the P70 skeletal muscle PO- assessment and the 
total M.O.F.-score (table 10.5). Because skeletal muscle PO- is 
closely related to pulmonary and cardiac function, the 
correlation between the pulmonary and cardiac organ failure score 
was analyzed as well. No significant correlation was found 
between skeletal muscle PO- and the pulmonary organ failure score 
(table 9.5), while a significant correlation was found between 
the mean and maximum P70 value of the skeletal muscle P0-
assessment and the cardiac organ failure score. We did not find 
any significant correlation between skeletal muscle PO- and 
survival (Wilcoxon two sample test, p>0.6). The only patient who 
died during the study period showed the lowest skeletal muscle 
P0_ of all patients. 
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Table 10.2. Minimum, mean and maximum of median and P70 skeletal 
muscle PO, assessment in 20 critically ill patients. 
nr. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
Mean 
SD 
mean 
2.8 
3.4 
6.5 
0.6 
2.6 
1.5 
2.3 
4.0 
2.6 
1.5 
4.8 
5.5 
1.2 
1.8 
2.8 
2.7 
2.8 
5.3 
2.7 
2.9 
6.4 
2.3 
3.2 
1.7 
median 
min 
1.1 
0.6 
4.2 
0.1 
0.3 
0.3 
1.5 
1.7 
1.1 
0.3 
3.1 
3.3 
0.4 
0.4 
1.9 
2.1 
2.4 
3.2 
1.1 
1.5 
4.8 
1.2 
1.7 
1.4 
max 
4.2 
6.8 
8.2 
1.0 
3.6 
2.4 
3.0 
6.9 
3.6 
3.9 
6.8 
10.2 
2.7 
4.2 
4.2 
3.3 
3.3 
7.0 
3.7 
3.8 
8.4 
3.1 
4.9 
2.4 
mean 
3.8 
4.3 
7.6 
1.0 
3.5 
1.6 
3.2 
4.5 
3.2 
2.8 
5.5 
6.4 
2.0 
3.0 
3.7 
3.6 
3.2 
7.1 
3.9 
3.7 
7.2 
3.0 
4.0 
1.9 
P70 
min 
2.3 
2.7 
5.6 
0.5 
1.2 
0.3 
2.2 
2.2 
1.6 
0.9 
3.6 
3.5 
1.0 
2.0 
2.4 
2.7 
2.7 
4.7 
2.4 
2.8 
5.5 
1.8 
2.5 
1.5 
max 
5.1 
8.4 
9.3 
1.7 
4.6 
2.6 
4.5 
7.2 
4.5 
4.1 
7.8 
10.7 
3.5 
6.8 
5.0 
4.8 
3.9 
11.9 
5.2 
4.7 
9.0 
3.9 
6.0 
2.8 
Nr.l is the same patients as nr.22, and nr.7 is the 
same patient as nr.10 
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Table 10.3. M.O.F. score of individual organ system, total M.O.F. 
score and survival in 20 critically ill patients. 
Nr. pulm. card, liver, renal, hemat. C.N.S. gastro. Total Surv. 
score 
1. 
2 . 
3 . 
4 . 
5. 
6. 
7. 
8 . 
9. 
10. 
11. 
12. 
1 3 . 
14. 
15. 
16. 
17. 
18. 
19. 
20 . 
2 1 . 
2 2 . 
Mean 
SD 
0 
0 
0 
2 
2 
2 
2 
1 
2 
2 
1 
2 
2 
0 
1 
0 
1 
2 
1 
2 
1 
0 
1. 
0, 
0 
0 
0 
2 
1 
1 
1 
1 
2 
2 
1 
0 
2 
1 
1 
1 
1 
0 
0 
2 
2 
0 
.18 0. 
.9 0. 
0 
0 
0 
1 
2 
2 
2 
1 
1 
2 
0 
0 
0 
0 
0 
0 
2 
0 
0 
1 
1 
0 
.95 0.68 
.8 0 .8 
0 
0 
0 
1 
0 
0 
0 
0 
2 
2 
0 
1 
0 
1 
0 
0 
0 
0 
0 
1 
2 
0 
0.45 
0.7 
1 
1 
0 
2 
0 
0 
0 
0 
1 
0 
0 
0 
1 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 . 3 2 
0 .6 
0 
0 
0 
2 
0 
2 
1 
1 
2 
1 
0 
0 
1 
0 
1 
0 
1 
1 
0 
2 
1 
0 
0 . 7 3 
0 .8 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 .05 
0 . 2 
1 
1 
0 
10 
5 
7 
6 
4 
10 
9 
2 
3 
6 
2 
4 
1 
5 
4 
1 
8 
7 
0 
4 
3 
Y 
Y 
Y 
N(O) 
Y 
N(305) 
Y 
Y 
N ( l ) 
Y 
Y 
Y 
Y 
Y 
N(2) 
Y 
Y 
N(20) 
Y 
N(5) 
N(14) 
Y 
.4 
.2 
Survival : Y = survived 
N = died (η) days after the study 
M.O.F. score, see table 10.1. 
Nr.l is the same patient as nr.22, and nr.7 is the same patient 
as nr. 10 
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Table 10.Α. Distribution of concerning M.O.F. score and skeletal 
muscle PO. in 20 patients 
;eletal muscle PO. 
mean < 2.0 kPa 
mean > 2.0 kPa 
< 5 
1 
12 
13 
M, .0 .F. -score 
> 5 
4 
3 
7 
5 
15 
Fisher exact test ρ < 0.05 
Table 10.5.Correlation between M.O.F. score and skeletal muscle 
PO, in 20 critically ill patients. 
P50 min 
P50 mean 
P50 max 
P70 rain 
P70 mean 
P70 max 
Tot 
spc 
-0.39 
-0.38 
-0.31 
-0.45 
-0.44 
-0.49 
al 
Ρ 
η.s. 
η.s. 
η.s. 
<0.05 
=0.05 
<0.05 
M.O.F. SCORE 
Pulmonary 
spc 
-0.32 
-0.28 
-0.21 
-0.37 
-0.28 
-0.32 
Ρ 
η.s. 
η.s. 
η.s. 
η.s. 
η.s. 
η.s. 
Card 
spc 
-0.34 
-0.41 
-0.35 
-0.40 
-0.46 
-0.52 
iac 
Ρ 
η.s. 
η.s. 
η.s. 
η.s. 
<0.05 
<0.05 
spc = Spearman rank correlation coefficient 
ρ = p-value of Spearman rank correlation coefficient 
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10.U. Discussion 
In t h i s s tudy we found a s i g n i f i c a n t l y dec reased s k e l e t a l 
muscle PO- i n m u l t i p l e organ f a i l u r e (M.O.F. s co re > 5 ) . 
The l ack of c o r r e l a t i o n between s k e l e t a l muscle PO- and 
s u r v i v a l i n t h e s e p a t i e n t s i s no t s u r p r i s i n g , s i n c e s k e l e t a l 
muscle PO- was measured on ly du r ing a s i n g l e 16 hour p e r i o d only 
and a dec reased s k e l e t a l muscle P0_ does no t n e c e s s a r i l y impai r 
t h e i n t e g r i t y of s k e l e t a l muscle t i s s u e . M.O.F score was 
s i g n i f i c a n t l y lower i n s u r v i v o r s t han i n n o n - s u r v i v o r s . As t h e 
M.O.F. score e s t i m a t e s t h e f a i l u r e of s e v e r a l organs i t i s b a r e l y 
i n f l u e n c e d by t r e a t m e n t , and t h e r e f o r e p r e d i c t s s u r v i v a l more 
a c c u r a t e l y . 
In c o n c l u s i o n t h i s s tudy shows t h a t a h igh M.O.F. s co re i s 
a s s o c i a t e d wi th a low s k e l e t a l muscle PO- and t h u s confirms the 
h y p o t h e s i s t h a t r e g i o n a l hypoxia c o n t r i b u t e s t o M.O.F. ( 3 , 4 , 6 ) . 
10.5. References 
1. Eiseman B, Beart R, Norton L: Multiple organ f a i l u r e . Surg Gynecol Obstet 
144:323-326, 1977. 
2. Fry DE, P e a r l s t e i n L, Fulton RL, Polk HC: Multiple system organ f a i l u r e . 
Arch Surg 115:136-140, 1980. 
3 . Goris RJA, Boekhorst t e ThPA, Nuytinck JKS, Gimbrere JSF: Multiple-organ 
f a i l u r e . Generalized au todes t ruc t ive inflammation? Arch Surg 
120:1109-1115, 1985. 
4. Cerra FB: The systemic s ep t i c response: mul t ip le systems organ f a i l u r e . 
Cr i t Care Clin 1:591-607, 1985. 
5. Nuytinck JKS: The adul t r e sp i r a to ry d i s t r e s s syndrome and mul t ip le organ 
f a i l u r e . Thes is , Nijmegen, 1985. 
6. Danek SJ, Lynch JP, Weg JG, Dantzker DR: The dependence of oxygen uptake 
on oxygen de l ivery in the adult r e sp i r a to ry d i s t r e s s syndrome. Am Rev 
Resp Dis 122:387-395, 1980. 
7. Shoemaker WC, Czer LSC: Evaluation of the b io log ic importance of various 
hemodynamic and oxygen t r anspor t v a r i a b l e s : Which var iab les should be 
monitored in pos topera t ive shock? Cr i t Care Med 7:424-431, 1979. 
8. Groeneveld ABJ, Bronsveld W, Thijs LG: Hemodynamic determinants of 
mor ta l i ty in human s e p t i c shock. Surgery 99:140- 153, 1986. 
147 

LIST OF ABBREVIATIONS 
Ag silver 
AgCl silver chloride 
Art arterial 
Au gold 
B.S.A. body surface area 
B.E. base excess 
С degree Celsius 
Ca02 arterial oxygen content 
C(a-v)02 arteriovenous oxygen difference 
C.I. cardiac index 
CISHS combined inotropic and shock score 
CO. cardiac output 
COHb carboxyhemoglobin 
C.V.P. central venous pressure 
CVO2 mixed venous oxygen content 
D.A.P. diastolic arterial blood pressure 
DO? arterial oxygen supply 
D.P.A.P. diastolic pulmonary arterial blood pressure 
2,3-DPG 2,3 diphosphoglycerate 
EO2 oxygen extraction ratio 
F1O2 inspiratory oxygen fraction 
h hour 
H height 
H2O water 
H2O2 hydrogen peroxide 
Ho _ hemoglobin 
HCO3" bicarbonate anion 
H.R. heart rate 
ie electrode current 
INS inotropic score 
К Krogh's diffusion coefficient 
KCN potassium cyanide 
Kg kilogram 
kPa kilopascal 
L.V.S.W. left ventricular stroke work 
M.A.P. mean arterial blood pressure 
%Methb methemoglobin 
M.O.F. multiple organ failure 
M.P.A.P. mean pulmonary arterial blood pressure 
η number 
yA microampere 
wl microliter 
pm micrometer 
O2 oxygen 
02Hb oxyhemoglobin 
ρ probability value 
pA pi coampere 
P20 20 of the obtained values are lower or equal and 
80 PO2 values are higher than this value 
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the oxygen partial pressure corresponding to 50% 
saturation of hemoglobin 
70 of the obtained values are lower or equal and 
30 PO2 values are higher than this value 
90 of the obtained values are lower or equal and 
10 PO2 values are higher than this value 
oxygen partial pressure in arterial blood 
carbon dioxide partial pressure in arterial blood 
carbon dioxide partial pressure 
conjunctival oxygen tension 
pulmonary capillary wedge pressure 
positive end expiratory pressure 
negative logarithm of activity of H ions 
oxygen partial pressure 
platinum 
carbon dioxide partial pressure in mixed venous blood 
oxygen partial pressure in mixed venous blood 
pulmonary vascular resistance 
radius tissue cylinder 
1. radius capillary 
2. correlation coefficient 
right ventricular stroke work 
percent oxyhemoglobin saturation of arterial blood 
systolic arterial blood pressure 
standard deviation 
standard error of mean 
oxygen saturation of blood 
shock score 
systolic pulmonary arterial blood pressure 
stroke volume 
stroke volume index 
percent oxyhemoglobin saturation of mixed venous blood 
systemic vascular resistance 
time 
total hemoglobin concentration 
venous 
polarization voltage 
oxygen consumption 
GENERAL DISCUSSION AND SUMMARY 
Shock is a complex syndrome with a wide variety of etiologic 
events, and remains a frequent acute life-threatening condition. 
Clinically it has almost always been characterized by 
hypotension. However, the early common physiological denominators 
of shock are inadequate tissue perfusion and inadequate tissue 
oxygenation. Monitoring skeletal muscle PO- in patients might 
allow early detection of shock, as skeletal muscle PO-, measured 
with a Polarographie needle electrode, decreased early during 
experimental hemorrhagic and septic shock. 
The purpose of this study was to improve the technique of 
skeletal muscle P0_ assessment, to investigate the cause of the 
early decline of skeletal muscle PO- in septic shock, and to 
study the usefulness of skeletal muscle PO- assessment in 
patients with severe burns, in patients after extracorporeal 
circulation and in critically ill patients. 
In chapter 3 a series of improvements have been described, 
optimizing the skeletal muscle PO- assessment. The skeletal 
muscle P0_ assessment consists of 100 PO- measurements at 
different places in the skeletal muscle tissue. The skeletal 
muscle P0_ assessment is then described by the median of these 
values. Reduction of the interval between the PO- measurements 
enabled the measuring time to be reduced from 16 to 5 minutes. 
The improved skeletal muscle PO- assessment was first studied 
under physiological conditions. Skeletal muscle PO- correlated 
with important parameters of tissue oxygenation such as systemic 
arterio-venous oxygen difference, arterio-venous oxygen 
difference in the hindlimb, systemic oxygen extraction ratio, SO-
in the femoral vein, mixed venous SO- and blood lactate level. 
Skeletal muscle PO- was measured in 31 healthy humans, the 
skeletal muscle PO, ranged from 1.4 to 7.6 kPa, mean 4.2 kPa ±1.8 
SD. 
To investigate the cause of the early decline of skeletal 
muscle PO- in experimental E.Coli septic shock we studied a large 
number of flow and oxygen related parameters. 
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In chapter 4 the flow related variables are discussed. In early 
septic shock no selective decrease in blood flow to skeletal 
muscle was found. The decrease of skeletal muscle blood flow 
corresponded with the decrease in arterial blood pressure. A 
consistent fall in femoral arterial blood flow, as a parameter of 
skeletal muscle blood flow, was found, while renal arterial blood 
flow did not change at all and cardiac output, hepatic arterial 
blood flow and superior mesenteric arterial blood flow recovered 
after an initial decline. 
The most pronounced change was a decline of hepatic arterial 
blood flow by more than 80% within 3 minutes after the start of 
the E.Coli infusion. Since there was an early severe fall in 
leucocyte count, it is possible that aggregation of leucocytes is 
involved in the acute increase of hepatic arterial vascular 
resistance. It is concluded that, during E.Coli sepsis, 
redistribution of blood flow to the vital organs occurred at the 
cost of the blood flow to skeletal muscle. 
In chapter 5 the oxygen related variables in this experiment 
are discussed. The early decline in skeletal muscle POj was not 
caused by an increased affinity of hemoglobin for oxygen, nor by 
an increase of oxygen consumption, nor by a decrease of arterial 
oxygen content. The decline of skeletal muscle PO, could not 
solely be explained by a decreased arterial blood flow. Thus 
maldistribution of the microcirculation and/or impaired transport 
of oxygen from hemoglobin to the mitochondria are the remaining 
possibilities. 
The consistent finding in all experimental and clinical studies 
performed by others and by us, that tissue PO- decreases before 
cardio-respiratory parameters deteriorate, strongly suggests that 
the initiating event of septic shock is not a decreased oxygen 
supply to the tissue, but rather a disturbance in the 
microcirculation, possibly maldistribution of blood flow and/or 
impaired diffusion of oxygen to the mitochondria. 
In chapter 6 thirteen patients with severe burns (25-90% body 
surface area burned) are described. Skeletal muscle PO- was 
significantly lower prior to hypotensive episodes as compared to 
skeletal muscle PO, prior to episodes without hypotension. If 
skeletal muscle PO- was above 2.5 kPa no hypotension was observed 
during the subsequent 2-6 hours. 
In chapter 7 eight patients who underwent elective coronary 
bypass operation were studied. Significant changes in arterial 
blood pressure, arterio-venous oxygen difference, P50 of the 
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oxyhemoglobin dissocation curve and skeletal muscle PO, were 
found. The results show that during the first hours after 
extracorporeal circulation, changes in the microcirculation 
occurred which were not reflected in the generally measured 
cardio-respiratory parameters. 
In chapter 8 twenty critically ill patienta are described. If 
skeletal muscle PO- was more than 4 2 kPa, no shock occurred in 
the period from 4 hours before to 6 hours after the skeletal 
muscle PO- assessment. During the first two hours after the 
skeletal muscle P0_ assessment the risk of shock was 4.3 times 
higher if skeletal muscle PO- was below 3.0 kPa as compared to 
skeletal muscle P0_ values above 3.0 kPa, provided no motropes 
were administered. Skeletal muscle PO- reflected the severity of 
shock. It is demonstrated that treatment with motropes may 
correct hemodynamic variables but at the same time impairs 
skeletal muscle oxygenation. 
In chapter 9 the relationship between skeletal muscle PO-/ 
hemodynamic and oxygen related parameters was studied in six 
critically ill patients in whom more extensive monitoring was 
possible. A significant correlation was found between the 
skeletal muscle PO- and arterial SO-/ mixed venous SO- and 
arteno-venous oxygen difference. It is concluded that skeletal 
muscle PO- assessment indicates the balance between oxygen 
delivery and oxygen consumption in the skeletal muscle tissue in 
these critically ill patients. 
In chapter 10 the relationship between skeletal muscle PO- and 
multiple organ failure is described. Skeletal muscle PO- was 
significantly lower in patients with a M.O.F.-score of more than 
5 compared with patients with a M.O.F.-score of 5 or less. No 
relationship was found between skeletal muscle PO- and survival, 
but skeletal muscle PO- was measured for only a short period 
(16h) during the course of illness. This study demonstrates the 
role of tissue hypoxia m multiple organ failure as hypothesized 
by other authors. 
It is concluded that measuring skeletal muscle PO-/ as 
described in this thesis, is a valuable method to assess skeletal 
muscle oxygenation. Skeletal muscle PO- assessment enables to 
monitor patients at risk, to detect imminent shock, to assess the 
severity of shock and to evaluate the effects of therapy in a 
wide variety of experimental and clinical conditions. 
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ALGEMENE DISCUSSIE EN SAMENVATTING 
Shock is een acuut, levensbedreigend ziektebeeld dat kan worden 
veroorzaakt door bloedverlies, vochtverlies, sepsis, cardiale 
insufficientie en anafylaxie. Klinisch wordt shock bijna altijd 
gekenmerkt door een lage bloeddruk. In de vroege fase van shock 
hebben de bovengenoemde oorzaken een inadequate weefselperfusie 
en weefseloxygenatie gemeenschappelijk. 
Uit experimenteel onderzoek is gebleken dat de spier PO-, 
gemeten met een polarografische naaldelektrode, in een vroeg 
stadium daalt gedurende een zich ontwikkelende hemorrhagische of 
septische shock. Meting van de PO- in de spier bij patiënten zou 
een vroege herkenning van shock mogelijk kunnen maken. 
Het doel van de studie was om de techniek van de spier P0-
meting te verbeteren, de oorzaak van de vroege daling van de 
spier PO- in septische shock te bestuderen en de bruikbaarheid 
van de spier PO- schatting te onderzoeken bij patiënten met 
ernstige brandwonden, bij patiënten na een open hartoperatie en 
bij ernstig zieke patiënten. 
In hoofdstuk 3 worden een serie veranderingen beschreven, 
waardoor de spier PO- schatting werd verbeterd. De spier PO-
schatting bestaat uit 100 PO- metingen op verschillende plaatsen 
in de skeletspier. De spier PO- schatting wordt beschreven door 
de mediaan van deze PO- waarden. Door het interval tussen twee 
PO- metingen te reduceren kon de meetduur van een spier PO-
schatting worden bekort van 16 minuten tot 5 minuten. 
Deze verbeterde spier PO- schatting werd bij honden bestudeerd 
onder fysiologische omstandigheden. De spier PO- correleert met 
belangrijke parameters van weefseloxygenatie zoals het 
systemische arterio-veneus zuurstof verschil, het arterio-veneus 
zuurstof verschil van de achterpoot, de systemische zuurstof 
extractie, de zuurstof saturatie van de vena femoralis, de 
gemengd veneuze zuurstof saturatie en de lactaat spiegel van het 
bloed. 
155 
De spier PO, werd gemeten bij 31 gezonde mensen. De spier PO-
varieerde van 1.4 - 7.6 kPa. De gemiddelde spier PO, was 4.2 kPa 
+1.8 SD. 
Om de oorzaak van de vroege daling van de spier PO- in 
experimentele E.Coli sepsis te onderzoeken bestudeerden wij een 
maximaal aantal aan bloedstroom en zuurstof gerelateerde 
parameters. In hoofdstuk 4 worden de bloedstroom variabelen 
besproken. In de vroege fase van septische shock werd geen 
selectieve afname van de bloedtoevoer naar de skeletspier 
waargenomen. De daling van de bloedtoevoer komt overeen met de 
daling van de arteriele bloeddruk. De meest uitgesproken 
verandering is een daling van meer dan 80% van de bloedstroom in 
de arteria hepática binnen 3 minuten na de start van de E.Coli 
infusie. Deze vroege verandering is in de zelfde orde van grootte 
als de daling in het leucocyten aantal. Het is mogelijk dat 
aggregatie van leucocyten in het arterieel vaatbed van de lever 
de weerstand in het arteriele vaatbed dermate verhoogt dat ook de 
bloedstroom in de arteria hepática daalt. Er werd een 
voortdurende daling van de bloedstroom in de arteria femoralis 
gevonden, terwijl de bloedstroom in de arteria renalis 
onveranderd bleef en de cardiac output, de bloedstroom in de 
arteria hepática en de arteria mesenterica superior zich na een 
aanvankelijke daling herstelde. Uit deze bevindingen blijkt dat 
gedurende E.Coli sepsis er redistributie van het hartminuutvolume 
plaatsvindt om de bloedtoevoer naar de vitale organen te behouden 
ten koste van de bloedtoevoer naar de skeletspier. 
In hoofdstuk 5 worden de zuurstof gerelateerde variabelen in 
het E.Coli sepsis experiment besproken. De vroege daling van de 
skeletspier PO- wordt niet veroorzaakt door een toegenomen 
affiniteit van hemoglobine voor zuurstof, niet door een toename 
van de zuurstof consumptie en niet door een daling van de 
hoeveelheid zuurstof in het arteriele bloed. De daling van de 
skeletspier PO- kan dus niet alleen worden verklaard door een 
daling van de arteriele bloedtoevoer. Maldistributie van de 
microcirculatie en/of een afgenomen transport van zuurstof van 
het hemoglobine naar de mitochondrien, mogelijk door afgenomen 
diffusie van zuurstof door de weefsels, zijn de overige 
mogelijkheden. De consistente bevinding in de spaarzame 
experimentele en klinische onderzoeken hierover, dat de weefsel 
PO- daalt voor de veranderingen van de cardio-respiratoire 
parameters, suggereert in hoge mate dat de eerste gebeurtenis in 
septische shock niet een gestoorde zuurstof voorziening aan de 
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spier is, maar eerder een verstoring van de microcirculatie 
(maldistributie) of meer waarschijnlijk een afgenomen diffusie 
van zuurstof naar de mitochondrien. 
In hoofdstuk 6 worden dertien patiënten met ernstige 
brandwonden (25-90% verbrand huidoppervlak) beschreven. Voor een 
periode met hypotensie was de spier PO, significant lager dan 
voor een periode zonder hypotensie. Als de skeletspier PO, boven 
de 2.5 kPa was werd geen hypotensie waargenomen tot de volgende 
meting, variërend van 2 tot б uur. 
In hoofdstuk 7 worden acht patiënten besproken die een 
electieve coronair bypass operatie ondergingen. Significante 
veranderingen traden op in de arteriele bloeddruk, het 
arterio-veneus zuurstof verschil, de P50 van de zuurstof 
dissociatiecurve en de skeletspier PO-. De resultaten laten zien 
dat gedurende de eerste uren na extracorporale circulatie 
veranderingen in de microcirculatie optreden die niet worden 
gereflecteerd in de normaal gemeten cardio-respiratoire 
parameters. 
In hoofdstuk 8 worden 20 ernstig zieke patiënten beschreven. 
Als de skeletspier PO- boven 4.2 kPa was (het gemiddelde van de 
skeletspier PO- bij normale mensen) dan trad in de periode van 4 
uur voor tot б uur na de meting geen shock op. Indien de patient 
geen inotropica kreeg toegediend dan was de kans op shock 
aanzienlijk hoger indien de spier PO- onder de 3.0 kPa was. 
Het onderzoek toont aan dat de skeletspier PO- een goede 
indicatie geeft over de ernst van de shock. Het onderzoek toont 
aan dat door de behandeling met inotropica de hemodynamisehe 
variabelen worden gecorrigeerd, maar dat de spier PO- op 
hetzelfde tijdstip verlaagd is. 
In hoofdstuk 9 wordt de relatie besproken tussen spier PO- en 
hemodynamisehe en zuurstof gerelateerde parameters. Deze relatie 
werd onderzocht bij zes ernstig zieke patiënten bij wie een meer 
uitgebreide monitoring mogelijk was. Een significante correlatie 
werd gevonden tussen de skeletspier PO- en de arteriele zuurstof 
saturatie, de mixed veneuze zuurstof saturatie en het 
arterio-veneus zuurstof verschil. Bij deze ernstig zieke 
patiënten geeft de skeletspier PO- schatting een indicatie over 
de balans tussen de zuurstof aanvoer en de zuurstof consumptie in 
het skeletspierweefsel. 
In hoofdstuk 10 is de relatie tussen de skeletspier PO- en 
multiple organ failure (M.O.F.) beschreven. De skeletspier PO-
was significant lager in patiënten met een M.O.F.-score van meer 
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dan 5 in vergelijking met patiënten die een M.O.F.-score hadden 
van 5 of minder. Geen relatie werd gevonden tussen de skeletspier 
PO- en de overleving, maar de skeletspier PO- werd alleen 
gedurende een korte periode (16 uur) tijdens het ziektebeloop 
gemeten. Deze studie toont de rol van weefsel hypoxie in multiple 
organ failure, zoals verondersteld door andere auteurs. 
Met de huidige stand van zaken maakt de methode van de 
skeletspier PO- schatting, zoals beschreven in deze dissertatie, 
het mogelijk de zuurstof oxygenatie van de skeletspier te 
bepalen. Skeletspier PO- schatting is een waardevol instrument om 
risico patiënten te bewaken, om dreigende shock te ontdekken, om 
de ernst van de shock vast te stellen en om de effecten van 
therapie in een brede variëteit van experimentele en klinische 
omstandigheden te evalueren. 
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STELLINGEN 
behorende bij het proefschrift 
Skeletal muscle P0_ assessment during imminent shock 
- an experimental and clinical study -
1. Spier P0_ gemeten met de in dit proefschrift beschreven 
methode geeft de balans weer tussen zuurstof aanbod en 
zuurstof consumptie (dit proefschrift). 
2. De systemische hemodynamische veranderingen gedurende E.Coli 
sepsis zijn het resultaat van processen gelegen op het niveau 
van de microcirculatie, mogelijk geïnduceerd door geactiveerde 
leucocyten (dit proefschrift). 
3. De bepaling van de spier P0_ kan een dreigende shock onder-
kennen (dit proefschrift). 
4. De bepaling van de spier PO. geeft bij ernstig zieke patiënten 
de mate van shock weer (dit proefschrift). 
5. De toediening van inotropica bij de behandeling van shock 
herstelt de bloeddruk maar niet de perifere circulatie. 
6. Als de patient een spier PO- heeft van meer dan 4.2 kPa dan is 
de cardio-pulmonale status van deze patient optimaal. 
7. Bij patiënten met een IUD (=intra uterine device), die klagen 
over irregulaire bloeding en buikpijn, dient men steeds bedacht 
te zijn op de mogelijkheid van een extrauteriene graviditeit. 
8. Bij de automatisering van patiënten gegevens dient de naam en 
de gegevens van de patient gescheiden te worden om de privacy 
van de patient beter te waarborgen. 
9. Een leucocyt is als de kop van Janus. 
10. Het bepalen van plasma elastase concentraties bij trauma-
patiënten kan van belang zijn bij het beoordelen van de 
ernst van het trauma, het risico voor het ontwikkelen van 
een "ARDS" en de ernst van een eventueel aanwezig "Multiple 
Organ Failure" (J.K.S.Nuytinck, et al. Arch Surg 121:886 -
890, 1986). 
11. Bij patiënten, ouder dan 60 jaar, met een bloeding uit de 
bovenste tractus gastrointestinalis is een aggressieve 
chirurgische behandeling te prefereren. 
(Morris DL, et al. Br Med J 288:1277-1280, 1984). 
12. De gezondheidszorg dient geen grootwinkelbedrijf te zijn. 
13. Automatisering in het ziekenhuis kan een belangrijke bijdrage 
leveren aan wetenschappelijk onderzoek en continue kwaliteits-
bewaking van de patiëntenzorg. 
14. De chirurgische patient op de intensive care afdeling is 
gebaat bij een gezamenlijke verantwoordelijkheid voor de 
behandeling van zowel de chirurg als de intensivist. 
15. Het vereist stuurmanskunst om op woelige wateren een voor de 
wind gaand schip op de juiste koers te houden. 
Nijmegen, 12 juni 1987. 
G.I.J.M.Beerthuizen. 


